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ABSTRACT 
Problem: Childhood and older adulthood represent critical periods for changes in body 
composition. Acquisition of excess body fat and loss of lean mass are linked with 
numerous co-morbidities and disabilities. This study explores the role of dietary protein 
as a modifiable determinant of body composition at different ages. 
Methods: Prospective data from two studies were used: 9-10 year-old girls (n=2330) 
followed for 10 years in the National Growth and Health Study and middle-aged/older 
adults (n=1490) followed up to 8 years in the Framingham Offspring Study. Diet was 
assessed using 3-day records. Body composition was assessed using body mass index 
(BMI), waist size (an anthropometric estimate of central adiposity), and bioelectrical 
impedance to estimate skeletal muscle mass (SMM) and percent body fat (%BF). 
Sarcopenia was defined as two SDs below mean SMM from young referent population. 
To avoid confounding of dietary protein by baseline weight, intake was expressed in two 
ways: per kilogram (kg) of nearest ideal body weight (IBW) and weight-adjusted protein 
residuals. 
lV 
Results: After adjusting for age, sex, height, socio-economic status, activity, smoking, 
energy intake, percent energy from fat and carbohydrates, increasing quintiles of protein 
intake (using weight-adjusted residuals) during early/mid-adolescence led to significantly 
lower %BF, BMI, and waist (p:<0.0001, 0.0003, 0.0025 respectively). With increasing 
quintiles of dietary protein, SMM increased linearly (p-trend: <0.0001). In older adults, 
higher total, animal, and plant protein intakes led to statistically significant 30%, 19%, 
and 37% reductions in risk of central adiposity, respectively. Risk of obesity was reduced 
by 35% (95% CI: 0.43-1.00), 21% (95% CI: 0.55-1.15) and 37% (95% CI: 0.42-0.97), 
respectively. Higher protein intakes led to nearly a 50% statistically significant reduction 
in risk of sarcopenia compared to the lowest tertile. Similar decreases in risk of obesity, 
central adiposity, and sarcopenia were observed with the clinically relevant measure of 
protein/kg IBW. 
Conclusion: Adolescent girls consuming more protein had a lower BMI and waist size 
and more SMM by late adolescence. Older adults consuming more protein had lower 
levels of body fat and a lower risk of developing sarcopenia over 8 years. 
v 
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CHAPTER 1: INTRODUCTION 
Childhood and older adulthood represent critical periods for changes in body 
composition. During childhood and adolescence, the acquisition of too much body fat or 
too little lean mass has lifelong adverse consequences. Amongst older adults, excess body 
fat and loss of lean mass is frequently linked with numerous co-morbidities and 
disabilities. The prevalence of overweight and obesity amongst children and adults has 
increased dramatically over the past several decades. Data from multiple NHANES 
periods has shown marked increases in rates of disability for all but the oldest Americans 
and these rates are highest among the overweight and obese.' Data from the 2007-2008 
National Health and Nutrition Examination Survey indicates that 16.9% of children and 
adolescents are obese with a BMI greater than the 95th percentile on the BMI-for-age 
growth charts while 31.7% were at or above the 85th percentile of BMI for age.2 
Similarly it is estimated that the prevalence of obesity in the elderly has increased from 
32% in 2000 to 3 7% in 2010 in men and women 60 years of age and older. 3;4 
1.1 Consequences of childhood obesity 
Substantial consequences to physical and mental health, both short and long term, are 
related to obesity during childhood. In the Fels Longitudinal Study, childhood was a 
strong predictor of overweight and obesity at age 35.5 Being overweight or obese from 
14 to 19 years of age is associated with a higher risk of premature adult mortality from 
chronic diseases. 6 Metabolic consequences of obesity may be already evident in young 
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children. Almost half of children with BMI higher than the 97th percentile have at least 
one component of the metabolic syndrome. 7 High childhood and adolescent BMI is also 
associated with increased risk of cardiovascular disease in adulthood. 8 Therefore, 
childhood obesity impacts obesity risk and other co-morbidities later in life and warrants 
the need for early intervention. 
1.2 Consequences of adult obesity 
The adverse effects of obesity carry over from childhood into adulthood. Obesity is a 
strong predictor for poor health, reduced functional capacity and quality of life in older 
individuals. Obesity is clearly related to several diseases including diabetes mellitus, 
hypertension, dyslipidemia, coronary artery disease 'and congestive heart failure. 9;10 
Additionally, an independent association between obesity and all-cause mortality has 
been demonstrated in adults. 11 
The prevalence of overweight and obesity is increasing among older age groups in both 
sexes, all ages, all races, all educational levels, both smokers and nonsmokers. 12;13 Cross-
sectional and longitudinal studies have shown that body composition changes with aging, 
with an increase in fat mass and a decrease in muscle mass. 14"16 Even without body 
weight changes, the amount of fat significantly increases with age. 17 18 Given the current 
increased prevalence of obesity with aging, as well as an increasing prevalence of older-
aged individuals, the problem of obesity in the older adults is becoming of greater 
relevance and requires more attention. 
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1.3 Changes in body fat and lean mass from childhood to adulthood 
Skeletal muscle mass is a large and important body-composition compartment that 
increases throughout childhood and adolescence. During the preschool years, body fat 
declines during the period nadir at ages 5-7 years. At this point of so-called adiposity 
rebound, fat-free mass increases in an age-dependent manner. During childhood and 
adolescent growth, children acquire both skeletal muscle mass and body fat in 
proportions that then to persist into adulthood. As Figure 1.1 demonstrates, some of the 
variation in muscle mass and muscle strength with aging can partly be explained by the 
peak muscle mass attained in early life. Observational studies have demonstrated that 
muscle mass and strength are highest from 20-40 years of age and then progressively 
19'20 decline. ' 
Figure 1.1 Age-related changes in muscle mass and strength 
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Associations between early growth and adult health have been explained by 
programming, which is the influence of exposures occurring at critical periods of early 
development on long-ferm organ structure, function, and regulation.21 Research into the 
etiology of suboptimal lean mass has focused on the adult determinants of muscle loss in 
older people. However, factors operating earlier in life to determine peak muscle mass 
and strength, and subsequent rate of loss, have been largely overlooked. A better 
understanding of the determinants of muscle mass and muscle strength during growth in 
childhood and adolescence may contribute to the development of strategies to slow down the 
loss of muscle loss that occurs with aging. 
1.4 The risk of sarcopenia increases with age 
The loss of muscle mass that occurs with aging is a process called sarcopenia,22 and is 
associated to an increased risk of physical functional decline and disability as well as to 
an increase in morbidity and mortality.23 The risk of sarcopenia increases with age?4 The 
development of sarcopenia can be attributed to several factors including lifestyle and 
genetics. Poor diet, smoking, physical inactivity, age-related hormone and cytokine 
changes are all proposed risk factors. 25 Plausible mechanisms leading to sarcopenia 
include age-related declines in alpha-motor neurons, growth hormone production, sex 
steroid levels, and alterations in muscle protein turnover, muscle tissue remodeling and 
• 22 
apoptOSlS. 
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Sarcopenia plays an important role in the pathogenesis of frailty and associated 
morbidity, disability and mortality_26;27 Epidemiological studies have demonstrated 
associations between low skeletal muscle mass and increased risk of physical disability, 
functional impairments, and low physical performance, as well as decreased muscular 
strength and endurance. 28-30 The large influence of sarcopenia on disability and associated 
morbidity warrants the search for interventions to prevent or delay the progression of the 
disease. 
While sarcopenia impairs quality of life in the elderly, the impact of obesity in the setting 
of sarcopenia is likely to exacerbate these problems. In normal aging, not only does 
muscle loss occur but also fat gain occurs over decades.31 -33 Most previous research has 
focused separately on the role of each one of these body composition changes on 
disability.34;35 However, it may be possible that the loss in muscle and the gain in fat act 
synergistically to cause disability or metabolic disorders. Subjects classified as having 
sarcopenic obesity showed significantly lower grip strength per kilogram body weight, 
independently of age, ethnicity, smoking and other co-morbidities, and had a greater 
· increase in the risk of functional impairment, disability and falls compared to that 
observed separately both in obese and sarcopenic elderly men and women.28 Only a few 
studies, however, have examined the joint effect of sarcopenia and obesity on disability. 
1.5 Dietary protein as a strategy to preserve body composition 
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Given the increasing prevalence of obesity in all age groups and sarcopenia in older 
adults, interventions to prevent or delay the progression of these disorders are needed. 
Multiple dietary strategies aiming at reducing body weight and preventing muscle loss 
have been proposed and high dietary protein has attracted considerable attention as a 
possible weight management aid in recent years. 
The protective effect of protein on body composition can partly be explained by the 
satiating effect of dietary protein. Protein increases satiety to a greater extent than 
carbohydrates or fat, and high-protein meals induce a greater acute appetite suppressive 
effect than low-protein meals.36 Protein-induced satiety might be mediated by gut 
neuropeptides and insulin secretion. Milk proteins have been suggested to stimulate GLP-
1 release,37 while the involvement of CCK in acute protein-induced satiety may be dose-
dependent. 38 Postprandial insulin response is thought to be an important satiety signal and 
when ingested alone, proteins elicit insulin secretion. 39 High-protein diets have also been 
shown to improve insulin sensitivity.40 High-protein intake also stimulates protein 
synthesis, accelerates protein turnover, and induces a small suppression of muscle protein 
breakdown.41 This subsequent greater lean body mass, especially muscle mass, is 
associated with higher energy expenditure. 
Apart from their effect on obesity, dietary protein and amino acid intakes affect the rate 
of muscle synthesis. Eighty percent (80%) of the stimulatory effect on protein synthesis 
observed after a meal can be attributed to amino acids, which play a role in protein 
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breakdown as well as protein synthesis. Several studies have demonstrated an acute 
increase in muscle protein synthesis with no compensatory change in muscle protein 
breakdown after protein ingestion42;43 or amino acid ingestion44;45 in both young and 
elderly individuals. Insufficient or ineffective protein intake in elderly individuals may 
facilitate the loss of muscle by blunting muscle protein synthesis and thus promoting net 
1 . b 1" 46'47 muse e protem cata o 1sm. · 
In addition to the quantity of protein ingested, there appear to be subtle inherent 
differences in the ability of different protein sources to promote muscle protein synthesis. 
The most · important difference is the essential amino acid content of a protein, in 
particular leucine, which serves as the primary determinant of its anabolic potential.48 Rat 
studies show that leucine can directly stimulate muscle protein synthesis through 
increasing messenger ribonucleic acid translation and thus global protein synthesis.49 
Thus, amino acids (especially leucine) and insulin are anabolic stimuli for muscle and 
share a common pathway of action via activation of a kinase known as mTOR.50 Because 
insulin sensitivity decreases with age, one possible mechanism by which amino acids 
might improve muscle mass is by providing another anabolic stimulus to activate the 
mTOR-controlled pathway. Increasing dietary protein is also known to increase 
circulating levels of insulin-like growth factor 1 (IGF-1), and conversely, a low-protein 
diet decreases IGF-1. 51 
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Therefore adequate dietary protein is an essential element of a healthy diet, supporting 
the growth of muscle mass and protecting against excess body fat. 
1.5 .1 Current protein requirements are insufficient for children and older adults 
The dietary protein requirement is the amount of protein or its constituent amino acids 
that must be supplied in the diet in order to satisfy the metabolic demands of the body 
and to achieve nitrogen equilibrium. The recommended dietary allowance (RDA) for 
protein and AA for all men and women (19 years and older) is a daily minimum intake of 
0.80 grams of protein per kg of body weight according to the American Food and 
Nutrition board.52 It is the level set at the minimal protein intake to assure growth in 97% 
of people. 52 . An intake up to 2.5 g/kg/day is considered acceptable and no upper limit has 
been identified. 
The determination of RDA for protein is based on the nitrogen (N) balance technique (N 
ingested/ N excreted). Nitrogen balance is the difference between nitrogen intake and the 
amount excreted in urine, feces, skin, and miscellaneous losses. Nitrogen balance remains 
the only method that has generated sufficient data for the determination of the total 
protein requirement. It is assumed that when needs are met or exceeded adults come into 
nitrogen balance; when intakes are inadequate, negative nitrogen balance results. In 
determining total protein (nitrogen) needs, high-quality proteins are utilized as test 
proteins to prevent negative nitrogen balance resulting from the inadequate intake of a 
limiting indispensable amino acid. 52 
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The level is set at the minimum intake of essential amino acids (EAA) needed to assure 
growth in 97% of people. 52 However, protein requirements, whether for young children, 
adolescents, adults, or the elderly have all for the most part been based on the same 
technique. Indeed, some advocate higher protein recommendations than the minimal 
requirement, because benefits of have been recognized for optimal muscle and bone 
health, and prevention of sarcoperiia, type 2 diabetes, cardiovascular disease, and obesity. 
Estimating protein requirements presents a problem in that individuals vary in their 
demand for and utilization of protein provided by food. For instance children and 
adolescent body composition changes and growth rates must be taken into account to 
estimate additional requirements for dietary protein that would satisfy the structural and 
metabolic demands of the body. A concern about the broad scope of the of the current 
protein recommendation is that the original data set used for the estimate was derived 
from nitrogen balance studies performed on young men. Although nitrogen balance 
studied may be appropriate for establishing the nitrogen or amino acid requirements to 
prevent deficiency, the question of whether they are an appropriate means of establishing 
optimal intakes for maintenance of muscle mass, strength, and metabolic function 
remains. 
1.5.2 Studies on dietary protein in late childhood and adolescence are sparse 
9 
The scientific literature is essentially void of studies directed specifically at quantifying 
protein needs of healthy children between 8 and 12 years of age. 53 ;54 Current 
recommendations for daily protein intakes in this population remain speculative given 
that allowances are basically estimates derived from interpolation of requirements 
determined for young adults and infants yet children have distinct nutritional needs 
relative to growth. Although there have been a number of published studies of children's 
protein requirements employing the nitrogen balance technique, the results of these 
studies in themselves are insufficient to derive requirement values for all ages. Instead, a 
meta-analysis of the data from a range of studies in children has been used to derive 
values for the requirement for maintenance (i.e., no growth) and for the efficiency of 
utilization of dietary protein for growth. For children, protein allowances were 
traditionally considered to be the amount of protein needed for sustaining positive 
nitrogen balance and therefore growth. 52-54 In recent years, the potential impact of dietary 
on outcomes other than growth (i.e., immune function, behavior) has led to a more 
critical evaluation of protein requirements for children have been recommended yet have 
not been adapted for making recommendations. 53;55 
Prospective data on the effect of dietary protein on obesity in late childhood and 
adolescence are sparse. Most studies have focused on protein intake in the first months of 
life and the subsequent risk of obesity. 56-59 The early protein hypothesis suggests high 
protein intake during infancy predisposes individuals to later obesity by adverse 
hormonal responses.60 The proposed mechanism is that a high protein intake stimulates 
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secretion of insulin-like growth factor I (IGF-I) and thereby triggers precocious cell 
multiplication and accelerates maturation. Increased IGF-I concentrations may then 
accelerate growth and increase adipose tissue as well as muscle mass, thereby inducing 
an early adiposity rebound. An early adiposity rebound is associated with an elevated risk 
of obesity later in childhood and possibly also in adulthood.61 -63 A study in the United 
Kingdom did not fmd an effect of early protein intake on the timing of adiposity 
rebound.64 
The protein-adiposity hypothesis has been examined in a few observational studies. Two 
studies found that a high protein intake early in life is associated with elevated BMI at 8 
and 5 years of age, respectively.60;65 It has been suggested that formula feeding during 
infancy (which was used in these studies to provide higher protein intakes) rather than 
breast feeding may lead to a host of bio-behavioral changes that impact food intake and 
subsequent obesity risk. In addition, the dietary protein content in some of these studies 
was quite high (20% of energy).65 
The Early Nutrition Programming Project, funded by the European Union, is also 
investigating the link between nutrition in earliest childhood and health outcomes later in 
life. It includes a randomized comparison between the growth rates of infants who were 
fed a normal high-protein infant formula with infants fed a low-protein formula during 
their first year of life. Early results showed that infants on the low-protein formula had 
slower growth rates, and had a significantly lower BMI by 2 years of age than infants on 
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the high-protein formula. 66 However, further follow-up and measures of body 
composition in the above ongoing study are needed to assess the relative effect of lower 
protein intake during infancy on lean versus fat body mass. 
Given the current state of evidence, while some studies have looked at the effects protein 
intake on early childhood obesity, the extent to which dietary protein affects obesity risk 
in late childhood and adolescence remains unclear and needs further investigation. 
Furthermore, as mentioned above, current recommendations for daily protein intakes in 
this population have been extrapolated from those of young adults and infants yet 
children have distinct nutritional needs relative to growth 
1.5.3 Older adults may require higher dietary protein for optimal muscle mass 
The current Recommended Dietary Allowance for protein (.8 g/kg/day) for men and 
women 19 years of age and older is based on nitrogen balance studies in young healthy 
adults. 67;68 Hence, some argue that these nutritional recommendations do not protect 
against sarcopenic muscle loss.69-71 Over the past 30 years, a small number of short-term 
nitrogen-balance experiments have been conducted to estimate the protein needs of older 
adults. The results of these studies are mixed and inconclusive, some supporting that the 
current RDA is adequate, whereas others indicating that higher intakes are needed to 
meet the dietary needs of virtually all healthy older adults. However, nitrogen-balance 
studies have not addressed the possibility that protein intake well above the RDA could 
prove beneficial in healthy older individuals. 
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The well-known limitations of using nitrogen balance studies to determine protein 
requirements are discussed in the 10M report. 52 Some are practical limitations, but others 
are methodological limitations that probably result in an underestimation of true protein 
requirements. There are well-known limitations of using nitrogen balance studies to 
determine protein requirements in older adults. Urea turnover in adults is slow, so several 
days of adaptation are needed to reach a new steady state. Studies employing nitrogen 
balance need to include a long adaptation time, which is often overlooked. Second, the 
measurement of nitrogen intake and excretion is difficult where intake is frequently 
overestimated and excretion is frequently underestimated. Finally, dermal and 
miscellaneous nitrogen losses are typically estimated and can vary greatly based on 
environmental conditions. 
The majority of nitrogen balance studies used low levels of protein intake, which 
produced a negative nitrogen balance. The protein level required to reach zero balance 
was then extrapolated by plotting nitrogen balance against protein intake. Because 
adaptation occurs during low protein intake, and the efficiency of nitrogen use declines as 
zero nitrogen balance is approached, extrapolating to zero balance would probably result 
in an underestimation of the true requirement. In a study designed to examine nitrogen 
balance in older women consuming three levels of dietary protein for three weeks, 
nitrogen balance had still not reached steady state by three weeks, and the authors 
concluded that protein needs for elderly women were at or above the current RDA. 
13 
Additionally, the relationship between nitrogen intake and balance is not likely to be 
linear, but linear interpolation had to be used in the 10M meta-analysis because the 
published studies do not include enough data points on each individual. Furthermore, the 
majority of the nitrogen balance studies used for the IOM meta-analysis were conducted 
on younger men, and it is tenuous to extrapolate those results to older men and women. 
Although protein synthesis and consequently, skeletal muscle mass are regulated by 
many factors, dietary derived amino acids are an elemental prerequisite for muscle 
protein synthesis and protein supplementation is being explored in the prevention of 
sarcopenia. 72;73 A combined analysis of several key nitrogen balance studies in aging 
populations (56-80 years of age) has indicated greater protein needs for the elderly (1.14 
g/kg/day) relative to the young (0.8 g/kg/day).74 It is estimated that 50% of the elderly 
consume less than the recommended daily allowance (RDA) of 0.8 g/kg/day. 
Furthermore, older individuals whose consumption levels approach the RDA are at 
greater risk for disease than those consuming more than 1.2 g/kg/day of protein.75 A 14-
week study assessing the effects of consuming the RDA for protein in older individuals 
indicated that nitrogen excretion continually decreased from weeks 2 to 14 (21 %), 
suggesting subjects had not yet reached a steady state. 76 There is some evidence that the 
synthetic response to amino acid intake may be blunted in older people, particularly at 
low intakes, 72 and when protein is consumed together with carbohydrate. 77 
Recommended protein intakes may, therefore, need to be raised in older people in order 
to maintain nitrogen balance and to protect them from sarcopenic muscle loss. While 
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there is no consensus on the degree to which dietary protein requirements change in older 
age, in the US Health, Aging and Body Composition Study, a greater loss of lean mass 
over three years, assessed using dual-energy X-ray absorptiometry (DXA), was found 
among older community-dwelling men and women who had low protein intakes at 
baseline.78 Subjects in the highest quartile of protein intake lost 40% less lean mass over 
the follow-up period when compared with those in lowest. 
There is some evidence that suggests that in older populations, there are changes in 
protein turnover favoring protein breakdown.79-82 When given 6.7 grams of essential 
amino acids, the protein synthesis response in the elderly was attenuated compared to 
younger adults. 79 ;80 This decrease in protein synthesis may be partly responsible by 
decreased sensitivity to leucine. When given a leucine-enriched bolus of essential amino 
acids to the same population, protein synthesis increased. 80 This can also be explained by 
a decrease in mTOR and an increase in negative regulators such as AMPK of the mTOR 
pathway. 83 Moreover, older adults may also have elevated rates of protein breakdown 
relative to younger adults. 81 This may be due to greater expression of ubiquitin-
proteasome-proteolytic pathway which is primarily responsible for the degradation of 
skeletal muscle protein. 84 
Therefore, higher dietary protein intakes have been associated with improved muscle 
mass in older adults. Moreover, older adults may have increased rates of protein 
degradation and decreased protein synthesis. The current RDA may not be adequate to 
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protect against muscle loss due to sarcopenia. Further study is needed on the association 
between intakes of dietary protein intake and body composition in older adults. 
1.5 .4 Dietary protein quality may affect the rate of protein synthesis 
Protein quality or protein intake from distinct food groups may also impact body 
composition in children and older adults. The quality of protein is defined as the capacity 
of the protein source to deliver essential amino acids to the individual. Protein rich foods 
from various sources differ in their protein content, amino acid composition, and protein 
digestibility. To be well-incorporated into new proteins, the overall composition of the 
dietary supply of protein must replicate the essential amino acid composition of the body 
protein being synthesis such as skeletal muscle proteins.85 A protein supply that is 
deficient in essential amino acids limits the protein synthesis process due to the lack of 
available substrate. 
Animal proteins from sources such as meat, poultry, fish, eggs, milk, cheese, and yogurt 
are considered high quality proteins because they contain all nine essential amino acids 
that can be readily used for protein synthesis. Plant proteins from legumes, grains, nuts, 
seeds and vegetables, however, are deficient or low in essential amino acids, especially 
lysine. 52 Lean protein-rich foods from animal sources provide a higher protein/energy 
ratio than plant sources. 86 Strict plant-based diets are shown to be associated with less 
daily protein intake than omnivorous diets.87 Additionally, branched-chain amino acids 
are largely transferred to the periphery when digested where they are available for protein 
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synthesis. 88 Leucine, an essential amino acid, is also recognized as a potent stimulator of 
muscle protein synthesis. 89 
Given the differing protein content and amino acid composition of food groups, it is 
important to determine the impact of protein quality on obesity risk in adolescence into 
adulthood and sarcopenia in older adults. Moreover, efficient dietary provision of protein, 
amino acids and nitrogen to meet basal demands in an individual will occur only when 
demands for energy and all other nutrients for normal cellular and tissue function are met. 
There are complex responses of protein and amino acid metabolism to alterations in 
dietary intakes of other nutrients. Protein-rich foods are frequently linked with less 
healthy eating patterns. However, the intake of these protein-rich foods in the context of 
healthy eating patterns has seldom been examined. Protein source foods vary widely in 
their macro- and micronutrient composition. Foods containing the most fat, saturated fat 
and cholesterol were thought to be largely responsible for the epidemic of cardiovascular 
disease in America. The emphasis on reducing intakes of these nutrients led to a targeting 
of many protein-rich foods and to the labeling of them as foods to avoid. Ironically, the 
resulting dietary changes may have led in part to a transition to the consumption of large 
amounts of energy-dense, nutrient poor foods. The careful examination of the role of 
dietary protein in a healthy diet is one important area of renewed focus. We plan to 
explore the consumption of protein in combination with other individual food groups 
typically associated with a healthy diet (e.g., whole grains, total fruits and vegetables, 
dairy). The protein quality analyses will focus on DASH-related food groups that include 
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fruit, vegetables, combined FV, dairy, whole grains, lean meats (including lean red meat, 
poultry and fish), and nuts, seeds and legumes. We will estimate the daily intake of 
protein-rich MyPyramid90 meat and dairy groups including, including red meat, poultry, 
fish/seafood, eggs, milk, cheese, and yogurt. Servings of plant-based foods of interest 
here include whole grains, soy and other legumes, nuts and seeds. 
1.5.5 Dietary protein can be measured in several ways 
Most studies on the effect of protein on various outcomes have so far concentrated on 
total protein intake. Yet, there are several ways to measure/express protein intake. These 
include total grams of dietary protein intake per day, total grams of dietary protein intake 
per kilogram of actual body weight, total grams of dietary protein intake per kilograms of 
ideal body weight, total grams of protein per kilogram of lean body mass, and weight-
adjusted protein residuals (total grams of protein uncorrelated with body weight). 
Protein requirements depend upon several factors including body weight, body 
composition, particularly lean mass and weight, rate of growth, physical activity level, 
type of physical activity, adequacy of energy and carbohydrate intake, and illness or 
injury. Therefore, expressing protein intake as total grams does not take into account the 
body weight of an individual leading to recommendations that are the same for 
underweight, normal weight, and overweight individuals. The RDA for protein is 
expressed as protein per kilogram of body weight according to the American Food and 
Nutrition Board. 52 These protein recommendations vary as a function of body weight. In 
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already obese individuals, there is an excess of body fat. However, do obese adults need 
protein in proportion to the amount of body fat? We hypothesize that the disproportionate 
excess of body fat does not need higher protein. Rather, the protein is supporting the lean 
tissue and the metabolic functions of the body. If an obese individual were advised to 
consume protein in proportion to total body weight, it is very possible that this would 
lead to excessive caloric intake. Ideally, we are interested in the amount of protein intake 
in the diet that the individual should consume if they were not overweight. This is the 
reasoning behind using total grams of dietary protein per kilogram of ideal body weight 
as a measure for protein intake.91 . In 2000, the Centers for Disease Control and 
Prevention (CDC) published age- and gender-specific BMI percentile growth curves for 
youth from 2 to 20 years of age. 92 Children below the 51h BMI percentile for age and sex 
are considered underweight. Children between the 85th and 94th age- and gender-specific 
BMI percentile are considered overweight and those at or above the 95th percentile are 
considered obese.93 Therefore, in order to calculate ideal body weight during childhood, 
for children whose weights are less than the 5th percentile for BMI for age, ideal body 
weight are adjusted to 5% of BMI for age. For children whose weights are greater than 
the 85th percentile for BMI for age, ideal body weight is adjusted to the corresponding 
BMI for age at the 84.9 percentile. For adults who are overweight/obese, body weights 
are adjusted to a body mass index (BMI) of 24.9 kg/m2 and for adults who were 
underweight, body weights were adjusted to a BMI of 18.5 kg/m2. 
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Similarly, the weight-adjusted residual method provides a measure of protein intake that 
is uncorrelated with body weight.94 Owing to the high inter-correlation of dietary protein 
intake with body weight, adjustment for body size reduces the variation in dietary protein 
intake resulting from differences in body size. In other words, the procedure is analogous 
to an animal study in which body weight is held constant and only the dietary protein is 
varied between the subjects. Weight-adjusted protein intake is computed as the residuals 
(g) from a linear regression model with weight (kg) as the independent variable and 
absolute protein intake (g) as the dependent variable as demonstrated in Figure 1.2. 
Weight-adjusted protein intake is equal to a+b where a is the residual for a particular 
subject and b is the expected protein intake for a subject with mean weight. A positive 
residual represents a higher than expected protein intake for a mean weight, while a 
negative residual represent a lower than expected protein intake for a mean weight. The 
weight-adjusted residual method provides a measure of dietary protein that is 
independent of weight. In Figure 1.3, the protein residuals (g) adjusted for weight are 
plotted with weight (kg) for adolescent girls. The correlation between the weight-
adjusted residuals and weight was 0.00029 suggesting that the residual method indeed 
provides a measure of dietary protein independent of weight. Similarly, in Figure 1.4, 
residuals adjusted for weight (g) in older adults was also uncorrelated with weight 
(correlation= -0.00968). Therefore, we will present protein intake using only those 
exposures that adjust for body weight: ideal body weight and weight-adjusted protein 
residuals. 
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Figure 1.2 Weight-adjusted protein intake 
Mean w eight 
Weight (kg) 
*Figure modified from Willet and colleagues94 
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Figure 1.3 Weight-adjusted protein residuals by weight in adolescent girls 
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Figure 1.4 Weight-adjusted protein residuals by weight in older-adults 
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1.6 Summary 
Childhood and older adulthood represent critical periods for changes m body 
composition. The acquisition of too much body fat or suboptimal muscle mass has 
lifelong adverse consequences. Dietary protein has been implicated as a strategy to 
reduce body weight and prevent muscle loss. Current protein requirements, however, may 
not be sufficient for obesity risk in children and older adults and sarcopenic risk in older 
adults. This study will determine the effects of amount and quality of dietary protein 
using different measures of protein intake on obesity and lean mass in children and 
adults. In this regard, nutritional recommendations regarding protein intake will be more 
specific to individuals within two critical age periods- adolescence and older age. 
The objectives of this dissertation are to use body composition data from 10 years in 
NGHS to quantify the longitudinal effects of different meas:ures of amount and quality of 
dietary protein on adolescent body composition. I will also use data from the 
Framingham Offspring Study to quantify the relationship between different measures of 
the amount and quality of dietary protein intake and risk of sarcopenia and obesity in 
middle-aged and older adults. I will also measure the long-term effects of dietary protein 
intake on age-related changes in functional limitations/disability in this population. 
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CHAPTER 2: The Effect of Protein on Childhood and Adolescent Body Composition 
2.1 BACKGROUND 
Childhood obesity is closely associated with adult obesity and related conditions 
including hypertension, high cholesterol and triglycerides, the metabolic syndrome, 
cardiovascular disease, type 2 diabetes as well as some cancers. 95 ;96 The prevalence of 
overweight and obesity amongst children has increased dramatically over the past several 
decades.97-99 Recent data from the 2007-2008 National Health and Nutrition Examination 
Survey indicates that 16.9% of children and adolescents are obese with a BMI greater 
than the 95th percentile on the BMI-for-age growth charts while 31.7% were at or above 
the 85th percentile of BMI for age.Z Additionally, adolescence is a critical period for the 
acquisition of skeletal muscle mass along with body fat. A number of epidemiologic 
studies have shown that men and women who had suboptimal lean mass in early life have 
lower adult muscle mass and strength independent of adult size. 100-103 
Dietary factors during childhood and adolescence are increasingly recognized as critical 
risk factors for adult disease, including obesity. Dietary protein as a potential determinant 
of body composition is of particular interest, in part due to its purported satiating 
effects. 36;37 High-protein intake also stimulates muscle protein synthesis, accelerates 
protein turnover, and induces a small suppression of muscle protein breakdown.41 This 
subsequent greater lean body mass, especially muscle mass, is associated with higher 
energy expenditure. 
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Prospective data on the effect of dietary protein on obesity in late childhood and 
adolescence are sparse. Several studies demonstrate high protein intake in the first 
months of life increase the risk of subsequent obesity.56-59 The "early protein hypothesis" 
suggests high protein intake from infant formula (as opposed to breast feeding) 
predisposes individuals to later obesity by adverse hormonal responses. 60;104 as well as 
behavioral programming. For infants, the unique composition of human breast milk 
protects against early excessive growth66. However, the scientific literature is essentially 
void of studies directed at quantifying the subsequent protein needs of healthy children 
and adolescents. 53 ;54 Children have distinct nutritional needs relative to growth and yet 
the current recommendations for protein intakes in this population are speculative and 
based on estimates derived by interpolating from the requirements for young adults and 
infants. 
There are also several ways to express protein intake. Most studies on the effect of 
protein in childhood have concentrated on total protein intake while the RDA for protein 
is expressed as protein per kilogram of body weight. 52 These protein requirements vary as 
a function of body weight. In already obese individuals, there is an excess of body fat. 
We hypothesize that the disproportionate excessive body fat in the obese does not have 
the same protein requirements and consuming protein in proportion to total body weight 
in this situation may lead to the consumption of too many calories, thereby further 
promoting obesity. An alternative measure of dietary protein that has been recommended 
25 
by some is intake "per kilogram of ideal body weight.'m Similarly, the weight-adjusted 
residual method provides a measure of protein intake that is uncorrelated with body 
weight.94 
Along with the quantity of protein, protein intake from various protein food sources may 
impact later obesity risk. Protein rich foods from various sources differ in their protein 
content, amino acid composition, and protein digestibility. Given the differing protein 
content and amino acid composition of food, it is important to determine the impact of 
protein food sources on the acquisition of fat and lean body mass during adolescence. 
Additionally, there are complex responses of protein and amino acid metabolism to 
alterations in dietary intakes of other nutrients. Protein-rich foods are frequently linked 
. with less healthy eating patterns. However, the intake of these protein-rich foods in the 
context ofhealthy eating patterns lias seldom been examined. 105 
To further explore the impact of dietary protein on obesity in children and adolescents, 
we will measure the longitudinal effects of the amount and quality of dietary protein on 
adolescent body composition. We hypothesize that higher dietary protein will be 
associated with improvements in body composition, including lower levels of body fat 
and greater acquisition of skeletal muscle mass in adolescents. 
2.2METHODS 
2. 2.1 Study Population 
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The present analyses use data from the National Heart, Lung, and Blood Institute's 
Growth and Health Study (NGHS) that was collected beginning in 1986 in this 
longitudinal prospective study. NGHS is a 10 year prospective study of 23 79 9-10 year 
old self-identified Caucasian (49.1%) and African-American (50.9%) girls. Participants 
were examined annually to investigate factors associated with obesity onset and related 
CVD risk factors in adolescence. 
In brief, the participants were recruited from three different geographical areas to allow 
for a wide range of socioeconomic backgrounds and to reduce the chance of biased 
results due to local habits or local ancestry. The three clinical centers are: University of 
California at Berkeley, University of Cincinnati/Cincinnati Children's Hospital Medical 
Center, and Westat, Inc./Group Health Association in Rockville, Maryland. 
Girls were eligible for enrollment in NGHS if: (1) they declared themselves as being 
either Black or White; (2) they were within two weeks of age 9 or 1 0 at the time of the 
first clinic visit; (3) they had parents or guardians who identified themselves as the same 
race as the child; (4) their parents or guardians completed a household demographic 
information form and gave consent. 
2. 2. 2. Dietary Assessment 
Diet intake was assessed by three-day food records consisting of two weekdays and one 
weekend day at study years 1-5, 7, 8, and 10. Girls were instructed by nutritionists on 
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how to record their food intake and were each given a set of measuring cups and spoons, 
a ruler, and a binder that contained illustrated instructions and guides for estimating 
portion sizes. Food consumed was recorded in household measures. After the records 
were completed, the girls were interviewed in depth by nutritionists who checked the 
food records. The records entered into the University of Minnesota's Nutrition Data 
System (NDS) and analyzed for nutrient content. 106 The nutrient analyses were averaged 
over three days. Of the 2379 girls enrolled in NGHS at baseline, food records were 
received from 2147 (86% of black girls and 95% of white girls). The NDS output 
provides estimates for the daily intake of total, animal , and vegetable protein and 18 
amino acids, including all essential amino acids. To derive Food Pyramid servings from 
NDS output, ingredient codes were linked with food codes from the USDA's 
"MyPyramid Equivalents Database."107 This linkage enables the determination of each 
subject's dietary intake in all USDA food groups and subgroups. Intake data on total 
dietary protein was extracted and assessed. In addition to dietary protein, other dietary 
factors such as total energy intake, energy-adjusted intakes of carbohydrates and fats, 
dairy intake, whole grains, and fiber were evaluated 
Protein intake was defined in the following ways: protein intake per day (g) I kilogram of 
ideal body weight, and weight-adjusted protein residuals. In children, effects of age, sex, 
puberty, and race or on growth make classification of obesity difficult. Because children 
are growing, their age and sex must be taken into account in order to evaluate their 
obesity status. In 2000, the Centers for Disease Control and Prevention published age-
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and sex-specific BMI percentile growth curves for youth from 2 to 20 years of age.92 
These BMI growth curves were based on nationally representative and ethnically-diverse 
samples and took age as well as sex into account. Children below the 51h BMI percentile 
for age and sex are considered underweight. Children between the 85th and 94th age- and 
sex-specific BMI percentile are considered overweight and those at or above the 95th 
percentile are considered obese.93 
To estimate protein intake per kg of ideal body weight for our subjects, we determined 
the closest "normal" weight (neither overweight nor underweight) for children of a given 
ages, sex, and height. For those whose weights were less than the relevant 5th percentile 
for BMI for age, we used the weight that the girl would have had if she was at the 5% 
percentile of BMI for age. For children whose weights were greater than the 85th 
percentile for BMI for age and sex, the ideal weight was computed as the nearest non-
overweight body weight (i.e., percentile 84.9). 
The second approach to expressing protein intake adjusted for body weight relied on the 
residual method. Here, we used linear regression analyses to compute residuals of protein 
intake by regressing each girl's protein intake on her body weight. The residuals from the 
regression represent the differences between each individual's actual protein intake and 
the intake predicted by their body size. The resulting protein residual is uncorrelated with 
body weight and this allows the variation due to protein intake to be evaluated directly. 
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Protein intake in the context of a healthy eating pattern was also examined. We explored 
the consumption of protein in combination with other individual food groups typically 
associated with a healthy diet including fruit, vegetables, combined fruit and vegetables 
(FV), dairy, whole grains, fiber, and the USDA category of solid fat and added sugars 
(SOFAs). Protein intake in grams per kilogram of IBW was dichotomized as <1.3 vs. 
2:1.3 g/kg and then combined with other diet data to create diet patterns. Weight-adjusted 
protein residuals (g) were dichotomized as <-1.4 vs. 2: -1.4 and were also combined with 
categories of other diet patterns. Total FV intake was dichotomized as <3.0 vs. 2:3 .0 
servings/day; fruits and non-starchy vegetables (FnsV) as <2 vs. 2:2 servings/day; whole 
grains as <0.75 vs. 2: 0.75 grams/day; fiber as <11.0 vs. 2: 11.0 grams/day; dairy intake as 
<1.5 vs. 2: 1.5 servings/day; and finally, the USDA category of added fats and sugars 
(SOFAs) were dichotomized as <38% vs. 2:38% per day. Using protein and each of the 
additional dietary factors, four categories were formed for each diet pattern: (a) low 
intakes of both protein and a second diet factor, (b) low intake of protein and high intake 
of the second factor, (c) high intake of protein but low intake of the second factor, and (d) 
high intakes of both. The process was used to examine intakes of protein combined with 
FnsV, FV, whole grains, fiber, dairy, and SOFAs. Cut-points were selected through 
sensitivity analyses and to optimize analytic power. 
2. 2. 3. Body Composition Data 
Data collectors obtained two measurements of height (em) and weight (kg) and then 
obtained a third measurement if the first two differed by a predetermined amount (0.5 em 
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for height, 0.3 kg for weight) at each exam. The average of all measurements was 
determined and used. BMI was calculated as weight in kilograms divided by height in 
meters squared (kg/m2). 
Beginning with visit 2, waist circumference (em) at the umbilicus was also measured 
annually. Resistance and reactance measures from bioelectrical impedance analysis were 
used to compute percent body fat as ~oe + ~1e * (height2/resistance) + ~2e * weight+ ~3e * 
reactance, where ~oe, ... , ~3e are ethnicity-specific coefficients (e = 1 if Caucasian and 2 
if African-American) from predictive models of fat-free mass (based on dual energy x-
ray anthropometry, R2 = 0.99), developed with a separate sample of 126 African-
American and Caucasian girls, age 6 to 17.5;108 Skeletal muscle mass (kg) was calculated 
using a BIA-based equation of Janssen et al 109 : 
SMM (kg)= [ht (cm)2 /BIA-resist (ohm)* 0.401) +(sex* 3.825)+(age * -0.071)] + 5.102 
where sex= 0, since this sample includes only girls. 
This BIA equation was developed and cross-validated against magnetic resonance 
imaging measures of whole-body muscle mass in a sample of 269 men and women 
varying widely in age (18-86) and adiposity (BMI=16-48 kg/m2). Abdominal adiposity 
at end of follow-up (ages 18-20 years) was defined as having a sex and age-specific waist 
circumference greater than the 90th percentile in NHANES III. Being overweight at end 
of follow-up (ages 18-20 years) was defined as BMI> 25 kg/m2. 
2.2.4. Data on Potential Confounders 
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Data on a number of potential confounding variables are available in these analyses 
including age, race, height, physical activity, television viewing time, Tanner stage of 
pubertal development, and a wide range of dietary factors. 
Demographics: Subject's age and race/ethnicity were collected at study entry from girls 
and their parents or guardians by self-report, using US Census categories. Age was coded 
as age at last birthday. Socioeconomic status (SES) was classified as low, moderate or 
high. Low SES levels included: (1) household income < $10,000, regardless of education 
level or (2) household income from $10,000 - <$20,000 and education level of high 
school or less. Moderate SES included: (1) household income $10,000 - <$20,000, (2) 
household income $20,000- <$40,000, regardless of education, or (3) household income 
$40,000 or more with only a high school education or less. Finally, the higher SES 
category included those with more than a high school education and an income of 
$40,000 or more. 
Anthropometries: Weight was measured annually using a Health-o-meter electronic scale. 
Two measurements were obtained, and a third measurements was taken if the first two 
differed by more than 0.3 kg. Height was measured annually using a custom portable 
stadiometer. Two height measures were obtained, with a third measure taken if the first 
two were more than 0.5 em apart. BMI calculated as weight in kilograms divided by 
height in square meters (kg/m2) annually. 
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Physical Activity and Television: Physical activity diaries were collected at baseline and 
in years 3, 5, and 7-10. The diary clustered activities of similar metabolic equivalent 
values. If the girl participated in more than one activity in the same cluster, she totaled 
the time for all activities in that cluster. The overall physical activity patterns score 
(MET) was used for this analysis. Whenever possible, the diaries were completed on the 
same days as the food diaries and the debriefing session was combined. The usual 
number of hours spent watching television and videos each day was assessed annually by 
means of a questionnaire in which the girl completed the usual number of hours watched 
each day. 
Pubertal Development: Age at which menarche was used as a measure of pubertal 
development. It was asked at each exam and subsequently recorded. 
Dietary Factors: Total energy intake, carbohydrate intake, fat intake, dairy intake, whole 
grain intake, fiber intake, saturated fat intake, animal protein intake, and plant protein 
intake will be assessed using three-day diet records collected on two weekdays and one 
weekend day during study years 1-5, 7, 8, and 10. These records were evaluated using the 
Nutrition Data System as previously described. 
2.3 STATISTICAL ANALYSIS 
Average servings of macronutrients, micronutrients, and usual servings per day in the 
five major USDA food groups were estimated as average servings from all days of diet 
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records collected between the ages of 9 and 17 years. Protein intake was expressed as 
grams of protein per kg of ideal body weight and weight-adjusted protein residuals. For 
each type of protein, intake was first classified into quintiles to evaluate the shape of the 
relations between protein and body composition outcomes. The following outcomes were 
investigated: mean adjusted BMI, waist circumference, % body fat, % skeletal muscle 
mass and the odds of being overweight associated with protein in the context of a healthy 
diet at the end of follow-up in late adolescence and adjusted means throughout the 
follow-up period (at two-year intervals). All analyses were performed using Statistical 
Analysis Systems software, version 9.1 (SAS Institute). 
Analysis of covariance (ANCOV A) models were used to obtain adjusted mean BMI, 
waist circumference, and % skeletal muscle mass at the end of follow-up (ages 18-20 
years). Final models also explored potential confounding by diet and non-diet variables 
including the following: age, race, socioeconomic status (SES), height, physical activity, 
age at menarche, TV /video time, and baseline weight, and a range of dietary habits 
averaged between ages 9-17 including dairy intake, whole grain intake, total fiber intake, 
total fat intake, total carbohydrate intake, sodium, calcium, magnesium, and potassium. 
Multiple logistic regression was also used to assess the odds of becoming overweight 
associated with protein intake in the context of a healthy eating pattern including fruits 
and vegetables, low-fat dairy, whole grains, and fiber. For example, fruit and vegetable 
intake (FV) was dichotomized (<3.0 v. ~3.0 servings/day for FV) and then combined into 
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one of four categories: (a) low intakes of both protein and FV, (b) low intake of protein 
and high intake of FV, (c) high intake of protein but low intake of FV, and (d) high 
intakes of both protein and FV. The process was repeated for fruit and non-starchy 
vegetables, fruits and total vegetables, whole grains, fiber, low-fat dairy, and SOFAs. 
Cut-points were chosen in part to optimize analytic power. 
When effect modification existed, stratification was maintained. Only variables that 
change the effect estimates by more than 1 0% will be retained in the final models as 
confounders. 
Longitudinal mixed modeling was used to determine the effects of dietary protein on 
mean percent body fat (from BIA) at each exam. This allowed for us to use repeated 
measures of dietary protein and body fat. 
2.4 RESULTS 
Table 2.1 shows the baseline characteristics of adolescent girls according to tertiles of 
protein intake per kg of ideal body weight per day. The mean protein intake per kg IBW 
was 1.35 g/kg. Girls in the highest tertile of protein intake were more likely to be shorter 
(p<0.0001), weigh less (p<0.0001), and have an overall lower BMI (p<O.OOOI) at 
baseline than girls in the lowest quintile of intake. Lean body mass (kg) and waist size at 
the umbilicus was also lower for girls in the highest tertile of intake compared to the 
lowest tertile. In terms of diet, total energy, percent of calories from protein, and percent 
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of calories from fat were higher in the highest tertile of protein intake while percent of 
calories from carbohydrates was lower. Girls in the highest tertile of protein ate more 
fiber, servings of low fat dairy, fruits and vegetables, and whole grains along with more 
calcium than girls in the lowest tertile. Girls in the highest tertile of protein intake were 
mostly Black, had higher caloric, and nutrient intakes, and spent more time watching TV 
(P<O.OOOI) than those in the lowest tertile of protein intake. 
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Table 2.1 Baseline characteristics according to tertiles of protein per kg IBW 
Tertiles of ~rotein ~er k2 ideal bw (g/kg} 
Tl T2 T3 
n=770 n= 771 n= 770 p value 
(mean± s.d.) 
Baseline Characteristics 
Age (yrs) 10.1 ± 0.5 10.0 ± 0.6 10.0 ± 0.6 0.0414 
Height (em) 143.8 ± 7.4 140.9 ± 7.1 139.0 ± 7.7 <0.0001 
Baseline weight (kg) 42.5 ± 10.5 37.2 ± 9.7 32.6 ± 7.9 <0.0001 
BMI (kg/m2) 20.4 ± 3.9 18.6 ± 3.7 16.7 ± 2.9 <0.0001 
Age at menarche (yrs) 12.1 ± 1.1 12.4 ± 1.2 12.5 ± 1.3 <0.0001 
Activity Score (METS)" 19.5 ± 9.8 19.9 ± 10.1 20.9 ± 11 .0 0.0241 
TVNideo (hrs)" 4.5 ± 1.9 4.6 ± 2.1 4.7 ± 2.2 0.2040 
Macronutrient Intakes" 
Energy 1612 ± 262 1864 ± 288 2138 ± 350 <0.0001 
% of calories from protein 13.5 ± 1.8 14.1 ± 1.8 14.8 ± 1.8 <0.0001 
% calories from fat 34.6 ± 4.0 35.2 ± 3.8 36.0 ± 3.9 <0.0001 
% calories from carbs 52.9 ± 4.8 51.7 ± 4.7 50.1 ± 4.7 <0.0001 
Total protein (glkg ideal bw) 1.0 ± 0.1 1.3 ± 0.1 1.7 ± 0.3 <0.0001 
Food Group Intake• 
Dietary fiber (g) 9.9 ± 2.6 11.4 ± 2.9 12.9 ± 3.2 <0.0001 
Low fat dairy servings 0.8 ± 0.5 1.0 ± 0.6 1.2 ± 0.8 <0.0001 
Fruits & vegetables servings 3.0 ± 1.1 3.4 ± 1.2 3.7 ± 1.3 <0.0001 
Whole grain servings 0.5 ± 0.3 0.5 ± 0.4 0.6 ± 0.4 <0.0001 
Micronutrient Intakes• 
Calcium (mg) 638 ± 165 766 ± 196 902 ± . 246 <0.0001 
Vitamin D (meg) 3.8 ± 1.5 4.7 ± 1.7 5.7 ± 2.2 <0.0001 
Race column percent (%) 
White(%) 47.7 52.5 47.0 0.7989 
Socio-economic Status 
Low(%) 22.6 21 .3 26.5 0.6832 
8 Mean values from Ages 9-17 
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Table 2.2 demonstrates the baseline characteristics of adolescent girls according to tertile 
of weight-adjusted protein residuals. The median protein intake per day according to 
weight-adjusted residuals was -1.41 grams. Baseline weight and height did not differ 
significantly between tertiles. BMI decreased slightly with increasing tertiles of protein 
intake. Girls in the highest tertile of dietary protein watched more hours of TV /video than 
girls in the lowest tertile. Total energy, percent of calories from protein, and percent of 
calories from fat also increased with increasing tertiles of dietary protein, while percent 
of calories declined. Intakes of dietary fiber, low-fat dairy, fruits and vegetables, and 
whole grains increased significantly with increasing tertiles of dietary protein. A higher 
percentage of African American girls were in the highest intake of dietary protein at 
baseline. 
Mean adjusted body composition values at the end of follow-up (18-20 years of age) 
according to quintiles of protein intake (per kg of IBW and as weight-adjusted protein 
residuals in grams) are presented in Table 2.3. BMI decreased significantly with 
increasing quintiles of protein per kg IBW from 25.9 kg/m2 to 23.5 kg/m2 (p for trend: 
<0.0001) after adjusting for baseline height and weight, tv/video viewing time, mean age 
during exposure period, race, SES, age at menarche, % of calories from carbohydrates 
and vitamin D. Waist circumference also declined significantly with increasing quintiles 
of protein intake per kg IBW from 85.9 em to 80.8 em across quintiles of protein intake 
(p for trend: <0.0001). % body fat decreased significantly with increasing quintiles of 
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protein/ kg IBW (p<O.OOOI). SMM (%) increased significantly with increasing quintiles 
of protein intake per kg IBW from 32.4% to 35.5% (p for trend: <0.0001). 
Table 2.2 Baseline characteristics according to tertiles of weight-adjusted protein 
residuals 
Tertiles of (!rotein residuals (g} adjusted for weight 
Tl T2 T3 
n= 770 n=771 n=770 p value 
(mean ± s. d.) 
Baseline Characteristics 
Age (yrs) 10.0 ± 0.5 10.0 ± 0.6 10.1 ± 0.6 0.0007 
Height (em) 140.7 ± 7.5 140.8 ± 7.4 142.1 ± 8.0 0.0005 
Baseline weight (kg) 37.9 ± 10.4 36.9 ± 9.8 37.6 ± 10.5 0.2093 
BMI (kg/m2) 18.9 ± 3.9 18.4 ± 3.7 18.4 ± 3.9 0.0177 
Age at menarche (yrs) 12.3 ± 1.2 12.3 ± 1.2 12.3 ± 1.3 0.9878 
Activity Score (METS)8 19.9 ± 10.0 19.7 ± 9.7 20.6 ± 11 .2 0.201 7 
TVNideo (hrs)" 4.4 ± 2.0 4.5 ± 2.0 5.0 ± 2.2 <0.0001 
Macronutrient Intakes" 
Energy 1563 ± 230 1855 ± 239.5 2197 ± 317.8 <0.0001 
% of calories from protein 13.3 ± 1.8 14.1 ± 1.7 15.0 ± 1.7 <0.0001 
% calories from fat 34.3 ± 3.9 35.0 ± 3.8 36.4 ± 3.8 <0.0001 
% calories from carbs 53.4 ± 4.8 51.9 ± 4.6 49.4 ± 4.4 <0.0001 
Protein residual, wt adj 
-14.5 ± 5.5 -1 .5 ± 3.2 15.8 ± 9.7 <0.0001 
Food Group Intake" 
Dietary fiber (g) 9.6 ± 2.5 11.4 ± 2.7 13.2 ± 3.1 <0.0001 
Low fat dairy servings 0.8 ± 0.5 1.0 ± 0.6 1.2 ± 0.8 <0.0001 
Fruits & vegetables servings 2.9 ± 1.1 3.3 ± 1.2 3.8 ± 1.3 <0.0001 
Whole grain servings 0.5 ± 0.4 0.5 ± 0.4 0.6 ± 0.4 <0.0001 
Micronutrient Intakes" 
Calcium (mg) 623.6 ± 152.3 765.1 ± 184.6 916.2 ± 246.5 <0.0001 
Vitamin D (meg) 3.8 ± 1.4 4.7 ± 1.7 5.8 ± 2.1 
Race column percent (%) 
White(%) 54.0 50.8 42.3 <0.0001 
Socio-economic Status 
Low(%) 21.0 23.4 26.0 0.4341 
"Mean values from Ages 9-17 
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The effect of dietary protein expressed as weight-adjusted residuals followed a similar 
but somewhat attenuated trend for mean body composition at end of follow-up. Mean 
BMI and waist circumference at 18-20 years of age declined significantly with increasing 
quintiles of intake of protein expressed as residuals (p for trend: 0.0003 and 0.0025 
respectively) after adjusting for baseline height, tv/video time, race, SES, age at 
menarche, and percent of calories from carbohydrates. There was also a significant 
decrease in %body fat with increasing quintiles of protein residuals (p-value <0.0001). 
Skeletal muscle mass increased from 33.0% to 34.5% with increasing quintiles of dietary 
protein (p for trend< 0.0001). 
Mean body composition in late adolescence is stratified by race in Table 2.4. When 
protein was expressed in grams per kg IBW, mean BMI decreased significantly for white 
and black girls at the end of follow-up (p for trend <0.0001 for whites and 0.0004 for 
blacks). Similarly, mean waist circumference decreased significantly for whites (p for 
trend< 0.0001) and for blacks (p for trend<0.0001) in late adolescence. Percent skeletal 
muscle mass increased for both races with increasing quintiles of protein per kg IBW (p 
for trend <0.0001 for both). These trends were attenuated when expressed as protein 
residuals. 
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Table 2.3 Mean adjusted body composition measures according to quintiles of 
protein intake 
Protein Exposure* BMI %Body Fat we %SMM 
g/kgiDW n (mean± s.e.) (mean± s.e.) (mean± s.e.) (mean± s.e.) 
Quintile 1 443 25.9±0.22 32.6 ± 0.28 85.9± 0.52 32.4± 0.20 
Quintile 2 434 26.0±0.20 32.0 ± 0.25 85.6± 0.47 32.8±0.18 
Quintile 3 429 25.4± 0.20 31.7 ± 0.25 84.9± 0.46 33.2± 0.18 
Quintile 4 432 24.8± 0.20 30.6 ± 0.25 83.4± 0.47 34.1±0.19 
Quintile 5 403 23.5±0.23 28.9 ± 0.29 80.8± 0.55 35.5±0.21 
pjor trend <0.0001 <0.0001 <0.0001 <0.0001 
protein residuals 
Quintile 1 429 25.7±0.30 32.2 ± 0.32 85.4± 0.66 33 .0± 0.24 
Quintile 2 425 25.5± 0.30 31.8±0.31 84.6± 0.65 33 .2± 0.24 
Quintile 3 430 25.2± 0.29 31.6±0.31 84.3 ± 0.64 33.3 ± 0.24 
Quintile 4 431 25.3 ± 0.29 30.7 ± 0.31 84.3 ± 0.64 33 .8± 0.24 
Quintile 5 426 24.0± 0.31 29.9± 0.32 82.2± 0.67 34.5± 0.25 
pfor trend 0.0003 <0.0001 0.0025 <0.0001 
*g/kg mw adjusted for baseline height & weight, tv/video, age at diet, race, SES, age at 
menarche, %cals from carbs, vit D 
*residuals adjusted for baseline height, tv/video, race, SES, age at menarche, %cals from carbs 
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Table 2.4 Mean adjusted body composition outcomes according to protein intake, 
stratifying by race 
White Girls, Ages 18-20 Years 
Protein Ex(!osure BMI we %SMM 
g/kg IBW n (mean± s .e.) (mean± s.e.) (mean± s.e.) 
Quintile 1 200 24.7± 0.3 84.3± 0.7 33.4±0.3 
Quintile 2 209 24.4± 0.2 83.9± 0.6 33.9±0.2 
Quintile 3 227 23.8± 0.2 82.5 ± 0.5 34.5 ± 0.2 
Quintile 4 216 23.4± 0.2 81.6± 0.6 35.1±0.2 
Quintile 5 182 22.2± 0.3 79.3± 0.7 36.6± 0.3 
pfortrend <0.0001 <0.0001 <0.0001 
protein residuals 
Quintile 1 239 23.9± 0.3 82.5± 0.7 34.6± 0.3 
Quintile 2 205 23.7± 0.3 81.9±0.7 34.6± 0.3 
Quintile 3 220 23.7± 0 .3 82.6± 0.7 34.5± 0.3 
Quintile 4 218 24.3± 0 .3 83.4± 0 .7 34.5± 0.3 
Quintile 5 152 22.9± 0.4 80.8± 0.9 35.5 ± 0.4 
pfor trend 0.4670 0.6539 0.1924 
Black Girls, Ages 18-20 Years 
Protein Ex(!osure BMI we %SMM 
g/kg IBW n (mean ± s.e.) (mean± s.e.) (mean± s.e.) 
Quintile 1 243 27.2± 0 .3 87.5± 0.8 31.5±0.3 
Quintile 2 225 27.5± 0.3 87.3±0.7 31.8±0.3 
Quintile 3 202 27.0± 0.3 87.2± 0.7 31.9±0.3 
Quintile 4 216 26.0± 0.3 84.9± 0.7 33.1±0.3 
Quintile 5 221 24.6± 0.4 82.1±0.8 34.5± 0.3 
pfortrend 0.0004 <0.0001 <0.0001 
protein residuals 
Quintile 1 190 27.6± 0.5 88.1 ± 1.2 31.4±0.4 
Quintile 2 220 27.2± 0.5 87.1±1.0 31.9±0.4 
Quintile 3 210 26.6± 0.5 85 .8± 1.1 32.2± 0.4 
Quintile 4 213 26.1 ± 0.5 85.2± 1.0 33.3 ± 0.4 
Quintile 5 274 25.3 ± 0.4 83.8± 1.0 33.5± 0.3 
pfor trend 0.2280 0.0025 <0.0001 
*g/kg mw adjusted for baseline height & weight, tv/video, age at diet, race, SES, age at 
menarche, %cals from carbs, vit D 
*residuals adjusted for baseline height, tv/video, race, SES, age at menarche, %cals from carbs 
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Table 2.5 shows the effects of protein expressed in kilograms of IBW in childhood in the 
context of a healthy diet on mean body composition at the end of follow-up. A diet high 
in protein alone or in combination with high fruits and non-starchy vegetables had lower 
BMI (p-value: 0.0002 and <0.0001 respectively), waist circumference (p-value: 0.0130 
and <0.0001) and higher skeletal muscle mass (p-value: <0.0001 for both) compared to a 
low protein, low fruits and non-starchy vegetables diet. A similar significant result was 
seen for high protein alone or in combination with fruits and total vegetables. A diet high 
in protein alone or in combination with high whole grains, high fiber, and high dairy were 
also associated with lower BMI, waist circumference, and % skeletal muscle mass in late 
adolescence. 
43 
Table 2.5 The effect of protein per kg IBW in the context of healthy diet on mean 
body composition 
BMI we SMM(%) 
Protein g!kg ffiW + Other n (mean± s.e.) E-value n (mean± s.e.) E-value n (mean± s.e.) E-value 
Fruits and Non-starchy Veg 
Low protein/ Low FnsV 596 25.7 ± 0.2 585 85.2 ± 0.4 590 32.8 ± 0.2 
Low protein/ High FnsV 532 25.9 ± 0.2 0.4862 530 85 .7 ± 0.5 0.4768 531 32.7 ± 0.2 0.6747 
High protein/ Low FnsV 384 24.6 ± 0.2 0.0002 385 83.5 ± 0.5 0.0130 383 34.1 ± 0.2 <0.0001 
High protein/ High FnsV 629 24.3 ± 0.2 <0.0001 628 . 82.3 ± 0.4 <0.0001 628 34.6 ± 0.2 <0.0001 
Total Fruits and Vegetables 
Low protein/ Low FV 939 25.8 ± 0.1 927 85.4 ± 0.3 933 32.8 ± 0.1 
Low protein/ High FV 189 25.6 ± 0.3 0.6200 188 85.7 ± 0.7 0.6433 188 32.9 ± 0.3 0.7711 
High protein/ Low FV 752 24.4 ± 0.2 <0.0001 752 82.9 ± 0.4 <0.0001 751 34.4 ± 0.2 <0.0001 
High protein/ High FV 261 24.4 ± 0.3 <0.0001 261 82.4 ± 0.6 <0.0001 260 34.6 ± 0.2 <0.0001 
Whole grains 
Low protein/ Low WG 909 25.9 ± 0.1 896 85.6 ± 0.4 903 32.7± 0.1 
Low protein/ High WG 219 25.5 ± 0.3 0.2666 219 84.9 ± 0.7 0.3768 218 33.1 ± 0.3 0.2478 
High protein/ Low WG 726 24.4 ± 0.2 <0.0001 726 82.7 ± 0.4 <0.0001 726 34.5 ± 0.2 <0.0001 
High protein/ High WG 287 24.5 ± 0.3 <0.0001 287 83.0 ± 0.6 0.0004 285 34.3 ± 0.2 <0.0001 
Fiber 
Low protein/ Low Fiber 720 25.5 ± 0.2 708 84.7 ± 0.4 715 32.9 ± 0.1 
Low protein/ High Fiber 408 26.3 ± 0.2 0.0027 407 86.8 ± 0.5 0.0010 406 32.5 ± 0.2 0.0564 . 
High protein/ Low Fiber 328 24.2 ± 0.2 <0.0001 329 82.5 ± 0.6 0.0014 327 34.4 ± 0.2 <0.0001 
High protein/ High Fiber 685 24.5 ± 0.2 <0.0001 684 82.8 ± 0.4 0.0007 684 34.4 ± 0.2 <0.0001 
*g/kg IBW adjusted for baseline height & weight, tv/video, age at diet, race, SES, age at 
menarche, %cals from carbs, vit D 
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The effects of weight-adjusted protein residuals in the context of a healthy diet on mean 
body composition in late adolescence are presented in Table 2.6. The combined effects of 
a high protein, high non-starchy fruits and vegetables diet as well as a high protein, high 
fruits and total vegetables diet were significantly associated with lower BMI, lower waist 
circumference, and a higher skeletal muscle mass compared to a low protein, low fruits 
and vegetables diet. 
Table 2.7 shows the odds ofbecoming overweight according to protein intake (IBW) in 
the context of a healthy diet pattern. Eating high protein alone or with high fruits and 
non-starchy vegetables was associated with a 54% (95% CI: 0.32-0.40) and 72% (0.20-
0.40) reduced odds of obesity at end of follow-up. Similarly, a high protein diet alone or 
in the context of a high whole grain diet was associated with significantly reduced odds 
of being overweight at ages 18-20. 
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Table 2.6 The effect of protein residuals (g) in the context of healthy diet on mean 
body composition. 
BMI we SMM (%) 
Protein residuals (g) n (mean± s.e.) p-value n (mean ± s.e.) p-value n (mean± s.e.) p-value 
Fruits and Non-starchy Veg 
Low protein/ Low FnsV 601 25.8 ± 0.3 591 85.3 ± 0.5 594 32.9 ± 0.2 
Low protein/ High FnsV 466 25.1 ± 0.3 0.0993 465 84.2 ± 0.7 0.1818 466 33.3 ± 0.2 0.2925 
High protein/ Low Fns V 379 25.0 ± 0.3 0.0635 379 84.4 ± 0.7 0.3228 379 33.6 ± 0.3 0.0646 
High protein/ High FnsV 695 24.7 ± 0.2 0.0010 693 83.0 ± 0.5 0.0021 693 34.3 ± 0.2 <.0001 
Total Fruits and Vegetables 
Low protein/ Low FV 907 25.6 ± 0.2 897 84.9 ± 0.4 900 33.1 ± 0.2 
Low protein/ High FV 160 25.3 ± 0.5 0.5756 159 84.9 ± 1.1 0.9819 160 33.1 ± 0.4 0.9975 
High protein/ Low FV 784 24.8 ± 0.2 0.0155 782 83.6 ± 0.5 0.0761 784 33.9 ± 0.2 0.0009 
High protein/ High FV 290 24.7 ± 0.4 0,0308 290 83.0 ± 0.8 0.0387 288 34.4 ± 0.3 <.0001 
Whole grains 
Low protein/ Low WG 856 25.6 ± 0.2 845 85.0 ± 0.5 850 33.0 ± 0.2 
Low protein/ High WG 211 25.1±0.4 0.2468 211 84.5 ± 0.9 0.6368 210 33.3 ± 0.4 0.4589 
High protein/ Low WG 779 24.7 ± 0.2 0.0018 777 83.3 ± 0.5 0.0159 779 34.1 ± 0.2 <.0001 
High protein/ High WG 295 25.1±0.4 0.1707 295 83.8 ± 0.8 0.2140 293 33.9 ± 0.3 0.0084 
Fiber 
Low protein/ Low Fiber 718 25.6 ± 0.2 708 84.9 ± 0.5 712 33.0 ± 0.2 
Low protein/ High Fiber 349 25.3 ± 0.3 0.5075 348 84.8 ± 0.8 0.9746 348 33.2 ± 0.3 0.5338 
High protein/ Low Fiber 330 24.9 ± 0.4 0.0787 329 83.9 ± 0.8 0.3167 330 33.7 ± 0.3 0.0480 
High protein/ High Fiber 744 24.7 ± 0.2 0.0065 743 83.3 ± 0.5 0.0224 742 34.2 ± 0.2 <.0001 
*residuals adjusted for baseline height, tv/video, race, SES, age at menarche, %cals from carbs 
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Table 2. 7 Odds of overweight (BMI> 25 kg/m2) at ages 18-20, excluding girls above 
95th percentile 
Protein (grams/ kg IBW) n Cases OR 95%CI 
Fruits and Non-starchy Veg 
Low protein/ Low FNSV 482 221 1.00 
Low protein/ High FNSV 442 178 1.19 0.86 - 1.64 
High protein/ Low FNSV 383 94 0.47 0.32 - 0.69 
High protein/ High FNSV 622 101 0.28 0.20 - 0.40 
Whole grains 
Low protein/ Low WG 740 324 1.00 
Low protein/ High WG 184 75 1.23 0.82 - 1.84 
High protein/ Low WG 712 140 0.34 0.25 - 0.46 
High protein/ High WG 293 55 0.33 0.21 - 0.51 
*g/kg ibw adjusted for baseline height & weight, tv/video, age at diet, race, SES, age at 
menarche, %cals from carbs, vit D 
2.5 DISCUSSION 
In this study, over a follow-up period of 10 years, expressed as grams per kilogram of 
ideal body weight, dietary protein was significantly associated with decreased BMI and 
waist circumference, and increased skeletal muscle mass. These results were slightly 
attenuated but still statistically significant when protein intake was expressed as weight-
adjusted protein residuals (in order to express dietary protein independent of body 
weight). Moreover, dietary protein consumption (IBW and residuals) during childhood 
was significantly associated with a lower percent body fat. 
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We also found a protective effect of dietary protein in the context of a healthy eating 
pattern on body composition. A high protein/high fruits and vegetables diet, high 
protein/high fiber diet, and a high protein/high whole grains diet were all associated with 
significant decreases in BMI and waist circumference and lower odds of being 
overweight in late adolescence. 
Higher dietary protein intakes led to lower levels of adiposity during adolescence, 
findings that should be considered in any future revisions to the DRI recommendations 
for children and adolescents. Our study also provides evidence that higher protein intakes 
promote the acceleration of skeletal muscle mass during adolescence. Current 
recommendations for daily protein intakes in children and adolescents remain speculative 
given that allowances are basically estimates derived from interpolation of requirements 
determined for young adults and infants. Data were not available to determine the 
maintenance protein requirement in children older than 14 years of age and were based 
on the adult estimates of maintenance requirements from nitrogen balance studies. A 
meta-analysis of the data from a range of studies in children has been used to derive 
values for the requirement for maintenance (i.e., no growth) and for the efficiency of 
utilization of dietary protein for growth. For children, protein allowances were 
traditionally considered to be the amount of protein needed for sustaining positive 
nitrogen balance and therefore growth. 52-54 However, protein r~quirements in children 
and adolescents should begin to encompass outcomes other than growth such as risk of 
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obesity and optimal skeletal muscle, given that there seems to be a protective effect of 
protein on body composition in younger age groups. 
While some studies have shown that high consumption of total protein might help 
reducing body weight, others have reported a positive association between high protein 
intake in very young children (i.e., 2 years of age) and later BMI-z-score.60 Two other 
small prospective studied also reported a positive association between protein intakes at 
12 months of age and obesity at 5 years of age65 and protein intake from 6-12 months and 
BMI at 6 years of age in boys. 110 The relevance of these studies in infants and toddlers to 
older children and adolescents is uncertain. Moreover, the scientific literature is lacking 
studies directed specifically at quantifying protein needs of children between 8 and 12 
years of age. Thus, our current study encompasses a wider age range (9-17 years) of 
childhood dietary data to determine the impact of early childhood protein intake on late 
adolescent obesity risk. Additionally, while many studies consider BMI as the endpoint 
for assessing obesity in children, our study included several measures of adiposity 
including waist circumference, lean mass, and risk of overweight and central adiposity. 
Our results are supported by a study in which higher intakes of protein were associated 
with less gain in fat mass over 6 years of follow-up in 9 year old girls. 111 The protective 
effect of protein on body composition can partly be explained by the satiating effect of 
dietary protein. Protein increases satiety to a greater extent than carbohydrates or fat, and 
high-protein meals induce a greater acute appetite suppressive effect than low-protein 
meals.36 Protein-induced satiety might be mediated by gut neuropeptides and insulin 
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secretion. Milk proteins have been suggested to stimulate GLP-1 release,37 while the 
involvement of CCK in acute protein-induced satiety may be dose-dependent.38 
Postprandial insulin response is thought to be an important satiety signal and when 
ingested alone, proteins elicit insulin secretion.39 High-protein diets have also been 
shown to improve insulin sensitivity.40 High-protein intake also stimulates protein 
synthesis, accelerates protein turnover, and induces a small suppression of muscle protein 
breakdown.41 This subsequent greater lean body mass, especially muscle mass, is 
associated with higher energy expenditure. 
Recent epidemiologic studies of diet and health outcomes including obesity have changed 
the focus to the overall diet quality and dietary pattern instead of single nutrients. 112;113 
This concept was emphasized in the Dietary Approach to Stop Hypertension (DASH) 
trial, where a diet rich in fruits, vegetables, and whole grains with only small amount of 
fat and meat has been shown to be effective in reducing blood pressure. 114 In addition, a 
higher intake of fruits, vegetables, and whole grains was recently confirmed to be 
associated with smaller gains in body mass index (BMI) and waist circumference, 115 and 
dietary 'meat' pattern was positively associated with BMI in a multiethnic group of 
women. 116 The OR of being obese was nearly twice as high among individuals with a 
poor diet compared to those with a good diet, the 'Western' dietary pattern with high 
intake of red meat, processed meat, refined grains, and high-fat dairy products was 
associated with higher risk of coronary heart disease compared to the 'prudent' dietary 
pattern rich in fruits, vegetables, fish, poultry, and whole grains in both men and 
women. 112;113;115 Our analysis demonstrates a positive effect of a diet high in protein 
50 
along with a healthy eating pattern including high fruits and vegetables, high whole 
grains, and high fiber on body composition in late adolescence. This suggests an that a 
healthy dietary pattern along with high protein may have beneficial effects on change in 
body composition not just in adults, but also in childhood and adolescence. 
The present study has numerous strengths including its prospective design with 10 years 
of follow-up throughout adolescence, the extensive number of 3 day dietary records, and 
the replicate measures of body composition and potential confounders. In addition, the 
complete ascertainment of food group intakes that were derived by the authors by linking 
Nutrition Data System data with USDA Food Pyramid data is an added strength. Despite 
using a gold-standard method for dietary assessment, younger subjects in particular have 
difficulty in reporting portion sizes and the details of foods eaten. This type of 
measurement error associated with diet (or other behavioral factors) would most probably 
be non-differential. Additionally, in this study is that the limited range of intake for some 
food groups such as whole grains or legumes or added fats and sugars made it difficult to 
assess the effects of these foods. We also used an average of dietary protein intake 
between the ages of 9 and 17 in these adolescent girls, which may raise the concern that 
changes in dietary protein intake within 8 years may not be taken into account with an 
average intake estimate. While there are a limited number of studies on the tracking of 
intakes of food and nutrients in childhood and adolescence, in the Framingham 
Children's Study of 3-4 year old children, nutrient tracking remained strong through the 
ages of 7-8 years. 117 Even children with extreme nutrient intakes tended to maintain those 
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levels over time. Also, by averaging dietary protein intakes, we can also reduce the 
variability around any unusual intakes of dietary protein reported by a subject due to 
misreporting, under-reporting, or over-reporting nutrient intake. Alternatively, in the 
future, we can use repeated measures of protein intake and body composition at each 
exam and examine the effect of protein on adolescent body composition at each visit as 
opposed to using an average of diet and determining body composition at the end of 
follow-up. We also did not control for energy in our final models of dietary protein and 
adolescent body composition. Firstly, calories are typically underreported by individuals. 
While the reporting of actual meals is often correct, high-calorie snacks such as potato 
chips and chocolate are underreported or not reported at all. 118 Moreover, at baseline girls 
in the lowest tertile of protein intake weighed more compared to the highest tertile of 
protein intake. However, their energy intake at baseline was lower compared to those 
girls in the highest tertile of protein intake. A higher weight is indicative of higher 
calories consumed and since this was not the case in our sample, this suggests 
uncierreporting of energy. Because of this underreporting, we did not include energy as a 
covariate in our model. 
In conclusion, in this longitudinal study, dietary protein was associated with lower BMI, 
lower waist circumference, lower % body fat, higher % skeletal muscle mass, and lower 
obesity risk in the context of a healthy diet in adolescence. Given the increasing 
incidence and prevalence of obesity in children and adolescents, current protein 
recommendations for this population should take into account the protective effect of 
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dietary protein during childhood and early adolescence on body composition in late 
adolescents. 
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CHAPTER 3: Effect of Protein on Body Composition in Older Adults 
3.1 BACKGROUND 
Aging triggers changes in body composition, specifically, increasing fat mass and 
decreasing lean mass. 119 Of particular concern in the elderly is the development of 
sarcopenia, a gradual loss of skeletal muscle mass. The substantial and involuntary loss 
of muscle mass is partly responsible for age-related changes in functional capacity, 
physical disability, decreased muscle strength, poor quality of life, and premature 
death. 120 In the year 2000, 600 million people around the world were 2:60 years of age 
and this figure is estimated to rise to 1.2 billion by 2025 and 2 billion by 2050. 121 Given 
the rise in the elderly population as well as the strong association between sarcopenia and 
disability, and the subsequent increase in healthcare expenditures in disabled persons, the 
. b d f . . d b 122 economic ur en o sarcopema IS presume to e great. 
Observational studies have demonstrated that muscle mass and strength peak between 20 
and 40 years of age and then decline progressively. 19;2° Consequently, the risk of 
sarcopenia increases with age.24 The development of sarcopenia can be attributed to 
several factors including lifestyle and genetics. Poor diet, smoking, physical inactivity, 
age-related hormone and cytokine changes are all proposed risk factors. 25 Plausible 
mechanisms leading to sarcopenia include age-related declines in alpha-motor neurons, 
growth hormone production, sex steroid levels, and alterations in muscle protein 
turnover, muscle tissue remodeling and apoptosis. 22 
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Perhaps the greatest impact of sarcopenia is on functional limitation and disability in the 
elderly. Sarcopenia plays an important role in the pathogenesis of frailty and associated 
morbidity, disability and mortality.26;27 Epidemiologic studies have demonstrated 
associations between low skeletal muscle mass and increased risk of physical disability, 
functional impairments, and low physical performance, as well as decreased muscular 
strength and endurance.Z8;29;34 The large influence of sarcopenia on disability and 
associated morbidity warrants the search for nutritional interventions such as dietary 
protein that may prevent or delay the onset and progression of this disorder. 
It is estimated that the prevalence of obesity in the elderly increased from 32% in 2000 to 
37% in 2010 in men and women 60 years of age and older.3;4 Body composition changes 
and increased prevalence of obesity in the elderly create a combination of excess weight 
and reduced muscle mass/strength, defined as sarcopenic obesity. While subcutaneous fat 
declines with aging, visceral and intramuscular fat increase 123-125 which, coupled with 
sarcopenia, may exacerbate functional disability 
Multiple dietary strategies aiming at reducing body weight and preventing muscle loss 
have been proposed and high dietary protein has attracted considerable attention as a 
possible weight management aid in recent years. Protein intake, especially essential 
amino acids, are anabolic stimuli for muscle metabolism via enhanced phosphorylation 
and activation of mammalian target of rapamycin (mTOR) signaling cascade, including 
the ribosomal protein S6 kinase and its target ribosomal protein S6.50 
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The current Recommended Dietary Allowance for protein (.8 g/kg/day) for men and 
women 19 years of age and older is based on nitrogen balance studies in young healthy 
adults.67;68 Hence, some argue that these nutritional recommendations do not protect the 
elderly from sarcopenic muscle loss.69-71 Over the past 30 years, a modest number of 
short-term nitrogen-balance experiments have been conducted to estimate the protein 
needs of older adults. The results of these studies are mixed and inconclusive, some 
supporting that the current RDA is adequate, whereas others indicating that higher 
intakes are needed to meet the dietary needs of virtually all healthy older adults. 
However, nitrogen-balance studies have not addressed the possibility that protein intake 
well above the RDA could prove beneficial in healthy older individuals. The Health ABC 
study suggests that 70-79 year olds in the highest quartile of protein intake lose 
approximately 40% less lean mass compared to those in the lowest quartile. 78 
Additionally, protein quality or protein intake from distinct food groups may also impact 
later obesity risk. Given the differing protein content and amino acid composition of food 
groups, it is important to determine the impact of protein quality on obesity and 
sarcopenic risk in middle aged and older adults. 
The recommended dietary guidelines as mentioned is 0.8 grams of protein per kilogram 
of body weight for all adults. One major concern is that this guideline for obese 
individuals may lead to unnecessarily high intakes of calorie-dense protein-source foods. 
One recommendation is that protein consumption should be proportional to an 
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individual's height and ideal weight (i.e. , the nearest weight that would reflect a non-
overweight status).91 
To explore the extent to which dietary protein affects body composition in middle-aged 
and older adults, we will use data from the prospective Framingham Offspring Study to 
determine the association between higher intakes of dietary protein and development of 
sarcopenia and obesity. Moreover, we will investigate the effects of protein in the context 
of healthy diet on risk of sarcopenia and obesity. We hypothesize that higher dietary 
protein will have a protective effect on the obesity and sarcopenia risk in middle-aged 
and older adults. Moreover, higher dietary protein in the context of a healthy eating 
pattern may also confer a lower risk of obesity and sarcopenia in this population. 
3.2METHODS 
3.2.1 Study Population: The Framingham Offspring Study is a second generation cohort 
of the Framingham Heart Study. The population comprises 2296 men and 2554 women, 
with an age range of 20 to 89 (mean age = 54 years). Participants were examined at four-
year intervals for the presence of coronary artery disease and associated risk factors. For 
this study, we will include subjects who were 40 years or older by the time of exam 3, the 
baseline exam for the dietary record data collection. We will exclude or selected co-
morbidities associated with dietary protein and body fat outcomes (i.e. CVD, diabetes, 
cancer). 
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3.2.2.Exposure Ascertainment 
Diet intake was assessed by three-day diet records collected during the third and fifth 
exam cycles (starting in 1984 and ending in 1991); diet records were completed by about 
65%-70% of subjects in each cycle (86% completeness overall). Approximately 16,000 
days of records were completed. They were collected using standardized methodology; a 
trained nutritionist instructed the families in the completion of the diet records, including 
the use of two-dimensional food models for estimating portion sizes. These records were 
entered into the NDS nutrient calculation program in accordance with a standardized 
protocol to calculate mean intakes of macro- and micronutrients. The NDS output 
provides estimates for the daily intake of total, animal, and vegetable protein and 18 
amino acids, including all essential amino acids. To derive Food Pyramid servings from 
NDS output, ingredient codes were linked with food codes from the USDA's 
"MyPyramid Equivalents Database."90 This linkage enables the determination of each 
subject's dietary intake in all USDA food groups and subgroups. Intake data on total 
dietary protein, animal protein, and vegetable protein will be extracted and assessed. 
Data for total energy intake, total carbohydrate intake, total fat intake, saturated fat 
intake, dairy intake, whole grain intake and fiber intake as potential confounders is also 
available by means of the three-day diet records. These records were entered into the 
NDS nutrient calculation program in accordance with a standardized protocol to calculate 
mean intakes of macro- and micronutrients. 
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For this study, protein intake will be defined in two ways: (1) total grams of protein per 
day I kilogram of nearest ideal body weight and (2) weight-adjusted protein intake using 
the residuals from a regression model. For adults who were overweight/obese, body 
weights were adjusted to a body mass index (BMI) of 24.9 kg/m2 and for adults who 
were underweight, body weights were adjusted to a BMI of 18.5 kg/m2. To remove 
variation in intake due to body weight, linear regression models were used to compute 
protein residuals (g). The protein intakes of the individuals were regressed on their body 
weight. The residuals from the regression represent the differences between each 
individual's actual protein intake and the intake predicted by their body size. The 
resulting protein residual is uncorrelated with body weight and this allows the variation 
due to protein intake to be evaluated directly. Protein quality will be defined as grams of 
animal protein and vegetable protein. 
Protein intake in the context of a healthy eating pattern was also examined. We explored 
the consumption of protein in combination with other individual food groups typically 
associated with a healthy diet including fruit, vegetables, combined FV, low-fat dairy, 
whole grains, fiber, and added fats and sugars (SOFAs). Protein intake in grams per 
kilogram of IBW was dichotomized as <1.3 vs. 2:1.3 g/kg and then combined into 
categories of other diet patterns. Weight-adjusted protein residuals were dichotomized as 
<-1.4 vs. 2: -1.4 grams and were also combined with categories of other diet patterns. 
Total fruit and vegetable intake was dichotomized as <3.0 vs. 2:3.0 servings/day. Fruits 
and non-starchy vegetables were <2.0 vs. 2:2.0 servings/day. Whole grains were <0.75 
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vs. ~ 0. 75 grams/day. Fiber was <11.0 vs. ~ 11.0 grams/day. Low fat-dairy was <1.5 vs. 
~ 1.5 servings/day. And finally, added fats and sugars (SOFAs) were dichotomized as 
<38% vs. ~ 38% per day. Four categories were formed for each diet pattern: (a) low 
intakes of both protein and healthy diet pattern, (b) low intake of protein and high intake 
of health diet pattern, (c) high intake of protein but low intake of healthy diet pattern, and 
(d) high intakes of both protein and health diet pattern. The process was repeated for fruit 
and non-starchy vegetables, fruits and total vegetables, whole grains, fiber, low-fat dairy, 
and SOP As. Cutpoints were chosen in part to optimize analytic power. 
3. 2. 3. Outcome Assessment 
Various measures of body composition are available in the Framingham Offspring 
Cohort. Weight (to the nearest 0.25 pound) and height (to the nearest 0.25 inch) were 
measured at each visit using a standard counterbalance scale with a measuring bar. Body 
mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Waist at 
the umbilicus and hip circumference were measured at each visit (to the nearest 
millimeter) with a cloth tape and five skinfold measures (triceps, subscapular, suprailiac, 
abdominal, thigh) were assessed using Lange calipers and a standard protocol at each 
exam. Bioelectrical impedance analysis was carried out using the standard tetrapolar 
technique according to the manufacturer's instructions for distal electrode placement on 
the right hand and foot and was used to calculate skeletal muscle mass. 
Sarcopenia was defined using the skeletal muscle mass equation of Janssen et al1 09 : 
Skeletal Muscle Mass (kg)= [(height2 I BIA-resistance x 0.401) +(sex x 
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3.825) + (age x -0.071)] + 5.102 
Height is in em; BIA-resistance is in ohms; for sex, men= 1 and women =0; and age is in 
years. This BIA equation was developed and cross...;validated against magnetic resonance 
imaging measures of whole-body muscle mass in a sample of 269 men and women 
varying widely in age (18-86) and adiposity (BMI 16-48 kg/m2). In this cohort, the 
correlation between muscle mass predicted using BIA and muscle mass measured using 
magnetic resonance imaging was 0.93, and the standard error of the estimate for 
predicting skeletal muscle mass from BIA was 9%. 109 Absolute skeletal muscle mass (kg) 
was then converted to percentage skeletal muscle mass termed the skeletal muscle index 
(SMI). 
SMI= skeletal muscle mass I body mass * 100 
Subjects were considered to have a normal SMI if their SMI was greater than the sex-
specific mean for young adults (aged 18- 39). We used the se.x-specific mean SMI for 
young adults calculated by Janssen and colleagues because of a higher number of 
subjects in their population (n= 3298 women and 3116 men). The mean SMI in 18-39 
year old women was 33.1% ± 5.5% and 42.5% ± 5.5% in 18-39 year old men. Class I 
sarcopenia was present when SMI was within -one to -two standard deviations of young 
adult values, and class II sarcopenia was present in subjects whose SMI was below -two 
standard deviations of young adult values. Obesity will be classified using the following 
definition of obesity: BMI 2: 30 kg/m2. The presence of central adiposity will be defined 
as a sex-specific waist circumference greater than 40 inches for men and greater than 35 
inches for women. 
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3.2.4.Data on Potential Confounders: 
Data on the following potential confounding factors will be examined at each available 
examination: subject's age, sex, alcohol intake, smoking status, physical activity, other 
dietary factors, and co-morbid diseases. 
Demographics: Subject's age and sex were collected at study entry. Exact age was 
calculated at each exam. Education level was assessed at exam 2 as the number of self-
reported years of education. 
Smoking and Alcohol: Detailed data on alcohol intake as a possible confounder is 
available, including drinking status (e.g., current or past drinker, abstainer, abuser), 
drinking frequency (lifetime abstainer, past drinker, occasional drinker, regular drinker), 
and drinking amount (light, moderate, heavy). Smoking status (current or past smoker) 
and smoking amount (packs per day and total pack-years) have been derived from 
standardized questionnaires collected at each exam visit. 
Physical Activity: Physical activity was assessed by interview at exams 2, and 4-8. 
While activity was assessed in several ways in Framingham, for these analyses, data on 
the number of hours per day spent in vigorous and moderate physical activity were used. 
Estimated average oxygen consumption for moderate and vigorous activities was used to 
create a numeric weight that was applied to the length of time spent in the corresponding 
level of activity. The sum of weight moderate and vigorous activity was used as the 
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physical activity index for each subject. Activity at exam 3 was the average of the 
physical activity index from exams 2 and 4. 
Dietary Data: Data for total energy intake, total carbohydrate intake, total fat intake, 
saturated fat intake, dairy intake, whole grain intake and fiber intake is available by 
means of three-day diet records collected during the third and fifth exam cycles. These 
records were entered into the NDS nutrient calculation program in accordance with a 
standardized protocol to calculate mean intakes of macro- and micronutrients. 
Co-morbid Diseases: Additionally, data on co-morbid diseases that may impact 
functional status intake were collected as potential confounders including type II 
diabetes, CVD, and cancer at each exam. However, such conditions may be 
independently associated with both the exposure (dietary protein) and the outcome (risk 
of sarcopenia and ob'esity). Therefore, we will exclude individuals with a history of type 
II diabetes, CVD, and cancer. 
3.3. STATISTICAL ANALYSIS 
The exposure variables (dietary protein intake and protein quality intake) will be 
examined as continuous and categorical variables. We will use a sensitivity analysis to 
explore different cutoff points for dietary protein to evaluate whether effects are linear or 
whether threshold effect might exist. The incidence of sarcopenia and obesity will be 
treated as categorical outcomes. For these variables we will generally classify subjects as 
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having the outcome or not. The potential confounding variables previously mentioned 
will be explored for inclusion in the multivariable models. Variables that change the 
mean differences by more than 1 0% will be retained in the final models. 
Only those subjects free of sarcopenia at baseline will be included and then followed 
forward for the development of sarcopenia. Follow up for the occurrence of sarcopenia 
will begin at the end of the exam 3 visit and continue until the first of the following 
events: diagnosis of sarcopenia, last date of contact for those lost to follow up, death, or 
end of Exam 7 (completed in 2002). Incidence rates of sarcopenia for each protein intake 
category will be calculated as the number of new cases of sarcopenia occurring during the 
follow-up period divided by the total number of person-years of follow up. Similarly, 
only those subjects free of obesity and central adiposity at baseline will be included and 
followed for the development of the obesity and central adiposity respectively. Multiple 
logistic regression analysis was used to estimate the relative odds (odds ratio, O.R.) of 
developing abdominal adiposity and risk of being overweight in late adolescence (18-20 
years) associated with protein intake. Follow up for the occurrence of obesity and central 
adiposity will begin at the end of the exam 3 visit and continue until the first of the 
following events: diagnosis of obesity or central adiposity, last date of contact for those 
lost to follow up, death, or end of Exam 7. Incidence rates of obesity and central 
adiposity for each protein intake category will be calculated as the number of new cases 
of obesity and central adiposity occurring during the follow-up period divided by the total 
number of person-years of follow up. 
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Final models for obesity and central adiposity outcomes contained the following potential 
confounding variables: age, sex, education level, height, physical activity, cigarettes per 
day, % cals from fat and energy intake. The final model for sarcopenia was adjusted for 
age, sex, education level, height, physical activity, cigarettes per day, and % cals from 
fat. Energy intake was not included as confounder because it does not seem to have a 
strong independent effect on skeletal muscle mass as it does on obesity outcomes. 
Multiple logistic regressiOn was also used to assess the relative odds of obesity, 
abdominal adiposity and sarcopenia associated with protein intake in the context of a 
healthy eating pattern including fruits and vegetables, low-fat dairy, whole grains, and 
fiber. For example, fruit and vegetable intake (FV) was dichotomized (<3.0 v. 2:3.0 
servings/d for FV) and then combined into one of four categories: (a) low intakes of both 
protein and FV, (b) low intake of protein and high intake ofFV, (c) high intake of protein 
but low intake of FV, and (d) high intakes of both protein and FV. The process was 
repeated for fruit and non-starchy vegetables, fruits and total vegetables, whole grains, 
fiber, low-fat dairy, and SOFAs. Cut-points were chosen in part to optimize analytic 
power. 
Sex-specific Cox proportional-hazards models will determine the effect of dietary protein 
intake on risk of central adiposity. Cox-proportional-hazard models will also determine 
the effect of dietary protein on sarcopenia risk, and obesity risk. In these multivariable 
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Cox models, we will adjust for the above-described potential confounders as fixed 
covariates. 
3.4 RESULTS 
Baseline characteristics of subjects between 30 to 54 years of age according to tertiles of 
protein intake per kg IBW are presented in Table 3.1. Subjects were slightly older in the 
first tertile of dietary protein (p-value: 0.0027). Energy intake and% of calories from fat 
were significantly higher in the highest tertile of protein intake (p-value <0.0001 and 
0.0082 respectively), while % of calories from carbohydrates were significantly lower at 
baseline (p-value <0.0001). Subjects in the highest tertile of intake also consumed more 
protein from both animal and plant sources. Lastly, intakes of dietary fiber, low-fat dairy, 
fruits and vegetables and whole grains were significantly higher in the highest tertile of 
protein intake per kg IBW (p-value < 0.0001 for all). 
Table 3.2 shows the baseline characteristics of subjects according to weight-adjusted 
protein residuals. Subjects in the first tertile of protein intake were slightly older (p-value: 
0.0099) and significantly shorter (p-value <0.0001) than those in the highest tertile. 
Subjects in the highest tertile of protein intake had higher energy intakes (p-value 
<0.0001), higher% of calories from fat (p-value: 0.0148) and lower% of calories from 
carbohydrates (p-value <0.0001). They also consumed more dietary fiber, low-fat dairy, 
fruits and vegetables and whole grains (p-value <0.0001 for all). These variables that 
differ across categories of intake will be considered as potential confounders. 
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Table 3.3 shows the mean BMI at the end of follow-up according to tertiles of protein 
intake per kg IBW. There was a significant decline in BMI for total protein and plant 
protein with increasing tertiles of intake (p for trend= 0.0015 and <0.0001, respectively). 
Similarly, when stratified by baseline weight, there was a significant decline in BMI with 
increasing tertiles of total protein and plant protein intake (p for trend= 0.0007 and 
<0.0001, respectively) for subjects that had a normal BMI (<25 kg/m2) at baseline. 
However, for subjects that were overweight or obese at baseline, higher animal plant 
protein intake was associated with a higher BMI at end of follow-up (p for trend: 0.0110). 
Table 3.1 Baseline characteristics according to protein per kg IBW 
Tertiles of urotein intake (g/ k2 IBW) 
T1 T2 T3 
n=530 n=529 n=522 p value 
(mean± s.d.) 
Baseline Characteristics 
Age (yrs) 44 .1} ± 6.10 43.7 ± 6.50 43 .7 ± 6.50 0.0027 
Height (em) 168.8 ± 9.10 169.3 ± 9.10 169.4 ± 9.30 0.5478 
Weight (kg) 74.3 ± 15.40 74.0 ± 15.70 73.8 ± 16.20 0.8809 
BMl (kg/m~) 26.1 ± 4.10 25.8 ± 4.40 25 .7 ±4.60 0.3499 
Physical Activity 12.1 ± 7.50 12.4 ± 8.00 12 .6 ± 8.20 0.6133 
Cigarettes/ day 6.6 ± 12.60 5.1 ± 10.80 5.4 ± 11.90 0.1061 
Macronutrient Intakes 
Energy 1591 ± 408 1916 ± 437 2345 ± 562 <0.0001 
% of calories from protein 15.4 ± 3.00 16.9 ± 3.20 17.9 ± 3.30 <0.0001 
% calories from fat 35 .1 ± 6.50 35.8 ± 6.50 36.3 ± 6.40 0.0082 
% calories from carbs 47.9 ± 8.30 45 .2 ± 7.80 43 .5 ± 7.50 <0.0001 
Total protein (glkg IDW) 0.9 ± 0.10 1.2±0.10 1.5 ± 0.20 <0.0001 
Animal protein (g/kg IDW) 0.6 ± 0.10 0.8 ± 0.10 1.1 ± 0.20 <0.0001 
Plant protein (g/kg IBW) 0.3 ± 0.10 0.3 ±0.10 0.4 ± 0.10 <0.0001 
Food Groups 
Dietary fiber (g) 13.5 ± 5.10 15.7 ± 5.50 18.4±7.10 <0.0001 
Low fat dairy servings 0.6 ± 0.50 0.8 ± 0.60 1.0 ± 0.90 <0.0001 
Fruits & vegetables servings 2.6 ± 1.30 3.0 ± 1.30 3.4 ± 1.60 <0.0001 
Whole grain servings 0.5 ± 0.60 0.6 ± 0.70 0.7 ± 0.80 <0.0001 
column percent (0/o) 
Education Level 35 .2 38.3 40.9 0.0694 
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Table 3.2 Baseline characteristics according to weight-adjusted protein residuals 
Tertiles of l!rotein intake in residuals (g) 
T1 T2 T3 
n=519 n=531 n=531 p value 
(mean± s.d.) 
Baseline Characteristics 
Age (yrs) 44.8 ±6.20 43 .9 ± 6.30 43.6 ± 6.60 0.0099 
Height (em) 166.9±8.60 168.6 ± 8.90 171.9±9.20 <0.0001 
Weight (kg) 74.1±17.00 72.3 ± 15.80 75.9 ± 14.20 0.0009 
BMI (kg/m~) 26.6± 5.00 25.4 ± 4.20 25.6 ± 3.70 <0.0001 
Physical Activity 12.1 ±7.40 11.9 ± 7.80 13.0±8.40 0.0473 
Cigarettes/ day 6.4 ± 12.20 5.0 ± 11.00 5.7± 12.20 0.1732 
Macronutrient Intakes 
Energy 1541 ± 353 1885 ± 406 2411 ± 530 <0.0001 
% of calories from protein 15.5±3.00 16.9 ± 3.30 17.8±3.20 <0.0001 
%calories from fat 35.1 ± 6.40 35.8 ± 6.60 36.3 ± 6.40 0.0148 
%calories from carbs 47.8 ± 8.40 45.4 ± 7.70 43.3 ± 7.60 <0.0001 
Total protein (residuals) 0.9±0.10 1.2±0.10 1.5 ± 0.20 <0.0001 
Animal protein (residuals) 0.6±0.10 0.8±0.10 1.1±0.20 <0.0001 
Plant protein (residuals) 0.3±0.10 0.3 ± 0.10 0.4±0.10 <0.0001 
Food Groups 
Dietary fiber (g) 13.0±4.50 15.7 ± 5.50 18.8 ± 7.10 <0.0001 
Low fat dairy servings 0.6 ± 0.50 0.7 ± 0.60 1.0 ± 0.90 <0.0001 
Fruits & vegetables servings 2.6 ± 1.20 3.0 ± 1.30 3.4±1.60 <0.0001 
Whole grain servings 0.5 ± 0.50 0.6 ± 0.80 0.7 ± 0.80 <0.0001 
column percent (%) 
Education Level 33.2 36.1 44.9 0.0002 
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Table 3.3 Mean BMI at follow-up associated with protein intake per kilogram of 
nearest ideal body weight 
BMI (kg/m·} at Follow-ul! 
Intake (Age 30-<55) Baseline Weight Baseline Weight 
All Subjects (BMI < 25 kg/m2) (BMI ~25 kg/m2) 
N mean± s.e. N mean± s.e. N mean ±s.e. 
Total Protein {g/k!!: IBW /day} 
Tertile 1 495 26.9 ±0.22 21S 23.6 ±0.16 277 2S.S ±0.27 
Tertile 2 510 26.6±0.19 240 23.4 ± 0.14 270 29.3 ± 0.24 
Tertile 3 4S5 25.S ±0.22 245 22.S ± 0.15 240 29.6 ± 0.30 
p-trend 0.0015 0.0007 0.0913 
Animal Protein {g/k!!: IBW /da,Y} 
Tertile 1 497 26.2 ± 0.20 244 23.4 ± 0.14 253 2S.5 ±0.27 
Tertile 2 506 26.S±0.19 224 23.2±0.14 2S2 29.5 ±0.23 
Tertile 3 4S7 26.2±0.21 235 23.1±0.15 252 29.6 ± 0.27 
p-trend 0.9157 0.1558 0.0110 
Plant Protein {g/kg IBW /da,Y} 
Tertile 1 499 27.5±0.21 195 23 .9±0.17 304 29.4 ± 0.26 
Tertile 2 499 26.4 ± 0.19 238 23 .6 ± 0.14 261 29.0 ± 0.24 
Tertile 3 492 25 .2 ± 0.22 270 22.5 ± 0.15 222 29.2 ± 0.31 
p-trend <0.0001 <0.0001 0.5025 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day, % cals from 
fat and energy intake. 
The risk of developing obesity according to tertiles of protein intake per kg IBW is 
presented in Table 3.4. Obesity risk was reduced by 32% (95% CI: 0.45-1.03) and 45% 
(95% CI: 0.37-0.83) for total protein and plant protein in the highest tertile of protein 
intake compared to the lowest tertile. Stratified by baseline BMI, in normal weight 
subjects, the risk of obesity declined by 35% (95% CI: 0.25-1.64), 26% (95% CI: 0.31-
1.75) and 45% (95% Cl: 0.19-1.62) for total protein, animal protein, and plant protein 
respectively. In overweight or obese subjects, obesity risk increased in the highest tertile 
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of protein intake by 35% (95% CI: 0.82-2.22), 63% (95% CI: 1.06-2.52) and 13% (95% 
CI: 0.72-1.79) for total, animal, and plant protein respectively. 
Table 3.5 shows the mean BMI at the end of follow-up associated with weight-adjusted 
protein residuals (g). Mean BMI declined linearly with increasing intakes oftotal protein, 
animal protein, and plant protein (p for trend <0.0001 for all). Stratified by baseline BMI, 
in overweight subjects, the mean BMI also declined significantly with increasing intakes 
of total, animal, and plant protein (p for trend <0.0001, 0.0012, and <0.0001 
respectively). 
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Table 3.4 Risk of obesity associated with protein intake per Kg of nearest ideal body 
weight (IBW) 
Risk of Developing Obesity (BMI > 30 kg/m"') 
All Subjects 
Intakes 
(ages 30-50) P-yrs Cases I /103 py 
Protein (g/k!! IDW /dal:} 
Tl 7151 92 12.9 
T2 7430 80 10.8 
T3 7491 64 8.5 
Animal Protein (g/k!! IBW /dal:) 
T1 7487 79 10.6 
T2 7208 88 12.2 
T3 7378 69 9.4 
Plant Protein (g/k!! ffiW /dal:} 
T1 6683 95 14.2 
T2 7623 77 10.1 
T3 7766 64 8.2 
RRI 95% CI 
1.00 
0.87 0.63-1.19 
0.68 0.45 - 1.03 
1.00 
1.27 0.92- 1.73 
1.02 0.71-1.47 
1.00 
0.75 0.54- 1.03 
0.55 0.37 -0.83 
Baseline BMI <25 kg/m2 
Protein (Ji:/kg IDW /dal:} 
Tl 4103 15 3.7 1.00 
T2 4587 9 2.0 0.51 0.21 - 1.23 
T3 4844 14 2.9 0.65 0.25- 1.64 
Animal Protein (g/kg IBW /dal:} 
T1 4525 13 2.9 1.00 
T2 4330 13 3.0 0.99 0.45-2.19 
T3 4679 12 2.6 0.74 OJ I - 1.75 
Plant Protein (g/k!! IDW/dal:) 
T1 3639 13 3.6 1.00 
T2 4606 13 2.8 0.83 0.36 - 1.94 
T3 5289 12 2.3 0.55 0.19-1.62 
3048 
2844 
2647 
2963 
2878 
2698 
3044 
3017 
2477 
Baseline BMI 2':25 kg/m2 
77 25.3 1.00 
71 25.0 1.33 0.92- 1.92 
50 18.9 1.35 0.82 -2.22 
66 22.3 1.00 
75 26.1 1.47 1.04-2.09 
57 21.1 1.63 1.06-2.52 
82 26.9 1.00 
64 21.2 1.04 0.73- 1.50 
52 21.0 1.13 0.72- 1.79 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day, % cals from 
fat and energy intake. 
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Table 3.5 Mean BMI at follow-up associated with protein intake adjusted for weight 
with residual method 
BMI {!ig/m"'} at Fo1low-u~ 
Intakes (Age 30- Baseline Weight Baseline Weight 
All Subjects (BMI < 25 kg/m2) (BMI ;::25 kg/m2) <55) N mean ±s.e. N mean ±s.e. N mean ±s.e. 
Total Protein {residuals {g)} 
Tertile 1 487 27.8 ± 0.22 210 23.3 ± 0.17 277 30.4 ± 0.27 
Tertile 2 506 26.1 ±0.19 268 23.3 ± 0.13 238 29.0 ± 0.25 
Tertile 3 497 25.4 ± 0.22 225 23.1±0.16 272 28.2 ± 0.28 
p-trend <0.0001 0.5843 <0.0001 
Animal Protein {residuals {g)} 
Tertile 1 494 27.0 ±0.20 229 23.2 ± 0.15 265 29.9 ± 0.26 
Tertile 2 497 26.5 ± 0.19 243 23.3 ± 0.14 254 29.2 ±0.24 
Tertile 3 499 25 .7 ± 0.20 231 23.2±0.15 268 28.6 ± 0.26 
p-trend <0.0001 0.8741 0.0012 
Plant Protein {residuals {g)) 
Tertile 1 490 27.8 ±0.22 206 23.5 ±0.18 284 30.3 ± 0.26 
Tertile 2 500 26.2 ± 0.19 252 23.3 ±0.14 248 28.8 ± 0.25 
Tertile 3 500 25.2 ± 0.22 245 23.0±0.17 255 28.4 ± 0.29 
p-trend <0.0001 0.0726 <0.0001 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day, % cals from 
fat and energy intake. 
The O.R. for developing obesity according to tertiles of weight-adjusted protein residuals 
is shown in Table 3.6. Obesity risk declined by 35% (95% CI: 0.43-1.00), 20% (95% CI: 
0.55-1.15), and 36% (95% CI: 0.42-0.97) in the highest tertile of total protein, animal 
protein, and plant protein intake compared with the lowest tertile. Similarly, when 
stratified by baseline BMI, subjects who were normal weight also had a reduced risk of 
obesity with increasing tertiles of total protein, animal protein, and plant protein. 
However, in overweight or obese subjects, the O.R. for obesity increased by 7% (95% CI: 
0.65-1.77) and 11% (95% CI: 0.73-1.69) for total and animal protein. 
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Table 3.6 Risk of obesity associated with protein intake adjusted for weight with 
residual method 
Risk of Developing Obesity (BMI > 30 kg/m:z) 
All Subjects 
Intakes 
(Age 30-<55) P-yrs Cases I /103 py RR1 95% CI 
Protein {residuals} 
Tertile 1 6549 84 12.8 1.00 
Tertile 2 7663 83 10.8 0.86 0.62 - 1.20 
Tertile 3 7860 69 8.8 0.65 0.43 - 1.00 
Animal Protein {residuals} 
Tertile 1 6883 82 11.9 1.00 
Tertile 2 7346 84 11.4 1.00 0.73 - 1.37 
Tertile 3 7843 70 8.9 0.80 0.55 - 1.15 
Plant Protein {residuals} 
Tertile 1 6415 90 14.0 1.00 
Tertile 2 7759 73 9.4 0.70 0.50 - 0.98 
Tertile 3 7899 73 9.2 0.64 0.42 - 0.97 
Baseline BMI <25 kg/m 2 Baseline BMI 2:25 kglm 2 
Protein {residuals} 
Tertile 1 3951 13 3.3 1.00 2599 71 27.3 1.00 
Tertile 2 5018 13 2.6 0.78 0.34 - 1.78 2645 70 26.5 1.24 0.86 - 1.81 
Tertile 3 4565 12 2.6 0.74 0.27 - 2.02 3295 57 17.3 1.07 0.65 - 1.77 
Animal Protein {residuals} 
Tertile 1 4245 14 3.3 1.00 2638 68 25.8 1.00 
Tertile 2 4682 13 2.8 0.83 0.38 - 1.81 2664 71 26.6 1.22 0.86 - 1.73 
Tertile 3 4607 11 2.4 0.65 0.27 - 1.58 3236 59 18.2 1.11 0.73 - 1.69 
Plant Protein {residuals} 
Tertile 1 3828 14 3.7 1.00 2587 76 29.4 1.00 
Tertile 2 4939 II 2.2 0.69 0.29 - 1.64 2820 62 22.0 0.89 0.62 - 1.29 
Tertile 3 4767 13 2.7 0.87 0.29 - 2.57 3132 60 19.2 0.96 0.60 - 1.53 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day, % cals from 
fat and energy intake. 
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Mean waist size at the end of follow-up associated with protein intake per kg IBW is 
presented in Table 3.7. With increasing tertiles of plant protein intake, waist size declined 
significantly and linearly in men and women (p for trend <0.0001 for both). When 
stratified by baseline BMI, higher tertiles of total protein intake were associated with a 
lower waist circumference in normal weight men (p for trend: 0.0065) while only plant 
proteins were protective for women (p for trend: 0.0007). 
The risk of central adiposity (estimated as a higher waist size) associated with protein 
intake per kg IBW is presented in Table 3.8. Overall, the risk of central adiposity 
declined by 18% (95% CI: 0.66-1.02) for those in the highest tertile of protein intake. 
Greater plant protein intake was associated with a 40% (95% CI: 0.48-0.75) reduction in 
risk of having a high waist size. When stratified by baseline BMI, subjects who were 
normal-weight had a 17% (95% CI: 0.58-1.20), 21% (95% CI: 0.58-1.08), and 32% (95% 
CI: 0.42-1.05) reduced risks of central adiposity in the highest (vs. lowest) tertile of 
dietary protein intake. This was not the case in overweight/obese older adults who 
actually showed an increased risk. 
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Table 3.7 Mean waist size for men and women at follow up associated with protein 
intake per kg of nearest ideal body weight (stratifying by baseline weight status) 
Men (Mean Waist Size at Follow U(!) 
Intakes 
(Ages 30-<55) All Baseline BMI <25 kg/m2 Baseline BMI ~25 kg/m2 
N mean ±s.e. N mean± s.e. N mean± s.e. 
Total Protein (g/k!! IBW /day) 
Tertile 1 172 38.7 ± 0.33 41 35 .6 ± 0.39 131 39.6 ± 0.35 
Tertile 2 227 38.3 ± 0.26 64 35 .0 ± 0.29 163 39.5 ± 0.28 
Tertile 3 259 38.1 ±0.27 78 34.2 ± 0.28 181 39.9 ± 0.30 
p-trend 0.2439 0.0065 0.4754 
Animal Protein (g/kg IBW /day) 
Tertile 1 182 38.0 ± 0.31 55 35 .3 ± 0.32 127 39.1 ± 0.34 
Tertile 2 220 38.6 ±0.26 57 34.7 ± 0.30 163 39.8 ± 0.27 
Tertile 3 256 38.4 ± 0.26 71 34.5 ± 0.28 185 39.9 ± 0.28 
p-trend 0.4225 0.0702 0.1298 
Plant Protein (g/k!! IBW /day) 
Tertile 1 207 39.4 ± 0.30 42 35.2 ± 0.40 165 40.3 ± 0.30 
Tertile 2 215 38.0 ± 0.26 61 34.9 ± 0.29 154 39.2 ± 0.28 
Tertile 3 236 37.7 ± 0.28 80 34.5 ± 0.29 156 39.5 ± 0.32 
p-trend <0.0001 0.2000 0.0705 
Women (Mean Waist Size at Follow U(!) 
Total Protein (g/k!! IBW /dav) 
Tertile 1 323 32.3 ± 0.29 177 29.6 ±0.26 146 35 .2 ± 0.43 
Tertile 2 283 32.3 ± 0.28 176 29.8 ±0.23 107 36.4 ± 0.44 
Tertile 3 226 31.0 ± 0.36 167 29.4 ±0.27 59 36.4 ± 0.69 
p-trend 0.0151 0.5482 0.1292 
Animal Protein (g/kg IBW /day) 
Tertile 1 315 31.9 ± 0.28 189 29.6 ±0.23 126 35.4 ± 0.43 
Tertile 2 286 32.3 ± 0.28 167 29.6 ±0.24 119 36.2±0.41 
Tertile 3 231 31.6 ± 0.33 164 29.6 ± 0.25 67 36.2 ± 0.60 
p-trend 0.5687 0.9321 0.251 7 
Plant Protein (g/k!! IBW /day) 
Tertile 1 292 33 .2 ± 0.32 153 30.3 ± 0.29 139 35.8 ± 0.44 
Tertile 2 284 32.0 ± 0.27 177 29.8 ±0.23 107 35.4 ± 0.44 
Tertile 3 256 30.5 ± 0.34 190 28.8 ± 0.26 66 36.7 ± 0.66 
p-trend <0.0001 0.0007 0.4379 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day, % cals from 
fat and energy intake. 
75 
Table 3.8 Risk of obesity associated with protein intake per kg of nearest ideal body 
weight (IBW) 
Intake 
Risk of Central Obesity (Waist >40", men and >35", women) 
All Subjects 
(Age 30-<55) P-yrs Cases I /103 py RR 95% CI P-yrs Cases I /103 py 
Protein (g/k!! IBW/dav) 
Tertile 1 5888 300 51.0 1.00 
Tertile 2 6214 283 45 .5 1.01 0.85 - 1.20 
Tertile 3 6536 244 37.3 0.82 0.66 - 1.02 
Animal Protein (g/k!! IBW /day} 
Tertile 1 6063 290 47.8 1.00 
Tertile 2 6129 281 45.9 1.08 0.91 - 1.28 
Tertile 3 6446 256 39.7 0.97 0.80 - 1.17 
Plant Protein (g/kg IBW /dav) 
Tertile 1 5624 313 55.7 1.00 
Tertile 2 6359 280 44.0 0.80 0.67 - 0.95 
Tertile 3 6655 234 35.2 0.60 0.48 - 0.75 
RRI 95% CI 
Baseline Weight (BMI < 25 kg/m2) Baseline BMI ~25 kg/m 2 
Protein (g/kg IBW /day} 
Tertile 1 3275 100 30.5 1.00 2613 200 76.5 1.00 
Tertile 2 3792 90 23 .7 0.92 0.68 - 1.25 2422 193 79.7 1.36 1.09 - 1.69 
Tertile 3 4219 81 19.2 0.83 0.58 - 1.20 2318 163 70.3 1.32 1.00 - 1.75 
Animal Protein (g/kg IBW /day} 
Tertile 1 3583 Ill 31.0 1.00 2480 179 72.2 1.00 
Tertile 2 3694 . 79 21.4 0.73 0.54 - 0.98 2435 202 83.0 1.39 1.1 2 - 1.72 
Tertile 3 4009 81 20.2 0.79 0.58 - 1.08 2437 175 71.8 1.36 1.06 - 1.75 
Plant Protein (g/k!! IBW/dav) 
Tertile 1 2885 89 30.8 1.00 2739 224 81.8 1.00 
Tertile 2 3830 95 24.8 0.89 0.64 - 1.22 2529 185 73.2 1.00 0.80 - 1.24 
Tertile 3 4570 87 19.0 0.68 0.45 - 1.02 2085 147 70.5 1.07 0.82 - 1.41 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day, % cals from 
fat and energy intake. 
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Table 3.9 shows mean waist circumference at the end of follow-up associated with 
weight-adjusted protein residuals. With increasing tertiles of protein intake, waist 
circumference declined significantly for total, animal, and plant protein in men (p for 
trend: <0.0001, 0.0387, <0.0001 respectively). When stratified by baseline BMI, 
overweight/obese men had significant decreases in waist circumference with increasing 
tertiles of total and plant protein (p for trend: 0.0029, <0.0001 respectively) Women also 
had statistically significant decreases in waist size with increasing tertiles of total, animal, 
and plant protein. When stratified by baseline BMI, overweight/obese women had 
significant decreases in waist circumference for total and animal protein intake (p for 
trend: 0.0074, 0.0038). 
The risk of central adiposity according to tertiles of weight-adjusted protein residuals 
decreased by 30% (95% CI: 0.56-0.88), 19% (95% CI: 0.67-0.99), and 36% (95% Cl: 
0.51-0.80) in the highest (vs. lowest) tertile of total, animal, and plant protein (Table 
3.10). When adjusted for baseline BMI, older adults with a BMI < 25 kg/m2 had a 20% 
(95% CI: 0.83-1. 75) higher risk of central adiposity for total protein, a 10% (95% CI: 
0.65-1.25) reduced risk for animal protein, and an 11% (95% CI: 0.73-1.70) increased 
risk for plant protein in the highest tertile of intake. For overweight/older adults, higher 
dietary protein was associated with a reduced risk of central adiposity however. 
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Table 3.9 Mean waist size for men and women at follow up associated with protein 
intake adjusted for weight using residual method 
Men (Mean Waist Size at Follow Ul!} 
Intakes (Ages 30-<55) All Baseline BMI <25 Baseline BMI ~25 
N mean ±s.e. N mean ±s.e. N mean ± s.e. 
Total Protein (residuals (g}} 
Tertile 1 136 39.9 ± 0.37 25 35.6 ± 0.49 111 40.8 ± 0.38 
Tertile 2 196 38.2 ± 0.28 57 35.0 ± 0.31 139 39.5 ± 0.30 
Tertile 3 326 37.7 ±0.23 101 34.5 ±0.24 225 39.2 ± 0.26 
p-trend <0.0001 0.0576 0.0029 
Animal Protein (residuals (g}} 
Tertile 1 157 39.0 ± 0.33 39 35.2 ±0.38 118 40.3 ± 0.35 
Tertile 2 197 38.2 ± 0.28 54 34.7±0.31 143 39.5 ± 0.29 
Tertile3 304 38.0 ± 0.23 90 34.7 ±0.25 214 39.4 ± 0.25 
p-trend 0.0397 0.4564 0.0842 
Plant Protein (residuals (g}} 
Tertile 1 169 40.0 ± 0.33 32 34.9 ± 0.45 137 41.1 ±0.33 
Tertile 2 183 38.0 ±0.28 48 34.7 ± 0.34 135 39.2 ±0.29 
Tertile 3 306 37.5 ± 0.24 103 34.8 ± 0.25 203 39.0 ± 0.27 
p-trend <0.0001 0.9508 <0.0001 
Women {Mean Waist Size at Follow Ul!} 
Total Protein {residuals {g}} 
Tertile 1 351 32.8 ±0.27 185 29.2 ±0.25 166 36.5 ± 0.38 
Tertile 2 310 31.8 ± 0.27 211 30.0 ± 0.21 99 35.5 ± 0.46 
Tertile 3 171 30.6 ± 0.40 124 29.5 ±0.31 47 34.2 ±0.74 
p-trend <0.0001 0.3690 0.0074 
Animal Protein {residuals {g}} 
Tertile 1 337 32.4 ± 0.27 190 29.3 ±0.23 147 36.5 ±0.39 
Tertile 2 300 32.2 ± 0.27 189 29.9 ±0.22 111 36.0 ± 0.43 
Tertile 3 195 30.8 ± 0.35 141 29.6 ±0.27 54 34.0 ±0.64 
p-trend 0.0017 0.3775 0.0038 
Plant Protein {residuals {g}} 
Tertile 1 321 33 .2 ± 0.30 174 30.0 ±0.28 147 36.4 ± 0.42 
Tertile 2 317 31.5 ± 0.26 204 29.5 ±0.21 113 35.1 ±0.43 
Tertile 3 194 30.7 ± 0.40 142 29.3 ± 0.31 52 36.2 ±0.74 
p-trend <0.0001 0.1222 0. 4310 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day,% cats from 
fat and energy intake. 
78 
Table 3.10 Risk of central obesity associated with protein intake adjusted for weight 
using residual method 
Risk of Central Obesitt (Waist >40" 2 men and >35" 2 women} 
Intakes All Subjects 
(Age 30-<55) P-yrs Cases I /103 py RR 95%CI P-yrs Cases I /103 py RR1 95%CI 
Protein (residuals} 
Tertile 1 5519 301 54.5 1.00 
Tertile 2 6419 278 43 .3 0.83 0.70 - 0.99 
Tertile 3 6699 248 37.0 0.70 0.56 - 0.88 
Animal Protein (residuals} 
Tertile 1 5714 297 52.0 1.00 
Tertile 2 6234 274 44.0 0.91 0.77 - 1.08 
Tertile 3 6689 256 38.3 0.81 0.67 - 0.99 
Plant Protein (residuals} 
Tertile 1 5498 312 56.7 1.00 
Tertile 2 6508 267 41.0 0.71 0.59 - 0.85 
Tertile 3 6631 248 37.4 0.64 0.51 - 0.80 
Baseline Weight (BMI < 25 kg/m~) Baseline BMI 2:25 kg/m 2 
Protein (residuals} 
Tertile I 3187 91 28.6 1.00 2333 210 90.0 1.00 
Tertile 2 4180 101 24.2 1.05 0.78- 1.42 2239 177 79.1 0.97 0.78 - 1.22 
Tertile 3 3918 79 20.2 1.20 0.83 - 1.75 2781 169 60.8 0.78 0.58 - 1.05 
Animal Protein (residuals} 
Tertile 1 3407 103 30.2 1.00 2307 194 84.1 1.00 
Tertile 2 3936 88 22.4 0.83 0.62 - 1.12 2298 186 81.0 1.10 0.89 - 1.36 
Tertile 3 3942 80 20.3 0.90 0.65 - 1.25 2748 176 64.1 0.95 0.74 - 1.22 
Plant Protein (residuals} 
Tertile 1 3087 93 30.1 1.00 2411 219 90.8 1.00 
Terti1e 2 4156 91 21.9 0.83 0.60 - 1.14 2352 176 74.8 0.81 0.65 - 1.01 
Tertile 3 4041 87 21.5 1.11 0.73 - 1.70 2590 161 62.2 0.78 0.60 - 1.03 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day, % cals from 
fat and energy intake. 
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Mean % skeletal muscle mass and risk of sarcopenia associated with protein intake per kg 
IBW are presented in Tables 3.11 and 3.12. Skeletal muscle mass increased significantly 
at the end of follow-up for increasing tertiles of total protein and plant protein (p for trend 
<0.0001 for both). Stratified by baseline BMI, % SMM increased significantly for total, 
animal, and plant protein in normal-weight and overweight/obese individuals (p for trend 
<0.0001 for all). The risk of developing sarcopenia was decreased by 17% (95% Cl: 
0.69-1.00), 10% (95% CI: 0.75-1.09), and 27% (95% CI: 0.60-0.88) in the highest tertile 
of total protein, animal protein, and plant protein intake compared to the lowest tertile. 
Table 3.11 Mean %smm at follow-up associated with protein intake per kg of 
nearest ideal body weight 
%SMM at Follow-up 
Intakes (Age 30- Baseline Weight Baseline Weight 
<55) All Subjects (BMI < 25 kg/m
2) (BMI 2:25 kg/m2) 
N mean± s.e. N mean± s.e. N mean± s.e. 
Total Protein (~:/k~:; IBW /day) 
Tertile 1 457 31.9 ± 0.18 215 31.9 ± 0.31 242 30.6 ± 0.31 
Tertile 2 469 32.2 ± 0.17 233 32.7 ± 0.30 236 31.7 ± 0.31 
Tertile 3 460 32.9±0.18 245 33.8 ± 0.29 215 33.5 ± 0.33 
p-trend <0.0001 <0.0001 <0.0001 
Animal Protein (g/kg IBW /day) 
Tertile 1 472 32.2 ± 0.18 242 32.0 ±0.29 230 31.1 ± 0.32 
Tertile 2 464 32.3 ±0.17 223 33.0 ± 0.30 241 31.3 ± 0.31 
Tertile 3 450 32.6 ± 0.18 228 33.7 ± 0.30 222 33.3 ± 0.33 
p-trend 0.1466 <0.0001 <0.0001 
Plant Protein (g/kg IBW/day) 
Tertile 1 441 31.6±0.18 183 31.9 ± 0.34 258 30.8 ± 0.30 
Tertile 2 464 32.2 ± 0.17 231 32.3 ± 0.29 233 32.3 ± 0.32 
Tertile 3 481 33 .2±0.17 279 33.9 ± 0.27 202 32.8 ± 0.35 
p-trend <0.0001 <0.0001 <0.0001 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals 
from fat. 
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Table 3.12 Risk of sarcopenia associated with protein intake per kg of nearest ideal 
body weight 
Risk of Developing Sarcopenia 
Intakes All Subjects 
(Age 30-<55) P-yrs Cases I /103 py RR1 95% CI P-yrs Cases I /103 py RR1 95% CI 
Protein {g/kg ffiW/day) 
Tertile 1 7661 261 
Tertile 2 7850 243 
Tertile 3 8007 205 
34.1 
31.0 
25.6 
Animal Protein (g/kg ffiW /day) 
Tertile 1 7682 251 32.7 
Tertile 2 7896 239 30.3 
Tertile 3 7939 219 27.6 
Plant Protein {g/kg ffiW/day) 
Tertile 1 7533 268 35.6 
Tertile 2 7906 246 31.1 
Tertile 3 8079 195 24.1 
1.00 
1.05 0.88 - 1.26 
0.83 0.69 - 1.00 
1.00 
1.02 0.85 - 1.22 
0.90 0.75 - 1.09 
1.00 
0.90 0.76 - 1.08 
0.73 0.60 - 0.88 
Baseline BMI <25 kg/m 2 
Protein (g/kg ffiW/day) 
Tertile 1 3680 73 19.8 1.00 
Tertile 2 4124 67 16.2 1.05 0.75 - 1.48 
Tertile 3 4465 64 14.3 0.86 0.61 - 1.21 
Animal Protein (g/kg ffiW/day) 
Tertile 1 4060 77 19.0 1.00 
Tertile 2 3966 60 15 .1 0.87 0.62 - 1.23 
Tertile 3 4244 67 15.8 0.86 0.61 - 1.20 
Plant Protein (glkg ffiW/day) 
Tertile 1 3212 68 21.2 1.00 
Tertile 2 4117 80 19.4 1.06 0.76 - 1.49 
Tertile 3 4941 56 11.3 0.65 0.45 - 0.94 
Baseline BMI ~5 kg/m 2 
3980 188 47.2 1.00 
3726 176 47.2 1.18 0.96 - 1.46 
3542 141 39.8 1.07 0.85 - 1.35 
3623 174 48.0 1.00 
3930 179 45.5 1.06 0.86 - 1.31 
3695 152 41.1 1.07 0.85 - 1.35 
4322 200 46.3 1.00 
3788 166 43.8 1.01 0.82 - 1.25 
3138 139 44.3 1.17 0.93 - 1.47 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals 
from fat 
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Tables 3.13 and 3.14 show mean %SMM and the O.R. for sarcopenia according to tertiles 
of weight-adjusted protein residuals. Increasing tertiles of protein intake were 
significantly associated with higher %SMM for total, animal, and plant protein (p for 
trend: <0.0001, 0.0020, <0.0001 respectively). Stratified by baseline BMI, %SMM also 
increased significantly for normal-weight and overweight/obese individuals for total 
protein, animal protein, and plant protein. Higher intakes of total, animal, and plant 
protein were associated with an 18% (95% CI: 0.68-0.99), 18% (95% CI: 0.67-0.99), and 
20% (95% CI: 0.66-0.96) reduced risk of sarcopenia, respectively. 
Table 3.13 Mean %smm at follow-up associated with protein intake adjusted for 
weight with residual method 
%SMM at Follow-up 
Intakes All Subjects Baseline Weight Baseline Weight 
N mean ±s.e. N mean ±s.e. N mean ±s.e. 
Total Protein (residuals (g)) 
Tertile 1 449 31.7±0.18 207 32.0 ± 0.32 242 30.2 ± 0.31 
Tertile 2 470 32.5 ±0.17 260 32.7 ± 0.28 210 31.6 ± 0.32 
Tertile 3 467 32.8±0.18 226 33.8 ± 0.30 241 33.8 ± 0.31 
p-trend <0.0001 <0.0001 <0.0001 
Animal Protein (residuals (g)) 
Tertile 1 462 32.0 ± 0.18 227 32.1 ± 0.30 235 30.6 ±0.32 
Tertile 2 464 32.4 ± 0.17 241 32.8 ± 0.29 223 31.5 ± 0.32 
Tertile 3 460 32.8 ± 0.18 225 33.7 ± 0.30 235 33.5 ± 0.32 
p-trend 0.0020 0.0003 <0.0001 
Plant Protein (residuals (g)) 
Tertile 1 437 31.5 ±0.18 195 32.0 ± 0.34 242 30.5 ± 0.31 
Tertile 2 461 32.5 ± 0.17 244 32.6 ± 0.29 217 32.0 ± 0.33 
Tertile 3 488 33.0±0.18 254 33.7 ± 0.30 234 33 .2 ± 0.32 
p-trend <0.0001 0.0003 <0.0001 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals 
from fat 
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Table 3.14 Risk of sarcopenia associated with protein intake adjusted for weight 
with residual method 
Risk of Developing Sarcopenia 
Intakes All Subjects 
(Age 30-<55) P-yrs Cases 1 !to3 PY RRt 95%CI P-yrs Cases I /103 py RRt 95% CI 
Protein {residuals (g}} 
Tertile 1 7437 262 35.2 1.00 
Terti1e 2 7985 230 28 .8 0.91 0.76 - 1.09 
Terti1e 3 8096 217 26.8 0.82 0.68 - 0.99 
Animal Protein (residuals {g}} 
Tertile 1 7519 257 34.2 1.00 
Terti1e 2 7848 238 30.3 0.97 0.82 - 1.16 
Tertile 3 8151 214 26.3 0.82 0.67 - 0.99 
Plant Protein {residuals{g}} 
Tertile 1 7381 270 36.6 1.00 
Tertile 2 8065 223 27.7 0.77 0.64 - 0.92 
Tertile 3 8072 216 26.8 0.80 0.66 - 0.96 
Baseline BMI <25 kg/m 2 Baseline BMI 2:25 kg/m 2 
Protein {residuals {g}} 
Tertile 1 3553 67 18.9 1.00 3884 195 50.2 1.00 
Tertile 2 4547 72 15.8 1.03 0.73 - 1.45 3438 158 46.0 1.07 0.86 - 1.32 
Tertile 3 4170 65 15.6 1.03 0.72 - 1.47 3926 152 38.7 1.01 0.80 - 1.28 
Animal Protein {residuals (g}} 
Tertile 1 3804 74 19.5 1.00 3715 183 49.3 1.00 
Tertile 2 4278 65 15.2 0.88 0.63 - 1.24 3570 173 48 .5 1.12 0.90 - 1.38 
Tertile 3 4188 65 15.5 0.88 0.62 - 1.24 3962 149 37.6 0.97 0.77 - 1.23 
Plant Protein (residuals{g}} 
Tertile 1 3383 73 21.6 1.00 3998 197 49.3 1.00 
Tertile 2 4484 71 15.8 0.82 0.58 - 1.15 3580 152 42.5 0.90 0.73 - 1.12 
Tertile 3 4403 60 13 .6 0.83 0.57 - 1.20 3669 156 42.5 1.13 0.89 - 1.42 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals 
from fat. 
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In the context of a healthy eating pattern, a high protein/high fruits and vegetables diet 
was associated with a 25% (95% CI: 0.49-1.13) reduced risk of developing obesity 
compared with a low protein/low fruits and vegetables diet (Table 3 .15). This finding was 
not different from the effects of a high protein diet alone, where a 23% reduced risk was 
shown. A combination of high protein and high whole grain intake was associated with a 
12% (95% CI: 0.59-1.32) reduced risk of obesity compared with a low protein/ low 
whole grain diet. However, a high protein diet alone, independent of other eating patterns 
was associated with a lower risk of obesity. 
Table 3.15 risk of obesity associated with protein intake (weight adjusted residual 
methods) and other diet patterns 
Risk ofDeveloJ:!ing Obesitv (BMI > 30 kl!lm") 
Intakes (Age 30-<55) P-yrs Cases 1/1000 py RR: 95%CI 
Protein residuals (g) I FV Intake (svgs) 
Low Prot I Low FV 6049.03 75 12.4 1.00 
Low Prot I High FV 4207.18 52 12.4 1.01 0.70 - 1.45 
High Prot I Low FV 4870.02 47 9.7 0.77 0.52 - 1.15 
High Prot I High FV 6946.44 62 8.9 0.75 0.49 - 1.13 
Protein residuals (g) I Fiber (g) 
Low Prot I Low Fiber 6439.15 72 11.2 1.00 
Low Prot I High Fiber 3817.06 55 14.4 1.36 0.94 - 1.97 
High Prot I Low Fiber 4399.03 36 8.2 0.76 0.50 
- 1.18 
High Prot I High Fiber 7417.43 73 9.8 0.98 0.64 - 1.50 
Protein residuals (g} I Whole Grains (g} 
Low Prot I Low WGr 5518.78 73 13.2 1.00 
Low Prot I High WGr 4737.43 54 11.4 0.98 0.68 - 1.41 
High Prot I Low WGr 5382.29 43 8.0 0.62 0.41 - 0.95 
High Prot I High WGr 6434.17 66 10.3 0.88 0.59 - 1.32 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
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*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals 
from fat. 
Similarly, in Table 3.16, a high protein/ high fruits and vegetables diet was associated 
with a 17% (955 CI: 0.68-1.02) decreased risk of sarcopenia compared to a low 
protein/low fruits and vegetables diet. A diet high in protein and fiber reduced the risk of 
sarcopenia by 12% (95% CI: 0.73-1.08) compared to a low protein/ low fiber diet. 
Finally, a combination of high protein and high whole grains was associated with an 18% 
(95% CI: 0.67-1.00) reduced risk of sarcopenia compared to a low protein/low whole 
grain diet. Again, a high protein diet alone was also associated with a lower risk of 
sarcopema. 
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Table 3.16 Risk of sarcopenia associated with protein intake (weight adjusted 
residual methods) and other diet patterns 
Risk of Develo(!ing Sarco(!enia 
Intakes (Age 30-<55) P-yrs Cases I /103 py RRI 95% CI 
Protein residuals (g} I FV Intake (svgs} 
Low Prot I Low FV 6615 229 34.6 1.00 
Low Prot I High FV 4711 157 33.3 0.99 0.80 1.22 
High Prot I Low FV 5160 134 26.0 0.83 0.66 1.03 
High Prot I High FV 7032 189 26.9 0.83 0.68 1.02 
Protein residuals (g} I Fiber (g} 
Low Prot I Low Fiber 7139 238 33.3 1.00 
Low Prot I High Fiber 4187 148 35.4 1.10 0.89 1.37 
High Prot I Low Fiber 4700 120 25.5 0.83 0.67 1.05 
High Prot I High Fiber 7492 203 27.1 0.88 0.73 1.08 
Protein residuals (g} I Whole Grains (g} 
Low Prot I Low WGr 6119 227 37.1 1.00 
Low Prot I High WGr 5206 159 30.5 0.80 0.65 0.98 
High Prot I Low WGr 5496 135 24.6 0.69 0.55 0.85 
High Prot I High WGr 6696 188 28.1 0.82 0.67 1.00 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals 
from fat. 
Table 3.17 demonstrates the effect of protein intake per kg of IBW in the context of a 
healthy diet on the risk of obesity in older adults. A diet high in protein and high in fruits 
and vegetables decreased obesity risk by 16% (95% CI: 0.56-1.26) while a high protein/ 
higher fiber diet increased the obesity risk by 10% (95% CI: 0.72-1.68) however, the 
results were not significant. A high protein diet alone also decreased obesity risk 
independent of other dietary factors although insignificantly. 
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Table 3.17 Risk of obesity associated with protein intake per kg of nearest ideal 
body weight (IBW) and other diet patterns 
Risk of Develol!ing Obesitv (BMI > 30 k!!im2) 
Intakes (Age 1/1000 
30-<55) P-yrs Cases py RRI 95%CI 
Protein {t!/kg lBW/day} I FV Intake 
Low Prot/ Low FY 642S.Y7 77 12.0 1.00 
Low Prot I High FY 4452.42 53 11.9 1.00 0.69 - 1.43 
High Prot I Low F Y 4490.0S 45 10.0 O.S6 0.5S - 1.2S 
High Prot I High FY 6701.20 61 9.1 O.S4 0.56 - 1.26 
Protein {t!/kg lBW /day} I ~'iber 
Low Prot/ Low Fiber 66SS.54 73 10.9 1.00 
Low Prot I High Fiber 4192.S5 57 13.6 1.30 0.90 - 1.SS 
High Prot I Low Fiber 4149.64 35 S.4 O.S3 0.54 - 1.2S 
High Prot I High Fiber 7041.64 71 10.1 1.10 0.72 - 1.6S 
Protein {t!/kg lBW /day} I Whole Grains 
Low Prot I Low W Ur 5S57.47 69 ll.S 1.00 
Low Prot I High W Ur 5023.92 61 12.1 1.16 O.Sl - 1.66 
High Prot I Low W Ur 5043.61 47 9.3 O.S5 0.57 - 1.29 
High Prot I High W Ur 6141.67 59 9.6 O.YS 0.65 - 1.47 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals 
from fat. 
The risk of sarcopenia associated with protein intake per kg of IBW in the context of a 
healthy diet is presented in Table 3 .18. Although not significant, sarcopenia risk 
decreased by 9% (95% CI: 0. 74-1.1 0) for a high protein/high fruits and vegetables diet, 
decreased by 5% (95% CI: 0.79-1.16) for a high protein/high fiber diet, and decreased by 
11% (95% CI: 0. 72-1.09) for a high protein/high whole grains diet. 
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Table 3.18 Risk of sarcopenia associated with protein intake per kg of nearest ideal 
body weight and other diet patterns 
Risk of DeveloJ!ing SarcoJ!enia 
I 11000 
Intakes (Age 30-<55) P-yrs Cases py RRt 95%CI 
Protein (glk~:; IDWiday} I FV Intake (svgs} 
Low Prot I Low FV 6842.78 222 32.4 1.00 
Low Prot I High FV 4691.03 153 32.6 1.02 0.82 - 1.26 
High Prot I Low FV 4932.19 141 28.6 0.97 0.78 - 1.20 
High Prot I High FV 7051.6 193 27.4 0.91 0.74 - 1.10 
Protein (glk~:; IDW ldav) I Fiber (~:;} 
Low Prot I Low Fiber 7174.83 228 31.8 1.00 
Low Prot I High Fiber 4358.99 147 33.7 1.09 0.88 - 1.35 
High Prot I Low Fiber 4663 .84 130 27.9 0.95 0.76 - 1.18 
High Prot I High Fiber 7319.95 204 27.9 0.95 0.79 - 1.16 
Protein (glk!! IBWiday} I Whole Grains(~:;} 
Low Prot I Low WGr 6171.14 213 34.5 1.00 
Low Prot I High WGr 5362.68 162 30.2 0.86 0.69 - 1.06 
High Prot I Low WGr 5444.35 149 27.4 0.83 0.67 - 1.03 
High Prot I High WGr 6539.44 185 28.3 0.89 0.72 - 1.09 
*Subjects with prevalent T2 diabetes, CVD, cancer or obesity at baseline were excluded 
*Adjusted for age, sex, education level, height, physical activity, cigarettes per day and % cals . 
from fat. 
3.5 DISCUSSION 
In this study, over a follow-up of up to 16 years, dietary protein was inversely associated 
with risk of obesity and sarcopenia in middle-age and older adults who had a normal BMI 
at baseline. Higher intakes of protein were associated with a lower BMI, lower waist 
circumference, and higher % SMM at the end of follow-up. Moreover, protein intake 
expressed as weight-adjusted residuals led to a 35%, 20%, and 36% reduced risk of 
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obesity in the highest tertile of total protein, animal protein, and plant protein intake 
compared to the lowest tertile. Higher intakes of total, animal, and plant protein were also 
associated with an 18%, 18%, and 20% reduced risk of sarcopenia, respectively. In 
subjects who were overweight/ obese at baseline, higher protein intake was associated 
with a greater risk of obesity; however, these results were not significant. The observed 
higher risk of obesity could be the result of not controlling for plant protein when 
examining the effect of animal protein on obesity risk and vice versa. Therefore, we may 
not see a true independent effect of animal or plant protein on obesity risk in this 
population. 
We also examined the effect of dietary protein in the context of a healthy eating pattern 
on risk of obesity and sarcopenia in older adults. While our study found that high dietary 
protein in the context of a healthy eating pattern was associated with a lower obesity and 
sarcopenia risk, these results were not significant. Again, we excluded subjects who were 
obese at baseline and then dichotomized them into protein and other dietary patterns. This 
could lead to low power of this particular analysis since the number of cases in each 
category of protein-food sources was small. 
Sarcopenia plays an important role in the pathogenesis of frailty and associated 
morbidity, disability and mortality in older adults. The large influence of sarcopenia on 
disability and associated morbidity warrants the search for nutritional interventions such 
as dietary protein to prevent or delay the progression of the disease. The current RDA, 
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however, does not take into account the changes that occur with age, such as reduced 
muscle mass, increased fat mass, changes in food intake and physical activity, and more-
frequent illness. Muscle synthesis is dependent on adequate quantities of protein and 
amino acids, particularly essential amino acids. Eighty percent of the stimulatory effect 
on protein synthesis observed after a meal can be attributed to amino acids. Amino acids 
also play a role in protein breakdown in addition to their role in protein synthesis. Several 
studies have demonstrated an acute increase in muscle protein synthesis with no 
compensatory change in muscle protein breakdown after protein42;43 or amino acid 
ingestion44;45 in both young and elderly individuals. Insufficient or ineffectual protein 
intake in elderly individuals may facilitate the loss of muscle by blunting muscle protein 
synthesis and thus promoting net muscle protein catabolism.46;47 
In addition to the quantity of protein ingested, there appear to be subtle inherent 
differences in the ability of different protein sources to promote muscle protein synthesis. 
The most important difference is the essential amino acid content of a protein, in 
particular leucine, which serves as the primary determinant of its anabolic potential.48 Rat 
studies show that leucine can directly stimulate muscle protein synthesis through 
increasing messenger ribonucleic acid translation and thus global protein synthesis.49 
Protein from animal sources such as meat, poultry, fish, eggs, milk, cheese, and yogurt 
are good sources of leucine including other essential amino acids. In a study comparing 
an omnivorous diet to a lacto-ovo vegetarian diet, males (51-69 years old) who ate an 
omnivorous diet increased lean body mass by 2.4 kg and decreased body fat by 1.4%. 73 
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Therefore, in our study individuals with high total protein intake had a lower risk of 
sarcopenia compared to an animal or plant protein diet perhaps because of increased 
consumption of leucine and other essential amino acids. Essential amino acids (especially 
leucine) and insulin are anabolic stimuli for muscle and share a common pathway of 
action via activation of a kinase known as mTOR. 50 Because insulin sensitivity decreases 
with age, one possible mechanism by which amino acids might improve muscle mass is 
by providing another anabolic stimulus to activate the mTOR-controlled pathway. 
Increasing dietary protein is also known to increase circulating levels of insulin-like 
growth factor 1 (IGF-1), and conversely, a low-protein diet decreases IGF-1. 51 
A few cross-sectional studies that have examined the association between dietary protein 
intake and body composition in older adults have not found an association between 
protein intake and lean body mass. Longitudinal data from the Health ABC Study found 
that dietary protein intake was associated with changes in lean body mass during a three-
year follow-up period in older, community-dwelling adults. 78 Participants in the highest 
quintile of energy-adjusted protein intake lost ~40% less lean mass and appendicular 
skeletal muscle mass over the three-year follow-up than those in the lowest quintile. 
Similarly, Stookey et al found that older Chinese adults with higher protein intake lost 
less mid-arm muscle area over four years of follow-up than those with lower protein 
intake. 126 A 1 0-year longitudinal study in New Mexico reported that women with protein 
intakes of 1.76 g protein • kg- 1 • dai1 had fewer health problems than those consuming 
the RDA.22 Several small, short term studies of 9-14 week duration have examined the 
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effects of alterations in protein intake on body composition and nitrogen balance. 
Castaneda et al found that older women fed a weight-maintenance diet with low protein 
content remained in a negative nitrogen balance throughout the nine-week study, and 
experienced significant losses in lean body mass, immune response, and muscle function, 
and muscle fiber atrophy.47 In another 14-week, controlled diet study, 10 ambulatory men 
and women, aged 55 to 77 years, who were provided eucaloric diets that contained 0.8 g 
protein·kg-1 :dai1, experienced significant loss of mid-thigh muscle mass and urinary 
nitrogen excretion. 76 
Other studies have failed to find significant increases in lean mass with higher protein 
intake. In one study, increasing protein intake from 0.87 g to 1.23 g protein • kg-1 • dai1 
by means of daily supplements promoted nitrogen retention but failed to increase lean 
body mass in frail elderly. 127 When older subjects in a different study were given 1.6 g 
protein • kg-1 • dai1 , the efficiency of nitrogen retention and protein utilization during 
resistance exercise training was higher than when they were fed 0.8 g protein.kg-1.dai1, 
but changes in body composition did not significantly differ between the low and high 
protein groups. 128 A meta-analysis of trials that investigated the effects of increased 
protein and energy intake on health outcomes found a small weight gain but no 
improvements in function or mortality in subjects receiving the supplement; 129 this meta-
analysis has been criticized for including heterogeneous trials in widely divergent 
populations, including hospitalized patients. A Icing-term randomized trial of high 
92 
protein-energy supplementation in frail elderly also found no difference in lean body 
mass between the placebo and protein-supplemented groups. 130 However, the biggest 
criticism here is that most studies of high protein intake were of short duration and longer 
duration may be needed to accrue new muscle mass. 
This study has several limitations that should be acknowledged. The individuals in our 
sample were primarily Caucasian and therefore, our results cannot be generalized to other 
racial or ethnic groups. The study included only participants that attended the on-site 
clinical examinations and therefore, excluded homebound or nursing home participants. 
Sarcopenia was defined using the skeletal muscle mass equation of Janssen and 
colleagues109 as mentioned previously. Although this equation has been validated, a 
direct objective measure of lean mass such as by using DXA would have provided a more 
precise assessment of body composition measures. Moreover, this current definition of 
sarcopenia uses SMM as a percent of total body mass. This presents a particular problem 
for those individuals who are overweight or obese who have higher amounts of fat mass 
and also lean mass compared to normal weight individuals. By converting skeletal 
muscle mass into a percent, skeletal muscle mass appears lower than it actually is in the 
overweight and obese given, which may lead to an overestimation of obese individuals 
classified as sarcopenic. Using total kilograms of skeletal muscle mass would give us a 
more precise and less biased estimate of the presence of sarcopenia particularly in the 
obese. Also, we did not classify older adults into subgroups by age. Even among older 
adults there may be considerable variation in terms of sarcopenia risk by age. For 
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example, individuals between the ages of 50-60 years probably still have higher skeletal 
muscle mass than subjects between the ages of 70-80 years. Therefore, it is important to 
determine the effects of protein on sarcopenia and even obesity risk by specific age 
groups among older adults given the changing body composition in older adults. 
There are also several key strengths of our study. The Framingham Offspring Study 
includes a prospective community-based design with up to 16 years of follow-up. We 
included both men and women in our analysis. Potential confounding variables were 
routinely ascertained at most examination visits and body composition was directly 
measured at those visits. Diet was estimated from multiple sets of three-day dietary 
records from two exams. In addition, the complete ascertainment of food group intakes 
that were derived by the authors by linking Nutrition Data System data with USDA Food 
Pyramid data is an added strength. 
In conclusion, in this longitudinal study, dietary protein adjusted for body weight was 
associated with lower BMI, lower waist circumference, higher % skeletal muscle mass, 
and lower obesity risk and sarcopenia risk in middle-aged and older adults. Given the 
increasing incidence and prevalence of obesity and sarcopenia in older individuals, 
current protein recommendations for this population should take into account the 
protective effect of protein on body composition. 
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CHAPTER 4: The Effect of Dietary Protein on Functional Limitations in Middle-aged 
and Older Adults 
4.1 BACKGROUND 
As men and women get older, skeletal muscle mass declines because of a decrease in the 
number and cross sectional area of muscle fibers and a preferential loss of fast twitch 
type II fibers. 131 The loss of muscle mass that occurs with aging (sarcopenia) is 
associated with a reduction in muscle strength. Loss of muscle mass and strength leads to 
impairment of physical function, as indicated by the impaired ability to rise from a chair, 
climb stairs, generate gait speed, and maintain balance.22;132;133 Limitations in physical 
function are associated with adverse health outcomes: increased risk of disability, 
mortality, hospitalization, and poor quality of life.28-30 
The 2003 National Health Interview Survey and 2004 US Census Bureau estimate that 
approximately 35-38 million non-institutionalized people have a disability due to a 
chronic health condition. 134 For people over age 65, 35 to 40% experience activity 
limitations or disability135 . Because U.S. population is aging, the percentage of 
population aged 65 years or over will increase from 12% in 2000 to 20% in 2030-to 
over 69 million. 121 The number of people aged 85 or over is expected to grow from 3 
million (2.1%) to 6.2 million (3 .4% ). The majority of individuals who reach this age will 
experience some limitation in function. Therefore, there is a pressing need for function 
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promoting anabolic therapies through nutritional, physical, as well as pharmacological 
means. 
Sarcopenia plays an important role in the pathogenesis of frailty and associated 
morbidity, disability and mortality_26;27 Epidemiological studies have demonstrated 
associations between low skeletal muscle mass and increased risk of physical disability, 
functional impairments, and low physical performance, as well as decreased muscular 
strength and endurance?8-30 While sarcopenia impairs quality of life in the elderly, the 
impact of obesity in the setting of sarcopenia is likely to exacerbate these problems. In 
normal aging, not only does muscle loss occur but also fat gain occurs over decades.31 -33 
Most previous research has focused separately on the role of each one of these body 
composition changes on disability.34;35 However, it may be possible that the loss in 
muscle and the gain in fat act synergistically to exacerbate disability. Subjects classified 
as having sarcopenic obesity have significantly lower grip strength per kilogram body 
weight, independently of age, ethnicity, smoking and other co-morbidities, and had a 
greater increase in the risk of functional impairment, disability and falls compared to that 
observed separately both in obese and sarcopenic elderly men and women.28 Only a few 
studies, however, have examined this joint effect of sarcopenia and obesity on disability. 
Functional limitations associated with aging are multifactorial in their pathophysiology; 
impaired protein and energy intake, androgen deficiency, abnormalities in the growth 
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hormone-insulin like growth factor-1 ax1s, anabolic resistance, inflammation, motor 
neuron remodeling, perturbations of muscle protein dynamics, and decreased physical 
activity are all likely contributors. 136;137 Of these factors, inadequate dietary protein intake 
has been documented to accelerate this process.43 ;44;138 
Alternatively, increasing daily protein consumption and dietary-derived amino acids 
represent one of the few alternatives to slow or prevent muscle protein catabolism and 
thereby preserve muscle function. Maintaining an adequate diet, in terms of protein 
intake, contributes to preserving muscle quality. 72 Maintaining muscle mass helps to 
protect against functional decline, and decline in physical performance. Muscle tissue is 
particularly sensitive to the anabolic effects of amino acids, even though this 
compensatory mechanism is less effective in the elderly.72 Protein intake, especially 
essential amino acids, are anabolic stimuli for muscle metabolism via enhanced 
phosphorylation and activation of mammalian target of rapamycin (mTOR) signaling 
cascade, including the ribosomal protein S6 kinase and its target ribosomal protein S6.50 
While dietary protein and protein-rich foods have the potential to impact skeletal muscle 
mass and consequently muscle function, few longitudinal studies, have studied measures 
of functional status in the context of protein intake in middle-aged and older adults. 
Therefore, the objective of this study is to measure the long-term effects of dietary 
protein intake on age-related changes in functional limitations/disability in middle-aged 
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and older adults using data from the Framingham Offspring Study. We will also measure 
the differences in functional limitations/disability among sarcopenic and obese 
individuals, including those with both. Results from this study will contribute to the 
scientific understanding of dietary protein's role in the risk of functional decline and have 
important implications for public health policy in terms of appropriate dietary protein 
recommendations for older adults. We hypothesize that increasing intakes of dietary 
protein are associated with a lower risk of functional decline in older adults including 
those that are sarcopenic, obese, and both sarcopenic and obese. Moreover, functional 
disability will be greater in individuals who are both sarcopenic and obese compared to 
those who exhibit only sarcopenia or obesity; and particularly compared with those who 
are neither sarcopenic nor obese. 
4.2METHODS 
4. 2.1 Study Population 
The Framingham Heart Study (FHS) was initiated in 1948 with the medical examination 
of 5,209 persons from randomly selected Framingham households. In 1972, a second-
generation study (referred to as the Offspring Study or FOS) was initiated with the 
enrollment of offspring of the original FHS cohort and their spouses, with a total of 5,124 
subjects. The second examination visit began in 1980 and from that point forward, 
participants were examined at four-year intervals for the presence of coronary artery 
disease, other diseases and conditions and associated risk factors. The study interviews 
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collected data on a variety of lifestyle habits, such as smoking and physical activity, as 
well as psychosocial factors, such as stress, anger, and hostility. 
4.2.2 Assessment o[Diet 
Diet was assessed using three-day diet records in the third and fifth examination cycles of 
the study (1984-1988 and 1991-1995). Approximately 70% of the participants who 
attended those exam visits kept food records which provided approximately 16,000 days 
of records. The diet records were collected using standardized methodology; a trained 
nutritionist instructed the families in the completion of the diet records, including the use 
of 2-dimensional food models for estimating portion sizes. These records were entered 
into a nutrient calculation program, the Nutrition Data System (NDS) (developed at the 
University of Minnesota). The NDS program calculates each subject's daily intake of 
nutrients (i.e., energy, macronutrients, vitamins, minerals). 
With respect to dietary protein intake, the NDS output provides estimates for the daily 
intake of total protein. Since the NDS system does not provide data on the amount or 
types of foods consumed, we completed this complex task with separate funding. Food 
intake in each of the USDA food groups and subgroups was derived by linking the 
underlying food codes from the NDS system (which are generated in the calculation of 
the nutrient content of a food) with those from the Continuing Survey of Food Intake of 
Individuals (CSFII) for which servings of USDA Pyramid food groups are available. This 
allowed us to calculate the number of servings for each food eaten (and then sum those 
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food servings per day within each major food group and food subgroup). Intake for each 
of the five major food groups and 30 subgroups in the USDA Food Guide Pyramid were 
previously determined. 
4.2.3 Dietary Protein Exposure Variables 
The nutrient intake information obtained from the Nutrition Data System includes grams 
of total protein, animal protein, vegetable protein · and 18 amino acids, including all 
essential amino acids. For this study, protein intake will be defined as weight-adjusted 
protein intake using the residuals from a regression model. To remove variation in intake 
due to body weight, linear regression models were used to compute protein residuals. The 
protein intakes of the individuals were regressed on their body weight. The residuals from 
the regression represent the differences between each individual's actual protein intake 
and the intake predicted by their body size. The resulting protein residual is uncorrelated 
with body weight and this allows the variation due to protein intake to be evaluated 
directly. 
We can also use the food group intake information to look at the effect of different food 
sources of protein. Our estimates of the daily intake of protein-rich MyPyramid food 
groups are calculated as cup equivalents per day of including milk, cheese, and yogurt as 
well as ounce-equivalents ofmeat, poultry, fish, eggs, soy, nuts and seeds. 
4. 2. 4 Assessment of Obesity and Sarcopenia 
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Sarcopenia was defined, as previously described, using the skeletal muscle mass equation 
of Janssen et al 1 09 : 
Skeletal Muscle Mass (kg)= [(height2 I BIA-resistance x 0.401) +(sex x 
3.825) + (age x -0.071)] + 5.102 
Height is in em; BIA-resistance is in ohms; for sex, men= 1 and women =0; and age is in 
years. Absolute skeletal muscle mass (kg) was then converted to percentage skeletal 
muscle mass termed the skeletal muscle index (SMI). 
SMI= skeletal muscle mass I body mass * 100 
Subjects were considered to have a normal SMI if their SMI was within one standard 
deviation below the sex -specific mean for young adults (ages 18-3 9). We used the sex-
specific mean SMI for young adults calculated by Janssen and colleagues because of a 
higher number of subjects in their population (n= 3298 women and 3116 men). The mean 
SMI in 18-39 year old women was 33.1% ± 5.5% and 42.5% ± 5.5% in 18-39 year old 
men. Class I sarcopenia was present when SMI was one to -two standard deviations 
below the reference mean, and class II sarcopenia was present in subjects whose SMI was 
two or more standard deviations below the mean. Obesity will be classified using the 
following definition of obesity: BMI 2: 30 kglm2• 
4.2.5 Assessment o(Functional Status 
Functional status and disability-related measures were collected routinely for subjects at 
older ages in the Framingham Studies. Three standardized instruments were used in 
Framingham to measure functional impairment: (a) the Rosow-Breslau assessment, 139 (b) 
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Katz ADL questions, 140 and (c) the Nagi scale. 141 The Nagi instrument, used to assess 
self-reported functional limitation, included an 11-item questionnaire scored on a scale of 
0-5. The Rosow-Breslau scale included a 6-item questionnaire scored on a scale of 0-1 
used to assess physical disability on gross-mobility tasks. Both instruments were 
administered to subjects at Exams 5-7. The Katz Activities of Daily Living Scale, a 10 
item standardized instrument scored on a scale of 0-4 used to assess functional 
performance at exams 5-7. We will use selected components of the Rosow-Btes1au, Nagi, 
and Katz instruments that reflect impairment in muscle strength and/ or endurance. 
The Rosow-Breslau Health Scale was developed in 1966 and is specifically used to 
measure functional status in the elderly. It focuses on functional health in terms of the 
ability to do independent living activities. It consists of the following questions: ability to 
do heavy work around the house (ex. shoveling, washing windows) without help, ability 
to walk up and down stairs to the second floor without any help, ability to walk half a 
mile without help (4-6 blocks), ability to drive a car in the past and present. The ability to 
perform these tasks is measured as follows: 
0= Cannot do 
1= Can do 
The Katz ADL questions cover basic self-care functions including: dressing (undressing 
and redressing), bathing (including getting in and out of tub or shower), eating, 
transferring (getting in and out of chair), toileting (using bathroom facilities and handle 
clothing), bladder continence, bowel continence, walking on level surface 50 yards, 
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walking up and down one flight of stairs, using a telephone, and taking medication. The 
ability to perform these tasks is measured as follows: 
0= Independent, no help needed 
1 =Independent with devices 
2= Minimally dependent, human assistance needed 
3= Dependent 
4= Do not do during a normal day 
The Nagi scale measures physical capacities and examines specific movements such as 
pulling or pushing large objects like a living room chair, stooping, crouching, or 
kneeling, reaching or extending arms below shoulder level, reaching or extending arms 
above shoulder level, writing, handling or fingering small objects, standing in one place 
for long periods (15 minutes), sitting for long periods (1 hour), lifting or carrying weight 
under 10 pounds, lifting or carrying weights over 1 0 pounds, getting in and out of the car, 
and putting on socks or stockings. The ability to perform these activities was measured as 
follows: 
0= No difficulty 
1 = A little Difficulty 
2= Some Difficulty 
3= A lot of Difficulty 
4= Unable to do 
5= Don' t do on MD orders 
Questions from each of these standardized instruments have been used to reflect different 
functional status domains, including mobility (including both gross and fine motor skills), 
strength (particularly upper extremity strength), endurance (physical stamina, walking 
distance, self-perceived energy level), basic · ADLs (largely self-care activities), and 
103 
instrumental ADL skills (higher-level skills such as shopping, pill-taking). The Katz 
instrument primarily measures limitations in basic ADL skills; such limitations generally 
reflect a later disability stage or more severe level of functional loss than do limitations in 
the instrumental ADLs. Both the Rosow-Breslau and the Nagi scales ascertain different 
aspects of various functional status domains including mobility, strength, endurance and 
IADLs. By combining these scales, we can provide a complete picture of functional and 
physical ability. 
For these analyses, we included those items from the three scales that reflect functional 
ability associated with the amount and quality of skeletal muscle mass. These items 
include the ability to walk up and down stairs to the second floor and the ability to do 
heavy work around the house (ex. shoveling, washing windows) from the Rosow-Breslau 
scale. The ability to transfer (getting in and out of chair), walk on a level surface 50 
yards, and walk up and down one flight of stairs from the Katz ADL scale. And finally, 
pulling or pushing large objects like a living room chair, stooping/crouching/kneeling, 
reaching or extending arms below shoulder level, reaching or extending arms above 
shoulder level, standing in one place (~15 minutes), sitting for long periods (~1 hour), 
lifting or carrying weight under 1 0 pounds, and lifting or carrying weights over 1 0 
pounds. 
We also created a separate scale to measure strength using the following eight variables 
from above: walking up and down one flight of stairs, transferring (getting in and out of 
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chair), doing heavy work around the house, pulling or pushing large objects, reaching or 
extending arms above shoulder level, stooping/crouching/kneeling, lifting or carrying 
weight under 10 pounds, lifting or carrying weights over 1 0 pounds and reaching or 
extending arms above shoulder level 
A separate scale measuring endurance will include the following six variables: walking 
up and down one flight of stairs, walking on level surface 50 yards, walking half a mile, 
doing heavy work around the house, standing in one place (:::: 15 minutes) and sitting for 
long periods (::::1 hour). 
4. 2. 6 .Assessment a( Potential Confounding 
Data on the following potential confounding factors will be examined at each available 
examination: subject's age, sex, alcohol intake, smoking status, physical activity, amount 
and distribution of body fat, occupation (type and status), other dietary habits and chronic 
medical conditions. Data on these factors have been collected systematically in the study. 
Demographics: Subject's age and sex were collected at study entry. Age was coded as 
age at each exam in years and months. Education level was assessed at exam 2 as the 
number of self-reported years of education. 
Smoking and Alcohol: Smoking information was collected usmg standardized 
approaches at every FHS examination in sufficient detail to evaluate both current and 
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past smoking as well as total pack-years. Those who smoke at least one cigarette per day 
will be considered current smokers at any given exam. Smoking is potentially an 
important confounder in these analyses since smokers may have very different dietary 
habits than non-smokers. Detailed data on alcohol intake as a possible confounder is 
available, including drinking status (e.g., current or past drinker, abstainer, abuser), 
drinking frequency (lifetime abstainer, past drinker, occasional drinker, regular drinker), 
and drinking amount (light, moderate, heavy). 
Physical activity: It was assessed by an interview in which subjects were asked to report 
the number of hours spent (in a 24-hour period) in sleep, sedentary activities, and light, 
moderate and vigorous physical activity (including occupationally-related activity). We 
created a modified Physical Activity Index by multiplying the number of hours spent in 
moderate or vigorous activity times the estimated energy expenditure (oxygen 
. ) . d <:' h . . 142 consumptiOn reqmre 10r t at activity. 
Functional status is strongly affected by the presence of co-existing debilitating 
conditions such as stroke or arthritis. Such conditions may be a part ofthe causal pathway 
between diet and functional status. As such, they may be examined as causal predictors 
by determining the extent to which their inclusion in the models attenuates the effects 
between diet and various functional outcomes. 
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4.3 STATISTICAL ANALYSIS 
The objective of this study is to estimate the independent effects of dietary protein-related 
exposures on measures of functional decline including measures of strength, endurance 
over in adults over the age of 54 years. 
We carried out the following analyses for this objective. Dietary protein was examined as 
a categorical variable: We used an analysis of covariance model to evaluate the adjusted 
mean functional status scores at the end of follow up in each tertile of protein consumed. · 
The variables listed in the above section on potential confounding were explored for 
inclusion in the multivariable models. Variables that changed the mean differences by 
more than 1 0% were retained in the final models. The following variables were included 
as confounders in the final model: age, sex, height, education level, physical activity, 
cigarettes per day and % energy from fat. 
Functional status was also dichotomized for the purpose of examining the risk ·of 
developing a domain-specific (i.e. strength and endurance) functional status limitation 
during follow up. For this analysis, only those subjects free of functional disability (at 
exam 5) were included and then followed forward for the development of 
disability/functional status loss. Follow up for the occurrence of functional status 
limitations began at the end of the exam 5 visit and continued until the first of the 
following censoring events: (a) diagnosis of functional limitation; (b) the last date of 
contact, for those lost to follow up; (c) death; or (d) the end of exam 7. Incidence rates of . 
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functional limitations for each protein intake category were calculated as the number of 
new cases of functional loss occurring during the follow-up period divided by the total 
number of person-years of follow up. 
The ability to perform a task independently or dependently was determined from one 
exam to another. The three scales were modified as follows to reflect independence in 
performing a specific activity at each exam: 
1) Katz scale: 0= dependent 1 = independent. 
Those individuals who were dependent (3) for a particular task were given a score of 
0. Those individuals who were independent (0), independent with devices (1), or 
minimally dependent (2) for a specific task were classified as independent for that 
activity and given a score of 1. 
2) Nagi Scale: 0= dependent 1 =independent 
Those individuals who reported they were unable to do the task (4) or could not 
do on doctor's orders (5) were classified as dependent and given a score ofO. 
Those individuals who could perform a task with no difficulty (0), a little 
difficulty (1), or some difficulty were classified as independent for that activity 
and given a score of 1. 
3) Rosow-Breslau Scale: 0= dependent 1 =independent 
Not being able to perform a task was classified as dependent and given a score of 
0. The ability to perform a task was classified as independent and given a score of 
1. 
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We also used a multivariable linear regression modeling to examine the relation between 
the amount of protein consumed and functional status outcomes. The functional outcomes 
were scored in two ways: (a) presence of disability at a given exam and (b) decline in 
functional status score from one exam to the next. Subjects who were independent in all 
activities or dependent in only 1 or 2 activities were included in the analysis on functional 
decline. 
4.4 RESULTS 
The baseline characteristics of men and women at least 50 years of age according to 
tertiles of weight-adjusted protein residuals are presented in Table 4.1. Subjects in the 
highest tertile of intake were taller and had a lower BMI compared to the first and second 
dietary protein tertiles (p-value <0.0001 for both). Subjects in the highest tertile of 
protein intake also consumed more energy, had slightly higher percent of calories from 
fat, and lower percent of calories from carbohydrates (p-value: <0.0001, 0.0371, <0.0001 
respectively). Subjects in the highest protein tertile were also more likely to be male and 
be college graduates (p- value: 0.0117 and <0.0001 respectively). 
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Table 4.1 Baseline characteristics according to weight-adjusted protein residuals 
(mean± s.d.) 
Baseline Characteristics 
Age (yrs) 57.1 ± 5.8 57.1 ± 5.4 56.4 ± 5.4 0.0672 
Height (em) 165.5 ± 8.7 166.9 ± 9.1 169.5 ± 9.3 <0.0001 
Weight (kg) 77.3 ± 16.7 73.1 ± 13 .7 76.3 ± 15.0 <0.0001 
BMI (kg/m~) 28.2 ± 5.2 26.2 ± 3.7 26.5 ± 3.9 <0.0001 
Physical Activity 13 .2 ± 7.9 12.7 ± 7.1 13 .9 ± 8.4 0.0472 
Cigarettes/ day 3.9 ± 9.4 2.7 ± 7.9 3.7 ± 9.6 0.0915 
Macronutrient Intakes 
Energy 1487 ± 339 1780 ± 363 2269 ± 491 <0.0001 
% of calories from protein 15.9 ± 3.3 17.4 ± 3.3 18.4 ± 3.2 <0.0001 
% calories from fat 33.7 ± 6.9 33.1 ± 6.7 34.3 ± 6.9 0.03 71 
% calories from carbs 49.4 ± 8.5 48.1 ± 7.9 45.7 ± 7.9 <0.0001 
protein (gms) 57.7 ± 10.5 75.0 ± 8.6 101.6 ± 17.4 <0.0001 
protein (gms/kg) 0.76 ± 0.13 1.04 ± 0.12 1.36 ± 0.24 <0.0001 
column percent (%) 
Education Level 
%college graduate 24.5 30.7 32.3 O.OIJ 7 
Sex 
%male 33 .1 39.6 61.7 <0.0001 
The proportion of subjects over the age of 54 that were unable to do selected functional 
tasks in the three individual scales (Katz, Rosow-Breslau, and Nagi) according to tertiles 
of weight-adjusted protein residuals are presented in Table 4.2 by each exam. The 
proportion of individuals unable to stoop/kneel/crouch and push/pull heavy objects were 
significantly lower (p for trend= 0.0192 and 0.0416 respectively) with increasing tertiles 
of protein intake at exam 7 along with the ability to lift more than 1 0 lbs (p for trend= 
0.0363). 
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Table 4.2 Proportion of subjects over age 54 unable to do selected functional tasks 
according to protein intake 
Tertiles of Protein Intake (from Residual Method) 
Earlier Protein Intake Tertile I Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile3 Tertile I Tertile 2 Tertile 3 (residual method) 
n=474 n=475 n=473 n=468 n=469 n=472 n=448 n=452 n=451 
Exam 5 Exam6 Exam 7 
Functional Status N ~lo unable) N ~lo unable) N ~lo unable) 
KatzADL 
Transferring I (0.2%) 0(0%) I (0.2%) I (0.2%) 0 (0.0%) I (0.2%) 2 (0.5%) I (0.2%) 4 (0.9%) 
p-value 0.9990 0.9961 0.3568 
Walk 50 yards (level) I (0.2%) 0(0%) I (0.2%) I (0.2%) I {0.2%) 2 (0.4%) 2 (0.5%) I (0.2%) 4 (0.9%) 
p-value 0.9990 0.5446 0.3568 
Flight of Stairs I (0.2%) 0 (0%) I (0.2%) 2 (0.4%) 0(0.0%) 3 (0.6%) 8 (1.8%) 2 (0.4%) 10 (2.2%) 
p-value 0.9990 0.5888 0.5893 
Rosow-Breslau 
Heavy work at home 48 (10.1%) 31 (6.5%) 32 (6.8%) 46 (9.8%) 33 (7.0%) 29 (6.1%) 64 (14.3%) 37 (8.2%) 47 (10.4%) 
p-value 0.0539 0.0339 0.0643 
Walk 1/2 mile 12 (2.5%) 6(1.3%) 20 (4.2%) 17 (3.6%) II (2.4%) 18 (3.8%) 29 (6.5%) 16 (3.5%) 21 (4.7%) 
p-va/ue 0.1059 0.8733 0.2077 
Nagi 
Push/Pull heavy objects 26 (5.5%) 20 (4.2%) 15 (3.2%) 22 (4.7%) 26 (5.5%) 19 (4.0%) 33 (7.4%) 25 (5.5%) 19 (4.2%) 
p-value 0.0790 0.6250 0.0416 
Stoop/Kneel/Crouch 36 (7.6%) 20 (4.2%) 30 (6.3%) 38 (8.1%) 24 (5.1%) 29 (6.1%) 45 (10%) 26 (5.8%) 27 (6.0%) 
p-value 0.4183 0.2194 0.0192 
Reach above shoulders 7 (1.5%) 5(1.1%) 7 {1.5%) 8 (1.7%) 6 (1.3%) 12 (2.5%) 7(1.6%) 5 (1.1%) 5 (1.1%) 
p-value 0.9970 0.3415 0.5422 
Stand ~ 15 minutes 8 (1.7%) 4(0.8%) 18 (3.8%) 12 (2.6%) 13 (2.8%) 11 (2.3%) 22 (4.9%) 9 (2.0%) 16 (3.6%) 
p-value 0.0235 0.8198 0.2667 
Sit ~ I hour 7(1.5%) 10(2.1%) 9(1.9%) 3 (0.6%) 5(1.1%) 4 (0.9%) 8 (1.8%) 9 (2.0%) 4 (0.9%) 
p-value 0.6246 0.7318 0.2754 
Lift <10 lbs 4(0.8%) I (0.2%) 6 (1.3%) 6 (1.3%) 2 (0.4%) 4 (0.9%) 6 {1.3%) 2 (0.4%) 2 (0.4%) 
p-value 0.4566 0.4705 0.1177 
Lift > 10 lbs 21 (.4%) 17 (3.6%) 15 (3.2%) 26 (5.6%) 19(4.1%) 18 (3.8%) 27 (6%) 21 (4.7%) 14 (3.1%) 
p-value 0.3065 0.1969 0.0363 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
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The change in functional status for selected activities in the Katz, Rosow-Breslau, and 
Nagi scales between exam 5 and 7 according to tertiles of protein intake are presented in 
Table 4.3. Those in the lowest tertile of protein intake had a greater decline in the ability 
to push/pull heavy objects compared with the highest tertile of intake (5.4% vs. 3.0%). 
Similarly, there was a greater percent decline in the ability to lift more than 10 lbs in the 
lowest tertile compared to the highest tertile of protein intake (4.0% vs. 2.1% 
respectively). The majority of subjects remained independent between exams 5 and 7 in 
their ability to climb a flight of stairs, do heavy work at home, walk a half mile, push/pull 
heavy objects, stand more than 15 minutes, and lift more than 10 lbs. 
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Table 4.3 Change in functional status from exam 5 to exam 7 according to tertiles of 
protein intake in residuals (g) 
Tertile 1 Tertile2 Tertile 3 
Functional Status Change from Exam 5-7 
N (column% change) 
Flight of Stairs 
Remained independent 440 (98.4%) 450 (99.6%) 441 (98.4%) 
Declined 7 (1.6%) 2 (0.4%) 7 (1.6%) 
Heavy Work at Home 
Remained independent 366 (90.2%) 399 (93.9%) 388 (92.6%) 
Declined 40 (9.9%) 26 (6.1%) 31 (7.4%) 
Walk a Half Mile 
Remained independent 413 (94.5%) 431 (96.6%) 417 (97.0%) 
Declined 24 (5.5%) 15 (3.4%) 13 (3.0%) 
Push/Pull Heavy Objects 
Remained independent 401 (94.6%) 417 (95.9%) 423 (97.2%) 
Declined 23 (5.4%) 18(4.1%) 12 (2.8%) 
Stand > 15 minutes 
Remained independent 423 (96.1%) 441 (98.4%) 422 (97.5%) 
Declined 17 (3.9%) 7 (1.6%) 11 (2.5%) 
Lift >10 lbs 
Remained independent 413 (96.1%) 424 (97.0%) 426 (97.9%) 
Declined 17 (4.0%) 13 (3 .0%) 9 (2.1%) 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
We then examined cross-sectionally the proportion of subjects over the age of 54 who 
were unable to do functional tasks that reflected strength and endurance (Table 4.4) 
according to their dietary protein intakes. In general, with increasing tertiles of protein 
intake at each exam, a higher proportion of individuals were independent in strength and 
endurance tasks. Conversely, fewer subjects with higher (vs. lower) protein intakes were 
dependent on 2: 2 tasks or 2: 3 tasks. 
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The effect of protein intake on the risk of becoming dependent on selected functional 
tasks between exams 5 and 7 is shown in Table 4.5. We examined only those individuals 
who were independent for these selected tasks at exam 5 in order to measure the 
incidence of becoming functionally dependent by exam 7. Those with higher protein 
intakes had about 25%-40% non-statistically significant reduced risk of becoming 
dependent in their ability to do heavy housework, walk half a mile, push/pull heavy 
objects, stand> 15 minutes, lift> 10 lbs, and stoop/kneel/crouch respectively. 
Table 4.6 shows the risk of developing a functional disability on the combined scores for 
strength and/or endurance tasks by exam 7 among those who were independent at exam 
5. With higher intakes of protein, there was a 30% (95% CI: 0.48-1.02), 25% (95% CI: 
0.50-1.12), and 26% (95% CI: 0.52-1.07) reduced risk of becoming dependent on the 
strength, endurance, and the combined strength/endurance scales, respectively compared 
to lower intakes of protein. While the 95% confidence intervals contained the null value, 
these results suggest a tendency for a protective effect of dietary protein. 
Table 4. 7 examines the risk of decline in strength, endurance, or both. These results show 
that there is about a 30% reduced risk of functional decline associated with higher protein 
intakes. (RR: 0.71 (95% CI: 0.50-1.00), 0.67 (95% CI: 0.46-0.98), and 0.71 (95% CI: 
0.51-1.00) for strength, endurance, and combined strength/endurance scales, 
respectively). 
114 
Table 4.4 Proportion of subjects over age 54 unable to do selected functional tasks 
according to protein intake 
Tertiles of Protein Intake (Residual Method) 
Earlier Protein Intake Tertile 1 Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile 3 (residual method) 
Functional Status 
Strength (7 items) 
Independent 
Dependent in I task 
Dependent with ~2 tasks 
Endurance (6 items) 
Independent 
p-value 
Dependent in I task 
Dependent with ~2 tasks 
p-value 
Strength/Endurance (11 items) 
n=474 n=475 n=473 n=468 n=469 n=472 n=448 n=452 n=451 
Exam 5 Exam6 Exam7 
N (column %) N (column %) N (column %) 
396 (83 .5) 419 (88 .2) 417 (88 .2)87 (82.7) 404 (86 .1) 403 (85.4) 349 (77.9) 388 (85.8) 382 (84 .7) 
44(9.3) 32(6.7) 35(7.4) 48(10.3) 34(7.3) 46(9.8) 54(12.1) 32(7.1) 41(9.1) 
34(7.2) 24(5 .1) 21(4.4) 33(7.1) 31(6.6) 23(4.9) 45(10.0) 32(7.1) 28(6.2) 
0.0279 0.1678 0.0065 
416 (87.8) 435 (91.6) 424 (89.6:410 (87.6) 425 (90.6) 429 (90.9) 365 (81.5) 402 (88.9) 396 (87.8) 
46(9.7) 32(6.7) 30(6.3) 42(9) 31(6.6) 28(5.9) 54(12.1) 33(7.3) 31(6.9) 
12 (2.5) 8 (1.7) 19 (4) 16 (3.4) 13 (2.8) 15 (3.2) 29 (6.5) 17 (3.8) 24 (5.3) 
0.8824 0.2020 0.0276 
Independent 391 (82.5) 413 (87) 406 (85.8)83 (81.8) 399 (85.1) 399 (84.5) 341 (76.1) 381 (84.3) 377 (83.6) 
Dependent in I task 45 (9.5) 36 (7.6) 37 (7.8) 47 (10 .0) 37 (7.9) 40 (8 .5) 50 (11.2) 35 (7.7) 37 (8.2) 
Dependent with 2 tasks 14 (3 .0) 12 (2.5) 12 (2.5) II (2.4) 14 (3.0) 15 (3 .2) 21 (4.7) 14 (3 .1) 15 (3.3) 
Dependent with ~3 tasks 24 ( 5 .I) 14(3.0) 18(3.8) 27(5.8) 19(4.1) 18(3.8) 36(8.0) 22(4.9) 22(4.9) 
p-value 0.1629 0.2250 0.0051 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
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Table 4.5 Risk of dependence in selected functional items associated with protein 
intake 
Protein Intake in Residuals (g} 
Tertile 1 Tertiles 2-3 
ent 
Heavy Work at Home 
OR 1.00 0.76 
95% CI 0.49 - 1.18 
Walk a Half Mile 
OR 1.00 0.72 
95% CI 0.40 - 1.29 
Push/Pull Heavy Objects 
OR 1.00 0.78 
95% CI 0.44 - 1.38 
Stand >15 minutes 
OR 1.00 0.61 
95% CI 0.31 - 1.24 
Lift >10 lbs 
OR 1.00 0.78 
95% CI 0.40 - 1.51 
Stoop/Kneel/Crouch 
OR 1.00 0.72 
95% CI 0.42 - 1.218 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
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Table 4.6 Effect of protein intake on risk of becoming dependent in one or more 
tasks by exam 7 among those who were independent at exam 5 
Strength 
OR 
95% CI 
Endurance 
OR 
95% CI 
Strength or Endurance 
OR 
95% CI 
Protein Intake in Residuals (g) 
Tertile 1 Tertile 2-3 
OR of Dependence in =:::1 Task 
(Change from Exam 5 to 7) 
1.00 
1.00 
1.00 
0.70 
0.48 - 1.02 
0.75 
0.50 - 1.12 
0.74 
0.52 - 1.07 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
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Table 4. 7 Effect of protein intake on risk of functional decline between exams 5 and 
7 
Protein Intake 
protein residuals (g) 
Strength 
OR 
95% CI 
Endurance 
OR 
95% CI 
Strength or Endurance 
OR 
95% CI 
Tertile 1 
1.00 
1.00 
1.00 
Tertile 2-3 
0.71 
0.50 - 1.00 
0.67 
0.46 - 0.98 
0.71 
0.51 - 1.00 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
Next we examined the proportion of subjects at exam 7 who had strength and/or 
endurance problems associated with being overweight/obese at exam 5 and associated 
with having sarcopenia beginning at exam 6 (Table 4.8). Those who were obese were 
more likely to become dependent in one or more tasks involving either the strength and 
endurance scales compared to those who were normal-weight or overweight. Similarly, a 
significantly higher proportion of subjects with sarcopenia (class I and II) were dependent 
in one or more strength and endurance tasks compared with those who were not 
sarcopenic. Moreover, those who were obese were more than twice as likely (95% CI: 
1.48-3 .37) to become dependent in one of the critical strength-related functional tasks 
compared with those who were of normal weight or who were overweight. Similarly, 
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obese individuals had an 88% increased risk (95% CI: 1.21-2.94) of dependence in one or 
more of the endurance-
Table 4.8 Proportion of subjects at exam 7 having strength and/or endurance 
problems associated with overweight, obesity, and sarcopenia 
Body Fat Sarcopenia 
NIWt Overwt* Obese* No Yes 
n=498 n=578 n=275 n=559 n=698 
Exam 7 Exam 7 
Functional Status N (column%) N (column%) 
Strength (7 items) 
Independent 423 (84.9%) 497 (86%) 199 (72.4%) 503 (90.0%) 550 (78.8%) 
Dependent in I task 45 (9.0%) 41 (7 .1%) 41 (14.9%) 33 (5.9%) 83 (11 .9%) 
Dependent with 2:2 tasks 30 (6.0%) 40 (6.9%) 35 (12.7%) 23(4.1%) 65 (9.3%) 
p-value 0.0003 <. 000/ 
Endurance (6 items) 
Independent 433 (87.0%) 515 (89.1%) 215 (78.2%) 507 (90.7%) 587 (84.1%) 
Dependent in I task 42 (8.4%) 41 (7 .1%) 35 (12.7%) 33 (5 .9%) 72 (10.3%) 
Dependent with 2:2 tasks 23 (4.6%) 22 (3 .8%) 25 (9.1%) 19 (3.4%) 39 (5.6%) 
p-value 0.0094 0.00/5 
Strength/Endurance (11 items) 
Independent 415 (83.3%) 491 (85.0%) 193 (70.2%) 497 (88.9%) 539 (77.2%) 
Dependent in 1 task 46 (9.2%) 38 (6.6%) 38 (13 .8%) 34 (6.1%) 79 (11.3%) 
Dependent with 2 tasks 15(3.0%) 21 (3.6%) 14(5.1%) 9 (1 .6%) 33 (4.7%) 
Dependent with 2:3 tasks 22 (4.4%) 28 (4.8%) 30 (10.9%) 19 (3.4%) 47 (6.7%) 
p-value 0.0001 <.000/ 
*Normal weight is defmed as a BMI of 18.5-<25; overweight is defined as a BMI of 25-<30; obesity is 
defmed as a BMI of 30 or more. 
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related tasks. Those who were sarcopenic were 1.83 times (95% CI: 1.22-1.83) and 1.35 
times (95% CI: 0.88-2.08) more likely to become dependent in one or more strength and 
endurance-related tasks, respectively, compared to those who were non-sarcopenic (Table 
4.9). The relative risk of functional decline in strength and endurance was also 
significantly increased for those who were overweight and those who were sarcopenic 
compared to normal/overweight and non-sarcopenic subjects, respectively (Table 4.1 0). 
Table 4.9 Effect of obesity on risk of becoming dependent in one or more tasks by 
exam 7 among those who were independent at exam 5 
Obesity 
BMI 18.5-<30 BMI 30+ 
Strength 
OR 1.00 2.23 1.00 
95% CI 1.48 - 3.37 
Endurance 
OR 1.00 1.88 1.00 
95% CI 1.21 - 2.94 
Strength or Endurance 
OR 1.00 2.23 1.00 
95% CI 1.49 - 3.33 
Sarcopenia 
Yes 
1.83 
1.22 - 2.77 
1.35 
0.88 - 2.08 
1.69 
1.14 - 2.50 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
Next, we examined the combined effects of sarcopenia and obesity on the risk of 
functional dependence in one or more tasks by exam 7 (Table' 4.11 ). Those who were 
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both sarcopenic and overweight were 2.57 times, 1.93 times, and 2.45 times more likely 
to become dependent in one or more strength, endurance, or strength and endurance 
scales compared with normal weight/non-sarcopenic individuals. Those who were only 
overweight, were 58% more likely to become dependent in endurance related tasks 
although this result was not significant most likely due to the small n (n=63) in this 
category. Individuals who were only sarcopenic had a 30% increased odds of becoming 
dependent in strength related tasks but this was not significant. 
Table 4.10 Effect of obesity on risk of functional decline between exams 5 and 7 
Strength 
OR 
95%CI 
Endurance 
OR 
95%CI 
Strength or Endurance 
OR 
95%CI 
Obesity Sarcopenia 
Yes BMI 18.5-<30 
1.00 
1.00 
1.00 
BMI 30+ No 
RR of Functional Decline 
(Change from Exam 5 to 7) 
2.28 1.00 
1.56 3.34 
2.24 1.00 
1.49 3.38 
2.35 1.00 
1.61 - 3.42 
1.80 
1.22 - 2.64 
1.34 
0.89 - 2.02 
1.66 
1.15 - 2.40 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
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Table 4.11 Combined effects of sarcopenia and obesity on risk of functional 
dependence in one or more tasks by exam 7 
Strength 
OR 
95%CI 
Endurance 
OR 
95%CI 
Strength or Endurance 
OR 
95%CI 
Normal Weight I No 
Sarcopenia 
n=463 
1.00 
1.00 
1.00 
Overweight I No Normal Weight I 
Sarcopenia Sarcopenia 
n=63 n=338 
RR of Dependence in ~1 Task 
(Change from Exam 5 to 7) 
1.04 1.30 
0.35 - 3.11 0.79-2.15 
1.58 1.04 
0.57 - 4.37 0.61 - 1.78 
1.17 1.17 
0.43-3.19 0.72 - 1.92 
Normal weight is defined as a BMI <28, overweight as a BMI 28+ 
Overweight I 
Sarcopenia 
n=295 
2.57 
1.60 - 4.14 
1.93 
1.16 - 3.203 
2.45 
1.55 - 3.9 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day and % 
energy from fat. 
In order to determine if obesity was in the causal pathway between dietary protein and 
risk of functional disability, we added obesity (BMI <30 kg/m2 vs. ~ 30 kg/m2) as a 
covariate into our final model. The effect of protein intake on the risk of becoming 
dependent in one or more strength and endurance-related tasks were slightly attenuated 
after adjusting for the presence of obesity (Table 4.12). Similarly, the risk of functional 
decline in strength and endurance between exams 5 and 7 associated with protein intake 
was also slightly attenuated after adjusting for the presence of obesity (Table 4.13) 
compared with earlier results shown in Table 4.7. 
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Table 4.12 Effect of protein intake on risk of becoming dependent in one or more 
tasks by exam 7 adjusting for obesity (BMI 2:: 30) 
Protein Intake 
(protein residuals) 
Strength 
OR 
95%CI 
Endurance 
OR 
95%CI 
Strength or Endurance 
OR 
95%CI 
Tertile 1 
1.00 
1.00 
1.00 
Tertile 2-3 
0.81 
0.55 - 1.19 
0.83 
0.55 - 1.26 
0.86 
0.59 - 1.26 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day, % energy 
from fat and BMI below 30 or 30 and above 
Table 4.13 Effect of protein intake on risk of functional decline between exams 5 
and 7 adjusting for obesity (BMI 2:: 30) 
Protein Intake 
(protein residuals) 
Strength 
OR 
95% CI 
Endurance 
OR 
95% CI 
Strength or Endurance 
OR 
95% CI 
Tertile 1 
1.00 
1.00 
1.00 
Tertile 2-3 
0.82 
0.57 - 1.18 
0.78 
0.53 - 1.16 
0.84 
0.59 - 1.19 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day,% energy 
from fat and BMI below 30 or 30 and above 
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Finally, to determine whether sarcopenia was in the causal pathway between dietary 
protein and risk of functional disability, we added the presence or absence of sarcopenia 
as a covariate to the final model. The effect of protein intake on the risk of becoming 
dependent in one or more strength and endurance related tasks were did not vary 
significantly (Table 4.14). Similarly, the risk of functional decline in strength and 
endurance between exams 5 and 7 associated with protein intake also remained the same 
after adjusting for the presence of sarcopenia (Table 4.15). 
Table 4.14 Effect of protein intake on risk of becoming dependent in one or more 
tasks by exam 7 adjusting for presence of sarcopenia 
Protein Intake 
protein residuals (g) 
Strength 
OR 
95%CI 
Endurance 
OR 
95% CI 
Strength or Endurance 
OR 
95% CI 
Tertile 1 
1.00 
1.00 
1.00 
Tertile 2-3 
0.72 
0.48 - 1.07 
0.79 
0.51 - 1.21 
0.76 
0.52 - 1.13 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day, and 
sarcopenia (present or absent). 
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Table 4.15 Effect of protein intake on risk of functional decline between exams 5 
and 7 adjusting for presence of sarcopenia 
Protein Intake 
protein residuals (g) 
Strength 
OR 
95% CI 
Endurance 
OR 
95% CI 
Strength or Endurance 
OR 
95% CI 
Tertile 1 
1.00 
1.00 
1.00 
Tertile 2-3 
0.74 
0.51 - 1.08 
0.73 
0.49 - 1.09 
0.76 
0.53 - 1.10 
*OR estimates adjusted for age, sex, height, education level, physical activity, cigarettes per day, and 
sarcopenia (present or absent) . 
4.5 DISCUSSION 
The effect of protein intake on functional status in middle-aged and older adults was 
examined in this longitudinal study with up to 16 years of follow-up. We found a 
decreased yet not statistically significant relative risk of becoming dependent in selected 
functional tasks with higher intakes of protein. Similarly, the relative risk of becoming 
dependent in strength and endurance tasks were 30% and 26% lower by exam 7 with high 
protein intake compared to low protein intake. 
We also found that subjects who were both overweight (BMI 2: 28 kg/m2) and sarcopenic 
had significantly increased risks of becoming dependent in strength as well as endurance 
125 
related tasks and were more likely to decline in function compared to those who were 
normal weight and those who were non-sarcopenic. Finally, individuals who were 
sarcopenic and overweight were 2.45 times more likely to become dependent in strength 
and endurance compared to normal weight non-sarcopenic individuals. 
Several diseases can impact the likelihood and severity of functional disability, a 
restriction in the ability to perform normal activities of daily living. Sarcopenia, the loss 
of skeletal muscle mass with aging, is associated with an increased risk of functional 
decline and disability as well as an increase in morbidity and mortality.22;23 . Similarly, 
our study found a 1.69 times increased odds of becoming dependent in strength or 
endurance related tasks compared to non-sarcopenic individuals. The odds of functional 
decline in strength or endurance was also 1.66 times more likely in sarcopenic older 
adults compared to non-sarcopenic older adults. Along with sarcopenia, obesity may also 
impact the risk of having a functional disability. Previous studies have suggested a 
relationship between overall obesity or BMI and risk of functional disabilities in elderly 
people. An increase in self-reported functional limitations has also been related to 
elevated current or past BMI of older persons. 143-145 Supportive findings have also 
related decreased physical performance test scores to elevated BMI. 146;147 Body 
composition analyses based on bioelectrical impedance148 and dual energy x-ray 
absorptiometry34 have suggested that fat mass is the body component most strongly 
associated with increased risk of disability. Our study also found significantly high odds 
of becoming dependent in strength and endurance related tasks as well as higher odds of 
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functional decline in obese individuals compared to normal weight and overweight 
individuals. High levels of fat in the body may be associated with chronic disease (such 
as type II diabetes mellitus), which in tum leads to functional limitations; although we 
excluded those individuals with a history of cancer, other chronic disease, such as type II 
diabetes, CVD, arthritis, stroke may impact the risk of functional decline and should be 
either controlled for or excluded from our analyses. Excess weight due to increased fat 
and muscle mass may increase the physical demands associated with movement and the 
strain placed on joints and muscles. Functional limitations may lead to accumulation of 
body fat due to restricted movement. Finally, high body fat may indicate a history of 
inactivity, which can lead to an increase in body fat and muscle atrophy and a decrease in 
functional ability. 
While the studies mentioned above have looked at the independent effects of obesity or 
sarcopenia on functional disability, it is possible that sarcopenia and obesity act 
synergistically to exacerbate disability. Our study suggests a significantly increased risk 
of becoming dependent in strength and endurance related tasks in individuals who were 
both sarcopenic and obese compared to sarcopenia alone, obesity alone, as well as normal 
individuals. Few studies have examined the combined effect of obesity and muscle mass 
or strength in older persons on physical functioning or disability. In a study by 
Baumgartner and colleagues, subjects classified as sarcopenic obese showed significantly 
lower grip strength per kilogram body weight, independently of age, ethnicity, smoking 
and other co-morbidities, and had a greater increase in the risk of functional impairment, 
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disability and falls compared to that observed separately both in obese and sarcopenic 
elderly men and women. 28In the cross-sectional Finnish Health 2000 Survey persons with 
combination of increased fat percentage and decreased muscle strength had higher 
prevalence of walking limitation compared to those with only high fat percentage or low 
muscle strength. 149 In the InCHIANTI study we showed recently that older persons with 
high BMI and low strength experience a steeper decline in walking speed and have higher 
probability of mobility disability than those with either poor muscle strength or obesity 
alone. 150 
Dietary protein has the potential to impact physical function and disability in middle-aged 
and older adults. Higher protein intake and the resulting increased availability of plasma 
amino acids stimulate protein synthesis. In tum, increased muscle protein synthesis leads 
to improved muscle mass, strength and function over time, which may be associated with 
lower levels of disability among older adults through effects on strength and muscle 
function. Our study demonstrated a decreased risk of functional decline, of becoming 
dependent in one or more tasks associated with strength and endurance, and a decreased 
risk of decline or dependence in activities of daily living with higher intakes of dietary 
protein compared to lower intakes in middle-aged and older adults. 80% of the 
stimulatory effect on protein synthesis observed after a meal can be attributed to amino 
acids. Amino acids also play a role in protein breakdown in addition to their role in 
protein synthesis. Several studies have demonstrated an acute increase in muscle protein 
synthesis with no compensatory change in muscle protein breakdown after protein 
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ingestion42;43 or ammo acid ingestion44;45 in both young and elderly individuals. 
Insufficient or ineffectual protein intake in elderly individuals may facilitate the loss of 
muscle by blunting muscle protein synthesis and thus promoting net muscle protein 
catabolism.46;47 Essential amino acids, particularly leucine, can directly stimulate muscle 
protein synthesis through increasing messenger ribonucleic acid translation and thus 
global protein synthesis 49 and also acts as an anabolic stimuli for muscle through the 
activation of mTOR. Given the effect of dietary protein on muscle protein synthesis and 
thereby, muscle strength and function, current protein recommendations should take into 
account the benefits of protein intake on functional disability in middle-aged and older 
adults. 
Our study demonstrates that the effects of dietary protein on functional decline and 
functional dependency in strength and endurance related tasks are independent of 
sarcopenia once adjusting for sarcopenia in the model. This suggests that the effect of 
dietary protein on functional status is not mediated by protein' s effect on sarcopenia. One 
possible explanation for these results is that the effects of dietary protein on function may 
potentially be mediated by its effect on total skeletal muscle mass since dietary protein 
increases the rate of muscle protein synthesis and thereby, muscle function. The 
definition of sarcopenia uses % skeletal muscle mass and perhaps including total skeletal 
muscle mass (kg) in the model would be a better choice. Additionally, we did not control 
for other co-morbidities such as arthritis, rheumatoid arthritis, CVD, type II diabetes, and 
stroke that may be affecting functional status in our study. On the other hand, adding 
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obesity as a covariate into our model attenuated the relationship between dietary protein 
and functional decline. Although these results were not significant, dietary protein's 
effect on functional ability is likely mediated through its effect on obesity by mechanisms 
mentioned above. 
This study has several limitations that should be acknowledged. The individuals in our 
sample were primarily Caucasian and therefore, our results cannot be generalized to other 
racial or ethnic groups. The study included only participants that attended the on-site 
clinical examinations and therefore, excluded homebound or nursing home participants 
who may have a higher risk of disability than our sample. Also, performance based 
measures were not assessed for this analysis, which would provide an objective measures 
of the ability to perform functional tasks. As mentioned previously, co-morbid diseases 
such as arthritis, rheumatoid arthritis, CVD, type II diabetes, and stroke that may be 
affecting physical impairments were not excluded or treated as covariates in our analyses 
apart from history of cancer. In the future, we will explore controlling for these and other 
co-morbidities in our models to determine the effect of sarcopenia on functional status as 
independent of other co-morbidities that may affect physical function. Sarcopenia was 
defined using the skeletal muscle mass equation of Janssen et alas mentioned previously. 
Although this equation has been validated, a direct objective measure of lean mass such 
as by using DXA would have provided a more precise assessment of body composition 
measures. Additionally, as on in our previous study we did not examine the effect of 
protein on functional status in different age groups amongst older adults. Even among 
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older adults, there remains significant variation in terms of functional ability. Individuals 
between the ages of 60-70 may still have higher skeletal muscle mass and therefore, 
lower functional disability compared to much older individuals between the ages of 80-
90. Therefore, it would be an important next step to determine the effects of protein on 
functional ability in various age subgroups among the older population. 
There are also several key strengths of our study. The Framingham Offspring Study 
includes a prospective community-based design with up to 16 years of follow-up. We 
included both men and women in our analysis. Potential confounding variables were 
routinely ascertained at most examination visits and body composition was directly 
measured at those visits. Diet was estimated from multiple sets of three-day dietary 
records from two exams. In addition, the complete ascertainment of food group intakes 
that were derived by the authors by linking Nutrition Data System data with USDA Food 
Pyramid data is an added strength. 
In conclusion, increasing protein consumption and dietary derived amino acids represents 
an alternative to preserve muscle function as evidenced by the decreased risk of 
functional decline with increasing protein intakes in our study. Maintaining an adequate 
diet, in terms of protein intake, contributes to preserving muscle quality and function and 
therefore, current recommendations for protein should more closely examine the benefits 
of higher protein intakes in middle-aged and older adults. 
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Katz Activities of Daily Living Scale 
F091 DURING THE COURSE OF A NORMAL DAY, 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
DRESSING (UNDRESSING AND REDRESSING) 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (25) 
F092 DURING THE COURSE OF A NORMAL DAY, 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
BATHING (INCLUDING GETTING IN AND OUT OF TUB OR 
SHOWER) 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (26) 
F093 DURING THE COURSE OF A NORMAL DAY, 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
EATING 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (26) 
F094 DURING THE COURSE OF A NORMAL DAY, 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
TRANSFERRING (GETTING IN AND OUT OF CHAIR) 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (25) 
F095 DURING THE COURSE OF A NORMAL DAY, 
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HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
TOILETING ACTIVITIES (USING BATHROOM FACILITIES AND 
HANDLE CLOTHING) 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (25) 
F096 DURING THE COURSE OF A NORMAL DAY, 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
BLADDER CONTINENCE (ASK IF PERSON HAS "ACCIDENTS") 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
5 USE SPECIAL PRODUCTS 
. UNKNOWN ( 40) 
F097 DURING THE COURSE OF A NORMAL DAY, 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
BOWEL CONTINENCE (ASK IF PERSON HAS "ACCIDENTS") 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
5 USE SPECIAL PRODUCTS 
. UNKNOWN (30) 
F098 DURING THE COURSE OF A NORMAL DAY, 
THURBER ST) 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
WALKING ON LEVEL SURFACE 50 YARDS (LENGTH OF 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (25) 
. F099 DURING THE COURSE OF A NORMAL DAY, 
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HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
WALKING UP AND DOWN ONE FLIGHT OF STAIRS 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (26) 
F100 DURING THE COURSE OF A NORMAL DAY, 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
USING A TELEPHONE 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
. UNKNOWN (25) 
F101 DURING THE COURSE OF A NORMAL DAY, 
Nagi Scale 
HOW DO YOU CARRY OUT THE FOLLOWING ACTIVITIES: 
TAKES OWN MEDICATIONS 
0 NO HELP NEEDED, INDEPENDENT 
1 USES DEVICE, INDEPENDENT 
2 HUMAN ASSISTANCE NEEDED, MINIMALLY DEPENDENT 
3 DEPENDENT 
4 DO NOT DO DURING A NORMAL DAY 
8 TAKES NO MEDICATIONS REGULARLY 
. UNKNOWN (37) 
F125 NURSE EXAMINER'S ID NUMBER 
22- 601 
. UNKNOWN (17) 
NAGI QUESTIONS (F126- F136) 
F126 NAGI:PULLING OR PUSHING LARGE OBJECTS LIKE A LIVING 
ROOM CHAIR 
0 NO DIFFICULTY 
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F127 
F128 
LEVEL 
F129 
LEVEL 
·1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN ( 40) 
NAGI:EITHER STOOPING, CROUCHING, OR KNEELING 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (28) 
NAGI:REACHING OR EXTENDING ARMS BELOW SHOULDER 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (24) 
NAGI:REACHING OR EXTENDING ARMS ABOVE SHOULDER 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (25) 
F130 NAGI:EITHER WRITING, OR HANDLING, OR FINGERING 
SMALL OBJECTS 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
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5 DON'T DO ON MD ORDERS 
. UNKNOWN (23) 
F131 NAGI:STANDING IN ONE PLACE FOR LONG PERIODS, SAY 
15 MINUTES 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (37) 
F132 NAGI:SITTING FOR LONG PERIODS, SAY 1 HOUR 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (25) 
F133 NAGI:LIFTING OR CARRYING WEIGHTS UNDER 10 POUNDS 
(LIKE A BAG OF POT A TOES) 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (32) 
F134 NAGI:LIFTING OR CARRYING WEIGHTS OVER 10 POUNDS 
(LIKE A VERY HEAVY BAG OF GROCERIES) 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (38) 
F135 NAGI:GETTING IN AND OUT OF CAR 
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0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (29) 
F136 NAGI:PUTTING ON SOCKS OR STOCKINGS 
0 NO DIFFICULTY 
1 A LITTLE DIFFICULTY 
2 SOME DIFFICULTY 
3 A LOT OF DIFFICULTY 
4 UNABLE TO DO 
5 DON'T DO ON MD ORDERS 
. UNKNOWN (26) 
Rosow-Breslau Scale 
ROSOW-BRESLAU QUESTIONS (F119- F124) 
F119 
SHOVEL 
F120 
SECOND 
ARE YOU ABLE TO DO HEAVY WORK AROUND HOUSE (LIKE 
WASH WINDOWS, WALLS OR FLOORS) WITHOUT HELP 
ONO 
1 YES 
. UNKNOWN (35) 
ARE YOU ABLE TO WALK UP AND DOWN STAIRS TO THE 
FLOOR WITHOUT ANY HELP 
ONO 
1 YES 
. UNKNOWN (35) 
F121 ARE YOU ABLE TO WALK HALF A MILE WITHOUT HELP 
(ABOUT 4-6 BLOCKS) 
ONO 
1 YES 
. UNKNOWN ( 48) 
F122 HAVE YOU DRIVEN A CAR IN THE PAST 
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ONO 
1 YES 
. UNKNOWN (26) 
F123 DO YOU DRIVE NOW 
ONO 
1 YES 
. UNKNOWN (30) 
F124 IF NO TO F123 , REASON FOR NOT DRIVING NOW 
1 HEALTH 
2 OTHER NON-HEALTH REASON 
3 NEVER DROVE A CAR 
8 CURRENT DRIVER 
. UNKNOWN (35) 
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CHAPTER 5: GENERAL DISCUSSION 
The current work shows that in prospective analyses, high protein diets during childhood 
were associated with decreased obesity risk in late adolescence along with a lower 
percent body fat, lower waist circumference, and higher skeletal muscle mass. Higher 
protein diets were also associated with a decreased risk of obesity and sarcopenia in 
middle-aged and older adults. Older adults who consumed more dietary protein also had a 
lower risk of becoming functionally dependent and experiencing declines in strength and 
endurance over eight years of follow up. Finally, this study found that individuals who 
were sarcopenic and had a BM1>28 were more likely to become dependent in functional 
tasks requiring strength and endurance compared with normal weight non-sarcopenic 
individuals. Given these observed benefits of increased dietary protein, the current 
recommended dietary allowance should take into account effects of protein on additional 
outcomes such as obesity and sarcopenia and not just growth. 
Protein recommendations are usually expressed as grams of protein per kilogram of 
actual body weight; however, because protein requirements are likely to be proportional 
to an individual' s absolute lean mass, which is generally increased in obese individuals, 
the higher proportion of fat to lean mass per kilogram of actual body weight renders 
estimates of lean body mass parameters in obese individuals artificially low. In the 
current work we used two approaches to avoid this problem: (a) estimating protein intake 
per kg of estimated nearest ideal (rather than actual) body weight and (b) calculating 
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protein residuals adjusting for body weight. While the residual method provides a 
measurement of protein that is uncorrelated with body weight, expressing protein per 
kilogram of ideal body weight is a simpler clinical construct for determining protein 
requirements. For non-overweight individuals, protein per kg IBW is the same as protein 
per kg of actual body weight. For overweight individuals, intake is expressed per kg of 
the closest weight that would correspond to being non-overweight for a given height. 
This is done by simply calculating the individual's protein intake per kg from the nearest 
BMI corresponding to normal-weight (i.e. BMI= 24.9 kg/m2). 
In our models, protein per kg IBW was a stronger predictor of body composition than 
was protein expressed as weight-adjusted residuals. However, by expressing protein per 
kg IBW, it is assumed that there is less lean mass than is actually the case since obese 
individuals have higher lean mass as well as fat mass. This could lead to a stronger 
apparent protective effect than actually exists. To address this issue in part, models using 
protein intake per kg IBW are adjusted for true baseline weight. These models (adjusting 
protein per kg IBW for baseline weight) yielded results that were very similar to those 
relying on protein residuals. An alternative approach that may be better still would be to 
determine protein requirements per kg of lean body mass. This would account for the 
increase in lean mass in obese people and express protein based on the effect of protein 
on body composition as opposed to just on body fat. Unfortunately these studies did not 
have direct measures of lean mass but future studies should look at these measures. 
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These prospective longitudinal studies add to the body of evidence that older adults may 
need higher intakes of dietary protein to decrease the risk of subsequent diseases and 
disability. The Dietary Reference Intakes for protein do not evaluate the effects of protein 
and amino acids on the risk of disease; rather, they are based on the amount of protein 
needed to attain nitrogen balance in adults. 
The Food and Nutrition Board has acknowledged the limitation of relying entirely on 
results from nitrogen balance studies to determine the RDA. Furthermore, the existing 
data were gathered almost entirely in college-aged men and a greater nitrogen intake is 
likely required to maintain nitrogen balance in elderly persons. The Food and Nutrition 
Board makes the same protein recommendations (0.8 g/kg/d) for 19-50 year old men and 
women and those above the age of 50 years because they found no significant effect of 
age on protein requirements in older adults. However, our study specifically studied the 
effects of protein on individuals older than 50 years of age. We found significant 
decreases in the risk of obesity, central adiposity, and sarcopenia with increasing intakes 
of dietary protein in older adults. Moreover, the risk of functional decline in those above 
the age of 50 years was also significantly lower in those consuming a high protein diet. 
Given the risk and consequences of both obesity and sarcopenia in older adults, it is 
essential that we determine the appropriate protein recommendations for this high-risk 
population. 
141 
In the future, we will also examine the effect of protein on body composition and 
functional status in different age groups amongst older adults. Even among older adults, 
there remains significant variation in terms of body fat, skeletal muscle mass, and 
functional ability. Individuals between the ages of 50-60 years may still have higher 
skeletal muscle mass and therefore, lower functional disability compared with much older 
individuals between the ages of 70-80 years. Therefore, it would be an important next 
step to determine the effects of protein in various age groups amongst the older 
population. 
Obesity during childhood tracks into adulthood and the peak skeletal muscle mass 
attained early in life may affect the muscle mass and strength in late adulthood, protein 
recommendations for children and adolescents should also be re-evaluated with these 
outcomes in mind. Specifically, the RDA for children between the ages of 14-18 years is 
based on adult estimates of nitrogen balance requirements as there are no available data 
on maintenance protein requirements in adolescents of this age. In this study, consuming 
a higher protein diet between the ages of 9-17 years was associated with beneficial effects 
on body fat, waist circumference, and skeletal muscle mass. Therefore, body fat and 
skeletal muscle mass should be considered as important end-points for developing age-
specific recommendations for protein for children and adolescents. Additional studies are 
need to determine the effects of dietary protein on body composition at various ages 
during childhood and adolescence. The current RDA for protein differs for children and 
adolescents 13 years of age or less compared with those 14-18 years of age. However, 
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there are essentially no data showing that the protein requirements from ages 1-13 years 
are the same (in terms of growth, obesity risk, and skeletal muscle mass). Therefore, 
more age-specific recommendations for protein in children and adolescents are needed. 
We used SMM as a percent of total body mass as an outcome in these studies and found a 
protective effect of dietary protein on skeletal muscle mass in late adolescence as well as 
a decreased risk of sarcopenia (suboptimal lean mass) in older adults. However, 
expressing SMM as a percent rather than as absolute SMM most likely overestimates the 
number of individuals classified as sarcopenic particularly amongst our obese subjects. 
The current definition for defining suboptimal skeletal muscle mass (i.e. sarcopenia) uses 
the SMI to classify those who are sarcopenic. 109 However, expressing suboptimal SMM 
as a percent of total body mass presents a problem with respect to those individuals who 
are overweight or obese. As discussed, overweight/obese individuals have increased lean 
mass. Therefore, not only is the total kilograms of fat mass higher but also, total 
kilograms of lean mass and thereby, skeletal muscle mass is also higher in obese 
individuals compared to normal weight individuals. By converting SMM into a percent, 
however, SMM will appear to be lower than it actually is in the overweight and obese. 
The reason for this is because the higher proportion of fat to lean mass per kilogram of 
actual body weight renders estimates of skeletal muscle mass lower than absolute skeletal 
muscle mass. Therefore, the current definition of sarcopenia may overestimate the 
number of individuals that are considered both obese and sarcopenic using %SMM. It is 
likely that more individuals were classified as overweight and sarcopenic using %SMM 
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than would be if we were to use absolute SMM. Since many of these subjects may have 
higher SMM than we estimated using the current definition of sarcopenia, we may have 
seen an overestimated effect of protein on risk of sarcopenia. Using total kilograms of 
skeletal muscle mass would give us a more precise and less biased estimate of the 
presence of sarcopenia particularly in the obese. Therefore, in future analyses we plan to 
determine the risk of sarcopenia using absolute SMM and then to determine the effects of 
protein on total skeletal muscle mass. We also plan to use more direct and valid estimates 
of skeletal muscle mass using Dual energy X-ray absorptiometry as opposed to a 
predictive model of SMM as used in the current analyses. 
This work also found a decreased risk of functional decline and functional dependency 
with higher intakes of dietary protein. Age-related sarcopenia is associated with not only 
the loss of muscle mass and strength but also an increased risk of adverse outcomes such 
as physical disability and a poor quality of life. Our study adds to the body of evidence 
linking dietary protein with functional status in older adults. The increased risk of 
disability with age and the associations of disability with increased risk of falls, fractures, 
and even mortality, suggests that functional disability should also be considered as an 
important outcome when making protein recommendations for older adults. While most 
definitions of sarcopenia focus on suboptimal SMM alone, the association of sarcopenia 
with increased risk of falls and fractures, impaired ability to perform activities of daily 
living, and other disabilities suggests that both low muscle mass and impaired muscle 
strength/performance may provide better diagnostic criteria for the presence of 
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sarcopenia. Future studies should incorporate measures of muscle strength such as 
handgrip strength and knee extension when examining the risk of sarcopenia as a 
function of dietary protein intake. While our study suggests a role of dietary protein in 
protecting against functional loss, there are a host of co-morbidities associated with aging 
and obesity than can also simultaneously be affecting functional status. For example 
rheumatoid arthritis, stroke and CVD are diseases that have an independent effect on 
functional and physical ability. Because we did not control for other co-morbidities that 
may be impact function and affect the amount of protein consumed, the protective effect 
of protein on functional status may be caused by not only obesity or low SMM but also 
any of these co-morbidities. In future analyses, we will control for co-morbidities to 
determine the independent effect of obesity and sarcopenia on functional status. 
Dietary protein has a direct effect on body composition in adolescents and older adults as 
shown by this current work. This effect has been largely overlooked with the current 
recommendations for protein intake. Particularly amongst two vulnerable populations, 
adolescence and older adulthood, the impact of protein is not only implicated in 
increasing lean mass but also decreasing percent body fat. Because adolescence is period 
of critical growth with changes in both lean mass and fat mass, dietary guidelines for this 
particular population should be given special consideration. The current RDA for protein 
for adolescents 14-18 years old are extrapolated from other populations; however, given 
the distinct needs and vital changes in growth among this population, this longitudinal 
analysis provides evidence that protein above the current recommendations can provide 
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additional benefits. Similarly, in older adults, the changes in body composition that occur 
during this time are unique to this population; therefore, more longitudinal studies such as 
ours should be conducted to specifically determine protein requirements and their effects 
on body composition measures in older adults. Body composition is also a key 
determinant of other diseases such as hypertension, type II diabetes, dyslipidemia, and 
cardiovascular disease. By impacting body composition, dietary protein may also play a 
role in the diseases mentioned above by affecting body fat and lean mass. Therefore, in 
addition to body composition, dietary protein's affect on obesity-related diseases should 
also be evaluated particularly in the adolescent and older adult population. These 
outcomes should then be considered in making additional requirements for protein 
beyond the current recommendations based on nitrogen balance. 
In conclusion, we observed a protective effect of dietary protein on body fat and SMM in 
younger and older populations. Moreover, dietary protein may serve as an important 
mediator of functional disability in the setting of obesity and sarcopenia. Given the 
increasing prevalence of obesity, sarcopenia, and functional decline with aging, dietary 
protein requirements in older adults may be higher than currently recommended. 
Similarly, the unique body composition changes that occur during adolescence may also 
require additional protein intake. More studies are needed to address age-specific protein 
recommendations particularly for children, adolescents, middle-aged, older, and elderly 
individuals. Such studies should directly evaluate the potential for dietary protein above 
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the current DRI to stimulate muscle protein synthesis in both the adolescent and older 
adult populations. 
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